US20190154683A1 - Hierarchical films having ultra low fouling and high recognition element loading properties - Google Patents
Hierarchical films having ultra low fouling and high recognition element loading properties Download PDFInfo
- Publication number
- US20190154683A1 US20190154683A1 US16/042,883 US201816042883A US2019154683A1 US 20190154683 A1 US20190154683 A1 US 20190154683A1 US 201816042883 A US201816042883 A US 201816042883A US 2019154683 A1 US2019154683 A1 US 2019154683A1
- Authority
- US
- United States
- Prior art keywords
- layer
- polymers
- polymer
- films
- density
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000011068 loading method Methods 0.000 title abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 64
- 229920000642 polymer Polymers 0.000 claims description 358
- 230000027455 binding Effects 0.000 claims description 86
- 239000000758 substrate Substances 0.000 claims description 59
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 44
- 229920001577 copolymer Polymers 0.000 claims description 41
- 229910052757 nitrogen Inorganic materials 0.000 claims description 25
- 102000008946 Fibrinogen Human genes 0.000 claims description 16
- 108010049003 Fibrinogen Proteins 0.000 claims description 16
- 229940012952 fibrinogen Drugs 0.000 claims description 16
- 125000005647 linker group Chemical group 0.000 claims description 16
- 102000016943 Muramidase Human genes 0.000 claims description 15
- 108010014251 Muramidase Proteins 0.000 claims description 15
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 15
- 239000004325 lysozyme Substances 0.000 claims description 15
- 229960000274 lysozyme Drugs 0.000 claims description 15
- 235000010335 lysozyme Nutrition 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- 239000011521 glass Substances 0.000 claims description 13
- 239000012491 analyte Substances 0.000 claims description 12
- 125000003118 aryl group Chemical group 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 10
- 210000004027 cell Anatomy 0.000 claims description 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 6
- 230000009870 specific binding Effects 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 claims description 5
- 125000000129 anionic group Chemical group 0.000 claims description 4
- 239000003575 carbonaceous material Substances 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000010703 silicon Substances 0.000 claims description 4
- 108010043958 Peptoids Proteins 0.000 claims description 3
- 229920006322 acrylamide copolymer Polymers 0.000 claims description 3
- 125000002091 cationic group Chemical group 0.000 claims description 3
- 239000000919 ceramic Substances 0.000 claims description 3
- 239000011152 fibreglass Substances 0.000 claims description 3
- 229920002521 macromolecule Polymers 0.000 claims description 3
- 229910044991 metal oxide Inorganic materials 0.000 claims description 3
- 150000004706 metal oxides Chemical class 0.000 claims description 3
- 229920002401 polyacrylamide Polymers 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 2
- 230000008685 targeting Effects 0.000 claims description 2
- 230000009871 nonspecific binding Effects 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 230000010354 integration Effects 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 329
- 239000010408 film Substances 0.000 description 288
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 138
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 103
- 229910001868 water Inorganic materials 0.000 description 101
- AUZONCFQVSMFAP-UHFFFAOYSA-N disulfiram Chemical compound CCN(CC)C(=S)SSC(=S)N(CC)CC AUZONCFQVSMFAP-UHFFFAOYSA-N 0.000 description 74
- 108090000623 proteins and genes Proteins 0.000 description 74
- 102000004169 proteins and genes Human genes 0.000 description 73
- 238000006116 polymerization reaction Methods 0.000 description 61
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 60
- 239000000427 antigen Substances 0.000 description 46
- 102000036639 antigens Human genes 0.000 description 46
- 108091007433 antigens Proteins 0.000 description 46
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 43
- 239000002953 phosphate buffered saline Substances 0.000 description 43
- 102000011923 Thyrotropin Human genes 0.000 description 42
- 108010061174 Thyrotropin Proteins 0.000 description 42
- 229920006254 polymer film Polymers 0.000 description 41
- 238000001179 sorption measurement Methods 0.000 description 40
- 210000002966 serum Anatomy 0.000 description 35
- 238000006243 chemical reaction Methods 0.000 description 34
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 30
- 238000010560 atom transfer radical polymerization reaction Methods 0.000 description 30
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 27
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 26
- 239000000872 buffer Substances 0.000 description 25
- 239000000463 material Substances 0.000 description 25
- 238000012856 packing Methods 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 239000000178 monomer Substances 0.000 description 22
- 239000000243 solution Substances 0.000 description 22
- 239000002904 solvent Substances 0.000 description 22
- 230000008961 swelling Effects 0.000 description 22
- 238000001514 detection method Methods 0.000 description 21
- 230000004044 response Effects 0.000 description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 210000002381 plasma Anatomy 0.000 description 20
- 238000010168 coupling process Methods 0.000 description 19
- 230000012010 growth Effects 0.000 description 19
- 125000002843 carboxylic acid group Chemical group 0.000 description 18
- 150000003254 radicals Chemical class 0.000 description 18
- 239000002356 single layer Substances 0.000 description 18
- 150000001540 azides Chemical class 0.000 description 17
- 238000007306 functionalization reaction Methods 0.000 description 17
- -1 poly(ethylene glycol) Polymers 0.000 description 17
- 150000002500 ions Chemical class 0.000 description 16
- 230000008878 coupling Effects 0.000 description 15
- 238000005859 coupling reaction Methods 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 14
- 238000005259 measurement Methods 0.000 description 14
- 230000001404 mediated effect Effects 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 239000007974 sodium acetate buffer Substances 0.000 description 14
- 241000894007 species Species 0.000 description 13
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 13
- 238000013459 approach Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 239000003999 initiator Substances 0.000 description 12
- 230000005855 radiation Effects 0.000 description 11
- 239000013545 self-assembled monolayer Substances 0.000 description 11
- 230000035945 sensitivity Effects 0.000 description 11
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 10
- 125000003277 amino group Chemical group 0.000 description 10
- 230000007423 decrease Effects 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 9
- 230000000875 corresponding effect Effects 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 239000010931 gold Substances 0.000 description 9
- 229910052737 gold Inorganic materials 0.000 description 9
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 8
- 238000012512 characterization method Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 125000000524 functional group Chemical group 0.000 description 8
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 7
- 239000003446 ligand Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000010526 radical polymerization reaction Methods 0.000 description 7
- 230000035484 reaction time Effects 0.000 description 7
- 238000005215 recombination Methods 0.000 description 7
- 230000006798 recombination Effects 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 6
- 239000007995 HEPES buffer Substances 0.000 description 6
- 230000004913 activation Effects 0.000 description 6
- 238000004630 atomic force microscopy Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000021164 cell adhesion Effects 0.000 description 6
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 6
- 238000000572 ellipsometry Methods 0.000 description 6
- 238000011065 in-situ storage Methods 0.000 description 6
- 102000005962 receptors Human genes 0.000 description 6
- 108020003175 receptors Proteins 0.000 description 6
- 238000000682 scanning probe acoustic microscopy Methods 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 230000002427 irreversible effect Effects 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- OXBLVCZKDOZZOJ-UHFFFAOYSA-N 2,3-Dihydrothiophene Chemical compound C1CC=CS1 OXBLVCZKDOZZOJ-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 125000001246 bromo group Chemical class Br* 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- 230000021615 conjugation Effects 0.000 description 4
- 230000009849 deactivation Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000000017 hydrogel Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000012643 polycondensation polymerization Methods 0.000 description 4
- 230000001902 propagating effect Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 239000010409 thin film Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- JVQTWZGZUCJHRV-UHFFFAOYSA-N 11-sulfanylundecyl 2-bromo-2-methylpropanoate Chemical compound CC(C)(Br)C(=O)OCCCCCCCCCCCS JVQTWZGZUCJHRV-UHFFFAOYSA-N 0.000 description 3
- 229910021590 Copper(II) bromide Inorganic materials 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000007942 carboxylates Chemical class 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000010894 electron beam technology Methods 0.000 description 3
- 150000002118 epoxides Chemical class 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 102000006240 membrane receptors Human genes 0.000 description 3
- 108020004084 membrane receptors Proteins 0.000 description 3
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 3
- 239000013580 millipore water Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000002094 self assembled monolayer Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000002407 tissue scaffold Substances 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000003926 acrylamides Chemical class 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Chemical group 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000008204 material by function Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000010297 mechanical methods and process Methods 0.000 description 2
- SNVLJLYUUXKWOJ-UHFFFAOYSA-N methylidenecarbene Chemical compound C=[C] SNVLJLYUUXKWOJ-UHFFFAOYSA-N 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000002482 oligosaccharides Polymers 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 150000004804 polysaccharides Polymers 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000009145 protein modification Effects 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000012421 spiking Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- KFYRJJBUHYILSO-YFKPBYRVSA-N (2s)-2-amino-3-dimethylarsanylsulfanyl-3-methylbutanoic acid Chemical compound C[As](C)SC(C)(C)[C@@H](N)C(O)=O KFYRJJBUHYILSO-YFKPBYRVSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- ZXMGHDIOOHOAAE-UHFFFAOYSA-N 1,1,1-trifluoro-n-(trifluoromethylsulfonyl)methanesulfonamide Chemical compound FC(F)(F)S(=O)(=O)NS(=O)(=O)C(F)(F)F ZXMGHDIOOHOAAE-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- VHBSECWYEFJRNV-UHFFFAOYSA-N 2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1O.OC(=O)C1=CC=CC=C1O VHBSECWYEFJRNV-UHFFFAOYSA-N 0.000 description 1
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 1
- CSWRCKVZMMKVDC-UHFFFAOYSA-N 3-[dimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azaniumyl]propanoate Chemical compound CC(=C)C(=O)OCC[N+](C)(C)CCC([O-])=O CSWRCKVZMMKVDC-UHFFFAOYSA-N 0.000 description 1
- QAQMTHGHDYCNSJ-UHFFFAOYSA-N 3-[dimethyl-[3-(prop-2-enoylamino)propyl]azaniumyl]propanoate Chemical compound C[N+](C)(CCCNC(=O)C=C)CCC([O-])=O QAQMTHGHDYCNSJ-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- 108010024212 E-Selectin Proteins 0.000 description 1
- 102100023471 E-selectin Human genes 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- XOJVVFBFDXDTEG-UHFFFAOYSA-N Norphytane Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 1
- 108010035766 P-Selectin Proteins 0.000 description 1
- 102100023472 P-selectin Human genes 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-O Pyrrolidinium ion Chemical compound C1CC[NH2+]C1 RWRDLPDLKQPQOW-UHFFFAOYSA-O 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 150000001224 Uranium Chemical class 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000007825 activation reagent Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical class C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000010505 homolytic fission reaction Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- GLUUGHFHXGJENI-UHFFFAOYSA-O hydron piperazine Chemical compound [H+].C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-O 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-O hydron;pyrimidine Chemical compound C1=CN=C[NH+]=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-O 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002463 imidates Chemical class 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000013033 iniferter Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-O morpholinium Chemical compound [H+].C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-O 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- KUHRIIPUCPOQMQ-UHFFFAOYSA-N n,n-diethyl-3-(ethyliminomethylideneamino)propan-1-amine Chemical compound CCN=C=NCCCN(CC)CC KUHRIIPUCPOQMQ-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960000380 propiolactone Drugs 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- ZUHZGEOKBKGPSW-UHFFFAOYSA-N tetraglyme Chemical compound COCCOCCOCCOCCOC ZUHZGEOKBKGPSW-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000004222 uncontrolled growth Effects 0.000 description 1
- 125000005500 uronium group Chemical group 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/55—Specular reflectivity
- G01N21/552—Attenuated total reflection
- G01N21/553—Attenuated total reflection and using surface plasmons
Definitions
- the invention provides hierarchical films.
- the film comprises a first layer having a first layer density, wherein the first layer is attached to a substrate; and a second layer having a second layer density, wherein the second layer is attached to the first layer, wherein the first layer density is greater than the second layer density.
- the film comprises a first nonfouling layer (low level of fibrinogen or lysozyme non-specific binding), wherein the first layer is attached to a substrate; and a second layer that can be functionalized to include recognition elements, wherein the second layer is attached to the first layer.
- the second layer of the films of the invention further comprises a plurality of recognition elements.
- Representative recognition elements include peptides, proteins, nucleic acids, and small molecules.
- the recognition element is an antibody or antibody fragment, or a DNA or an RNA.
- the first layer comprises a plurality of polymers.
- the first layer is a polymer brush.
- the first layer is a nonfouling layer.
- the first layer has a fibrinogen binding level less than about 30 ng/cm 2 .
- the first layer has a lysozyme binding level less than about 30 ng/cm 2 .
- the first layer comprises a first polymer layer having a first polymer density, and the first polymer layer comprises a plurality of first polymers, each of the first polymers having a first end and a second end, wherein each first polymer is attached to a substrate through its first end.
- the first polymers are grafted from the substrate. In other embodiments, the first polymers are grafted to the substrate.
- the second layer comprises a plurality of polymers.
- the second layer is a crosslinked layer (e.g., a hydrogel).
- the second layer comprises a second polymer layer having a second polymer density, wherein the second polymer layer comprises a plurality of second polymers, each of the second polymers having a first end and a second end, wherein each second polymer is attached to a first polymer through its first end.
- the second polymers are grafted from the first polymers. In other embodiments, the second polymers are grafted to the first polymers.
- the first or second polymers are independently selected from charged polymers and copolymers and non-charged polymers and copolymers.
- Representative charged polymers and copolymers include zwitterionic polymers and copolymers and mixed charge copolymers.
- Representative zwitterionic polymers include polysulfobetaines, polycarboxybetaines, polyphosphobetaines, peptides, and peptoids.
- Non-charged polymers include alkylene oxide polymers and copolymers (e.g., PEGs), polysaccharide polymers and copolymers (e.g., dextrans), acrylamide polymers and copolymers (e.g., acrylamide and methacrylamide polymers and copolymers), and hydroxy-terminal polymers and copolymers (e.g., HEMA and HPMA).
- alkylene oxide polymers and copolymers e.g., PEGs
- polysaccharide polymers and copolymers e.g., dextrans
- acrylamide polymers and copolymers e.g., acrylamide and methacrylamide polymers and copolymers
- hydroxy-terminal polymers and copolymers e.g., HEMA and HPMA
- the films of the invention include one or more additional layers attached to the second layer.
- the first layer is attached to a substrate surface.
- Suitable surfaces include metal and metal oxide surfaces, ceramic surfaces, synthetic and natural polymeric surfaces, glass surfaces, fiber glass surfaces, silicon/silica surfaces, carbon-based material surfaces, cell surfaces, and macromolecule surfaces (e.g., protein, DNAs, lipids).
- Representative substrates include diagnostic devices, medical devices, separation devices, targeting delivery carriers, tissue scaffolds, and marine devices.
- the method includes forming a first layer having a first layer density on a substrate; and forming a second layer on the first layer, the second layer having a second density, wherein the first layer density is greater than the second layer density.
- the method further comprises attaching a plurality of recognition elements to the second layer.
- the method further comprises attaching one or more additional layers to the second layer.
- forming the first layer comprises grafting first polymers from the substrate. In other embodiments, forming the first layer comprises grafting first polymers to the substrate.
- forming the second layer comprises grafting the second polymers from the first polymers. In other embodiments, forming the second layer comprises grafting the second polymers to the first polymers.
- the invention provides methods for determining the presence of an analyte in a sample.
- the method comprises contacting a sample with a film of the invention comprising one or more recognition elements, wherein the recognition element has a specific binding affinity for the analyte, and interrogating the film to determine whether the analyte has bound to the film.
- FIG. 1 is a schematic illustration of a representative polymer film of the invention having an ultra low fouling first layer and high-loading second layer.
- FIGS. 2A-2C compare IgG functionalization levels ( 2 A), fouling levels in the presence of undiluted serum or plasma, before and after IgG functionalization ( 2 B), and antigen detection ( 2 C) on films with one-layer (One) and hierarchical (HA) structures prepared via SI-ATRP and SI-PIMP.
- FIG. 3 is an SPR sensorgram for a fouling test in the presence of undiluted blood plasma or serum on a representative hierarchical pCB film of the invention.
- FIG. 4 is an SPR sensorgram for a fouling test on a representative hierarchical pCB film of the invention following modification with TSH IgG, deactivation with SC buffer, and then used for TSH antigen detection.
- FIGS. 5A and 5B are schematic illustrations of conventional platforms.
- FIG. 5A illustrates a single layer 2D pCB platform having excellent nonfouling properties, but low antibody loading (left panel) and a commercial dextran platform having high antibody loading, but poor nonfouling properties (right panel).
- FIG. 5B is a schematic illustration of a representative two-layer film of the invention having a first dense pCB layer to resist nonspecific adsorption and a second loose (less dense) pCB layer to achieve high antibody loading.
- FIG. 6 is a schematic illustration of a photoiniferter-mediated polymerization of surface-tethered pCB brushes in the presence of TED deactivator.
- FIG. 7A compares SPR sensorgrams for fouling tests on pCB films prepared from 100% MeOH without TED addition in contact with undiluted plasma ( ⁇ ), fibrinogen ( ⁇ ), lysozyme ( ⁇ ).
- FIG. 7B compares film thickness and IgG binding capacity of pCB films as a function of the TED concentration.
- the dry film thicknesses were measured using ellipsometer.
- IgG molecules were chemically conjugated on binding platforms with one- and two-layer pCB structures and their binding capacities were estimated using SPR.
- FIG. 8A compares IgG binding capacity and dry thickness of the second layer as a function of the water content in the polymerization for the second layer.
- FIG. 8B compares IgG binding capacity versus EDC/NHS activation time.
- FIG. 9A compares SPR sensorgrams for fouling tests with undiluted blood plasma on the two-layer structured pCB films with and without IgG functionalization.
- FIG. 9B compares TSH binding capacity and surface bioactivity on pCB films with one-layer and two-layer structures.
- FIG. 10A is a schematic illustration of the preparation of representative films of the invention for sensing and detection in undiluted complex media using a two-layer architecture integrated with zwitterionic dual-functional pCB.
- FIG. 10B is a schematic illustration of the preparation of representative films of the invention.
- FIG. 11 compares antibody immobilization versus azide exposure time for second layer pCB films grown from 10% and 50% water content.
- FIG. 12 compares antigen response versus azide exposure time for second layers made using 10% and 50% water content.
- 10% SI-ATRP water content all responses were very similar with surfaces resulting in antigen-antibody saturation.
- 50% water content both the 0 min and the 120 min conditions resulted in saturation.
- the antigen solution was flowed for a fixed time of 10 min.
- FIG. 13 compares fouling to undiluted human serum versus azide exposure time for second layer films made using 10% and 50% water content.
- FIG. 14 compares the effect of solvent water concentration on the second layer polymerization using a one hour azide treatment.
- FIG. 15A compares thicknesses and swelling ratios of pCB films with dry thicknesses of about 10 nm.
- FIG. 15B compares the fouling tests for pCB films from (a) with serum (darker bars) and plasma (lighter bars) were determined using a SPR sensor.
- FIG. 16 compares serum fouling versus dry film refractive index and illustrates a minimum packing density that is necessary to achieving ultra low fouling properties.
- the present invention provides hierarchical films with structurally regulated functionalities through the integration of two-dimensional and three-dimensional structures to achieve ultra low nonspecific binding and high loading of molecular recognition elements. Methods for making and using the films are also provided.
- the term “hierarchical” refers to the layered architecture of the films, where the individual layers have specific functions and properties.
- the present invention provides dual-functional nonfouling films, methods for making dual-functional nonfouling films, and devices that include dual-functional nonfouling films.
- the dual-functional films of the invention are films that are nonfouling (e.g., ultra low-fouling) surfaces that resist non-specific protein adsorption and cell adhesion.
- the dual-functional films of the invention also include covalently coupled recognition elements (e.g., target binding partners) that impart specific binding activity to the surfaces. Because the dual-functional films of the invention are nonfouling and include immobilized recognition elements, these films are useful in any method or device that requires sensitive specific binding or specific binding measurement and at the same time requires resistance to non-specific protein binding and cell adhesion.
- the dual-functional films of the invention are useful in medical diagnostic applications, biomaterials and tissue engineering, and drug delivery.
- the invention provides a film that includes two layers: a first layer having a first layer density and attached to a substrate; and a second layer having second density and attached to the first layer.
- the density of the first layer is greater than the density of the second layer.
- the film comprises a first nonfouling layer (low level of fibrinogen or lysozyme non-specific binding as described below), wherein the first layer is attached to a substrate; and a second layer that can be functionalized to include recognition elements, wherein the second layer is attached to the first layer.
- the second layer of the films of the invention includes a plurality of recognition elements.
- film refers the constructs of the invention having two layers as described above.
- the first layer is a nonfouling layer.
- nonfouling and “ultra low fouling” refers to layers and films of the invention that resist or prevent non-specific protein adsorption and cell adhesion. Non-specific protein adsorption can be measured by determining the level of protein (e.g., fibrinogen or lysozyme) adsorption that adsorbs to the surface per unit area.
- protein e.g., fibrinogen or lysozyme
- the first layer of the films of the invention adsorb less than about 30 ng/cm 2 fibrinogen or lysozyme.
- the first layer has a fibrinogen or lysozyme adsorption less than about 10 ng/cm 2 ; in one embodiment, the fibrinogen or lysozyme adsorption is less than about 5 ng/cm 2 ; in one embodiment, the fibrinogen or lysozyme adsorption is less than about 3 ng/cm 2 ; and in one embodiment, the fibrinogen or lysozyme adsorption is less than about 0.3 ng/cm 2 .
- the nonfouling function of the film is imparted to the first layer by the materials of the first layer coupled to the surface.
- These materials include zwitterionic materials.
- Suitable materials useful in making the surfaces include the polymers and copolymers described in U.S. Pat. No. 7,879,444 (Superlow-Fouling Sulfobetaine and Carboxybetaine Materials and Related Methods) and US 20090259015 (Mixed Charge Copolymers and Hydrogels), each expressly incorporated herein by reference in its entirety. Methods for measuring protein adsorption (fibrinogen) are described in U.S. Pat. No. 7,879,444, expressly incorporated herein by reference.
- the thickness of the first layer of the film of the invention can vary depending on the intended use of the film. In certain embodiments, the first layer has a thickness from about 1 to about 100 nm. In certain other embodiments, the first layer has a thickness from about 1 to about 20 nm.
- the second layer of the films of the invention is attached to the film's first layer and has a density less than the density of the first layer.
- recognition elements are attached to the second layer to render the films dual-functional films.
- the second layer includes materials having a functional group or groups suitably reactive to immobilize recognition elements (e.g., proteins such as antibodies).
- Representative functional groups for these dual-functional materials include carboxylic acid groups and amino groups, among others.
- the dual-functional materials are zwitterionic materials that can be attached (e.g., covalently coupled) to a surface and that have terminal carboxylic acid groups. These terminal carboxylic acid groups can be activated for coupling to one or more amino groups present in a biomolecule.
- the carboxylic acid groups may be converted to active esters (e.g., N-hydroxysuccinimide esters) and then reacted with one or more amino groups (e.g., amino group of a lysine residue of a protein) to form an amide bond thereby immobilizing the protein to the surface to provide a dual-functional film of the invention.
- active esters e.g., N-hydroxysuccinimide esters
- amino groups e.g., amino group of a lysine residue of a protein
- the materials can include carboxylic acid groups and certain of these carboxylic acid groups are available for further chemical reaction, specifically the immobilization of recognition elements (i.e., target binding partners) to the materials and, therefore, the film.
- recognition elements having available amino groups —NH 2
- recognition elements having available amino groups can be covalently coupled to the materials' available carboxylic acid groups to immobilize the recognition element through stable amide linkages (—CONH—).
- a portion of the materials having available carboxylic acid groups are activated for coupling and then covalently coupled to the recognition elements to provide immobilized recognition elements.
- recognition elements immobilized to the films of the invention can be readily controlled through the reaction conditions (e.g., extent of carboxyl group activation and concentration and amount of recognition elements exposed to the activated layer for immobilization.
- Schematic illustrations of representative nonfouling films of the invention having immobilized recognition elements are shown in FIGS. 1, 10A, and 10B . It will be appreciated that in certain circumstances, due to the difference in densities between the second and first layers and the nature of the first layer, recognition elements may be attached to the first layer.
- the thickness of the second layer of the film of the invention can also vary depending on the intended use of the film.
- the second layer has a thickness from about 10 nm to about 300 ⁇ m. In certain other embodiments, the second layer has a thickness from about 100 nm to about 100 ⁇ m.
- films with additional layers are within the scope of the invention.
- the additional layers can be formed on the two-layer film described herein.
- the third layer can be formed on the second layer (e.g., by “graft from” or “graft to” techniques). Subsequent layers can be similarly formed.
- Representative films of the invention include polymer films.
- the term “polymer film” refers to a film of the invention in which the first layer is a polymer layer, the second layer is a polymer layer, or the first and second layers are polymer layers.
- the first layer comprises a plurality of polymers.
- the first layer is a polymer layer.
- Suitable polymers layers include polymer brushes.
- the term “polymer brush” refers to an assembly of polymer chains in which an end of each polymer chain is attached to a substrate surface.
- the second layer may also comprise a plurality of polymers.
- the second layer is a polymer layer.
- the second layer is a crosslinked polymer layer and, in certain of these embodiments, the second layer is a hydrogel.
- the films of the invention the density of the first layer is greater than the density of the second layer.
- the first layer of the films of the invention have a density greater than the density of the second layer.
- density has its common meaning: mass per unit volume.
- the greater density of the first layer of films of the invention is readily apparent from the schematic illustrations of representative films in FIG. 10A . Referring to FIG. 10A , because not every first polymer in the first layer is attached to a second polymer in the second layer, the density of the second layer is necessarily less than the density of the first layer.
- the density of layers can be determined by refractive index or swelling ratio as described herein.
- Representative films of the invention have a dry film refractive index from about 1.40 to about 1.57 RIU. In one embodiment, the dry film refractive index is greater than about 1.45 RIU. In another embodiment, the dry film refractive index is greater than about 1.48 RIU. In a further embodiment, the dry film refractive index is greater than about 1.50 RIU. Dry film refractive index is measured as described in Example 4. See also FIG. 16 .
- Representative films of the invention have a swelling ratio from about 1 to about 5. In one embodiment, the swelling ratio is less than about 4. In another embodiment, the swelling ratio is less than about 3. In a further embodiment, the swelling ratio is less than about 2.5. Swelling ratio is measured as described in Example 5. See FIGS. 15A and 15B .
- the film comprises a first nonfouling layer (low level of fibrinogen or lysozyme non-specific binding), wherein the first layer is attached to a substrate; and a second layer that can be functionalized to include recognition elements, wherein the second layer is attached to the first layer.
- the first layer need not have a density that is greater than the second layer.
- the first layer comprises a first polymer layer having a first polymer density
- the first polymer layer comprises a plurality of first polymers, each of the first polymers having a first end and a second end, wherein each first polymer is attached to a substrate through its first end.
- the second layer comprises a second polymer layer having a second polymer density
- the second polymer layer comprises a plurality of second polymers, each of the second polymers having a first end and a second end, wherein each second polymer is attached to a first polymer's second end through the second polymer's first end.
- the polymer film of the invention includes a first layer comprising a first polymer layer having a first polymer density, the first polymer layer comprising a plurality of first polymers, each of the first polymers having a first end and a second end, wherein each first polymer is attached to a substrate through its first end; and a second layer comprising a second polymer layer having a second polymer density, wherein the second polymer layer comprises a plurality of second polymers, each of the second polymers having a first end and a second end, wherein each second polymer is attached to a first polymer's second end through the second polymer's first end.
- the polymers are attached end to end (first polymer first end attached to the substrate, and first polymer second end attached to second polymer first end), it will be appreciated that the polymers need not be attached end to end.
- the polymers can be attached through attachment sites that are not at the polymer end (terminus). The attachment sites can be near the polymer end or, for example, near the middle of the polymer.
- the first polymers are grafted from the substrate surface.
- the term “grafted from” refers to an attachment method in which the polymer is formed from the substrate.
- each of the first polymers are formed by polymerization from the substrate. Suitable polymerization methods include free radical polymerization, atom transfer radical polymerization (ATRP), reverse addition fragment transfer (RAFT), photoiniferter-mediated polymerization (PIMP), and condensation/ring opening polymerization.
- the first polymers are grafted to the substrate surface.
- the term “grafted to” refers to an attachment method in which the first polymer is attached to the substrate surface.
- each of the first polymers are first formed and then attached to the substrate surface.
- the nature of the attachment of the first polymer to the substrate surface is not critical; the attachment site of each of the first polymer and substrate is suitably reactive to the other.
- the first polymer is attached to the substrate surface by click chemistry. See, for example, http://onlinelibrary.wiley.com/doi/10.1002/1521-3773(20010601)40:11%3C2004::AID-ANIE2004%3E3.0.CO;2-5/full.
- the first polymer is attached to the substrate surface by thiol-ene chemistry. See, for example, http://onlinelibrary.wiley.com/doi/10.1002/anie.200903924/full.
- non-covalent association e.g., ionic, hydrophobic, hydrogen bonding, or mechanical methods such as entanglement
- entanglement are effective graft to methods.
- the second polymers are grafted from the first polymers. This refers to an attachment method in which the second polymer is formed from the first polymer.
- each of the second polymers are formed by polymerization from a first polymer. Suitable polymerization methods include free radical polymerization, atom transfer radical polymerization (ATRP), reverse addition fragment transfer (RAFT), photoiniferter-mediated polymerization (PIMP), and condensation/ring opening polymerization.
- the second polymers are grafted to the first polymers.
- each of the second polymers are first formed and then attached to a first polymer.
- the nature of the attachment of the second polymer to the first polymer is not critical; the attachment site of each of the first and second polymers is suitably reactive to the other.
- the second polymer is attached to the first polymer by click chemistry.
- the second polymer is attached to the first polymer by thiol-ene chemistry.
- non-covalent association e.g., ionic, hydrophobic, hydrogen bonding, or mechanical methods such as entanglement
- the second polymer may be attached to the first polymer by covalent coupling the second polymer to the first polymer.
- Suitable first and second polymers include charged polymers and copolymers and non-charged polymers and copolymers.
- Suitable charged polymers include zwitterionic polymers and copolymers and mixed charge copolymers.
- Suitable non-charged polymers and copolymers include alkylene oxide polymers and copolymers, polysaccharide polymers and copolymers (dextrans), acrylamide polymers and copolymers, and hydroxy-terminal polymers and copolymers (HEMA).
- Representative zwitterionic polymers useful in the first and second layers include polysulfobetaines, polycarboxybetaines, polyphosphobetaines, peptides, and peptoids.
- Representative zwitterionic polymers useful in the second layer include polycarboxybetaines and mixed charge peptides.
- the first polymers are selected from polysulfobetaines, polycarboxybetaines, polyphosphobetaines, and peptides
- the second polymers are selected from polycarboxybetaines and peptides.
- the first polymers are polycarboxybetaines and the second polymers are polycarboxybetaines.
- the first and/or second polymers of the first and second layers of the polymer film of the invention are zwitterionic polymers.
- these polymers may be prepared by polymerization of a zwitterionic (or latent zwitterionic) monomer.
- Representative zwitterionic first or second polymers have the formula:
- PB is the polymer backbone having n pendant zwitterionic groups
- R 2 and R 3 are independently selected from the group consisting of hydrogen, alkyl, and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
- L 1 is a linker that covalently couples the cationic center [N+(R 5 )(R 6 )] to the polymer backbone;
- L 2 is a linker that covalently couples the anionic center [A( ⁇ O)—O ⁇ ] to the cationic center;
- A is C, S, SO, P, or PO
- X ⁇ is an optional counter ion associated with the cationic center
- n is an integer from 1 to about 10,000.
- Representative zwitterionic first or second polymers comprise a plurality of repeating units, each repeating unit having the formula:
- R 1 is selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C1-C6 alkyl, and C6-C12 aryl groups;
- R 2 and R 3 are independently selected from the group consisting of hydrogen, alkyl, and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
- L 1 is a linker that covalently couples the cationic center [N+(R 5 )(R 6 )] to the polymer backbone [—(CH 2 —CR 4 ) n —];
- L 2 is a linker that covalently couples the anionic center [A( ⁇ O)—O ⁇ ] to the cationic center;
- A is C, S, SO, P, or PO
- X ⁇ is an optional counter ion associated with the cationic center
- n is an integer from 1 to about 10,000.
- the polymer is a polycarboxybetaine.
- Suitable polycarboxybetaines can be prepared from one or more monomers selected from the group consisting of carboxybetaine acrylates, carboxybetaine acrylamides, carboxybetaine vinyl compounds, carboxybetaine epoxides, and mixtures thereof.
- the monomer is carboxybetaine methacrylate.
- carboxybetaine methacrylates such as 2-carboxy-N,N-dimethyl-N-(2′-methacryloyloxyethyl) ethanaminium inner salt
- carboxybetaine acrylates such as 2-carboxy-N,N-dimethyl-N-(2′-methacryloyloxyethyl) ethanaminium inner salt
- carboxybetaine acrylates such as 2-carboxy-N,N-dimethyl-N-(2′-methacryloyloxyethyl) ethanaminium inner salt
- carboxybetaine acrylates such as 2-carboxy-N,N-dimethyl-N-(2′-methacryloyloxyethyl) ethanaminium inner salt
- carboxybetaine acrylates such as 2-carboxy-N,N-dimethyl-N-(2′-methacryloyloxyethyl) ethanaminium inner salt
- the first and/or second polymers of the first and second layers of the polymer film of the invention are mixed charge copolymers.
- mixed charge copolymer refers to a copolymer having a polymer backbone, a plurality of positively charged repeating units, and a plurality of negatively charged repeating units.
- the mixed charge copolymer includes a plurality of positively charged repeating units, and a plurality of negatively charged repeating units.
- the mixed charge copolymer is substantially electronically neutral.
- substantially electronically neutral refers to a copolymer that imparts advantageous nonfouling properties to the copolymer.
- a substantially electronically neutral copolymer is a copolymer having a net charge of substantially zero (i.e., a copolymer about the same number of positively charged repeating units and negatively charged repeating units).
- the ratio of the number of positively charged repeating units to the number of the negatively charged repeating units is from about 1:1.1 to about 1:0.5.
- the ratio of the number of positively charged repeating units to the number of the negatively charged repeating units is from about 1:1.1 to about 1:0.7. In one embodiment, the ratio of the number of positively charged repeating units to the number of the negatively charged repeating units is from about 1:1.1 to about 1:0.9. In the practice of the invention, these copolymers may be prepared by polymerization of an ion-pair comonomer.
- the copolymers are prepared by copolymerization of suitable polymerizable ion pair comonomers.
- Representative mixed charge first or second polymers have the formula:
- PB is the polymer backbone having n pendant cationic groups and p pendant anionic groups
- R 6 , R 7 , and R 8 are independently selected from hydrogen, alkyl, and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
- A( ⁇ O)—OM) is an anionic center, wherein A is C, S, SO, P, or PO, and M + is an optional counter ion;
- L 3 is a linker that covalently couples the cationic center [N + (R 6 )(R 7 )(R 8 )] to the polymer backbone;
- L 4 is a linker that covalently couples the anionic center [A( ⁇ O)—OM] to the polymer backbone;
- X ⁇ is an optional counter ion associated with the cationic center
- n is an integer from 1 to about 10,000;
- p is an integer from 1 to about 10,000.
- Representative mixed charge first or second polymers comprise a plurality of repeating units, the copolymer having the formula:
- R 4 and R 5 are independently selected from hydrogen, fluorine, trifluoromethyl, C1-C6 alkyl, and C6-C12 aryl groups;
- R 6 , R 7 , and R 8 are independently selected from hydrogen, alkyl, and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
- A( ⁇ O)—OM) is an anionic center, wherein A is C, S, SO, P, or PO, and M + is an optional counterion;
- L 3 is a linker that covalently couples the cationic center [N + (R 6 )(R 7 )(R 8 )] to the polymer backbone;
- L 4 is a linker that covalently couples the anionic center [A( ⁇ O)—OM] to the polymer backbone;
- X ⁇ is an optional counter ion associated with the cationic center
- n is an integer from 1 to about 10,000;
- p is an integer from 1 to about 10,000.
- M + and X ⁇ are optional as the cationic center and the anionic center provide an inner salt.
- the polymer backbone may be any one of a variety of backbones known to those of skill in the art (e.g., acrylic acid, alkylacrylic acid, such as methacrylic acid; acrylamide, alkylacrylamide such as methacrylamide).
- backbones known to those of skill in the art
- acrylic acid alkylacrylic acid, such as methacrylic acid
- acrylamide alkylacrylamide such as methacrylamide
- the nature of the polymer backbone is not critical.
- Suitable backbones include vinyl backbones (i.e., —C(R′)(R′′)—C(R′′′)(R′′′′)—, where R′, R′′, R′′′, and R′′′ are independently selected from hydrogen, alkyl, and aryl) derived from vinyl monomers (e.g., acrylate, methacrylate, acrylamide, methacrylamide, styrene).
- vinyl backbones i.e., —C(R′)(R′′)—C(R′′′)(R′′′′)—, where R′, R′′, R′′′, and R′′′ are independently selected from hydrogen, alkyl, and aryl
- vinyl monomers e.g., acrylate, methacrylate, acrylamide, methacrylamide, styrene.
- Other suitable backbones include polyamide backbones, such as poly(amino acid) backbones.
- N + is the cationic center.
- the cationic center is a quaternary ammonium (e.g., N bonded to L 1 , R 2 , R 3 , and L 2 ).
- other useful cationic centers include imidazolium, triazaolium, pyridinium, morpholinium, oxazolidinium, pyrazinium, pyridazinium, pyrimidinium, piperazinium, and pyrrolidinium.
- R 1 -R 8 are independently selected from hydrogen, alkyl, and aryl groups.
- Representative alkyl groups include C1-C10 straight chain and branched alkyl groups.
- the alkyl group is further substituted with one of more substituents including, for example, an aryl group (e.g., —CH 2 C 6 H 5 , benzyl).
- R 2 and R 3 , and R 6 , R 7 , and R 8 are methyl.
- R 1 —R 8 are methyl.
- Representative aryl groups include C6-C12 aryl groups including, for example, phenyl.
- R 2 and R 3 , and/or R 6 , R 7 , and R 8 are taken together with N + form the cationic center.
- R 7 and R 8 are C1-C3 alkyl.
- R 6 , R 7 , and R 8 are C1-C3 alkyl.
- L 1 is a linker that covalently couples the cationic center to the polymer backbone.
- L 1 includes a functional group (e.g., ester or amide) that couples the remainder of L 1 to the polymer backbone (or polymerizable moiety for the monomers).
- L 1 can include an C1-C20 alkylene chain.
- L 2 is a linker that covalently couples the cationic center to the anionic group.
- L 2 can be a C1-C20 alkylene chain.
- Representative L 2 groups include —(CH 2 ) n —, where n is 1-20 (e.g., 1, 3, or 5).
- L 3 is a linker that covalently couples the cationic center to the polymer backbone.
- L 3 includes a functional group (e.g., ester or amide) that couples the remainder of L 3 to the polymer backbone (or polymerizable moiety for the monomers).
- L 3 can include an C1-C20 alkylene chain.
- L 3 is —C( ⁇ O)O—(CH 2 ) n —, wherein n is 1-6.
- L 4 is a linker that covalently couples the anionic group to the polymer backbone.
- L 4 is a C1-C20 alkylene chain.
- Representative L 4 groups include —(CH 2 ) n —, where n is 1-20 (e.g., 1, 3, or 5).
- alkyl groups include C1-C30 straight chain and branched alkyl groups.
- the alkyl group is further substituted with one of more substituents including, for example, an aryl group (e.g., —CH 2 C 6 H 5 , benzyl).
- aryl groups include C6-C12 aryl groups including, for example, phenyl including substituted phenyl groups (e.g., benzoic acid).
- X ⁇ is the counter ion associated with the cationic center.
- the counter ion can be the counter ion that results from the synthesis of the cationic polymers or the monomers (e.g., Cl ⁇ , Br ⁇ , I ⁇ ).
- the counter ion that is initially produced from the synthesis of the cationic center can also be exchanged with other suitable counter ions.
- counter ions also can be chosen from chloride, bromide, iodide, sulfate; nitrate; perchlorate (ClO 4 ); tetrafluoroborate (BF 4 ); hexafluorophosphate (PF 6 ); trifluoromethylsulfonate (SO 3 CF 3 ); and derivatives thereof.
- suitable counter ions include salicylic acid (2-hydroxybenzoic acid), benzoate, and lactate.
- A is C or SO.
- n is an integer from 5 to about 5,000.
- R 4 , R 5 , R 6 , R 7 , and R 8 are methyl, L 3 is —C( ⁇ O)O—(CH 2 ) 2 —, and L 4 is —CH 2 —, A 1 is C or SO, and n is an integer from 5 to about 5,000.
- the degree of polymerization (DP or n), number average molecular weight (M n ), and the ratio of weight average and number average molecular weights (M w /M n .), also known as polydispersity index can vary.
- the polymers have a degree of polymerization (n) from 1 to about 10,000.
- n is from about 10 to about 5,000.
- n is from about 100 to about 3,500.
- the polymers have a number average molecular weight (M) of from about 200 to about 2,000,000 Da.
- M n is from about 2,000 to about 100,000 Da.
- M n is from about 20,000 to about 80,000 Da.
- the polymers have a ratio of weight average and number average molecular weight (M w /M n .) of from about 1.0 to about 2.0.
- M w /M n . is from about 1.1 to about 1.5.
- M w /M n . is from about 1.2 to about 2.0.
- the second layer includes a plurality of recognition elements.
- recognition elements and “target binding partners” are used interchangeably.
- the binding affinity of a target molecule toward to the surface results from the target binding partners immobilized on the surface.
- the target binding partner and the target molecule each termed a binding pair member, form a binding pair.
- Each binding pair member is a molecule that specifically binds the other member.
- the target binding partner has affinity to a target molecule with K d less than about 10 ⁇ 8 .
- a binding pair member can be any suitable molecule including, without limitation, proteins, peptides, proteins, poly- or oligo-saccharides, glycoproteins, lipids and lipoproteins, and nucleic acids, as well as synthetic organic or inorganic molecules having a defined bioactivity, such as an antibiotic, anti-inflammatory agent, an enzyme substrate, or a cell adhesion mediator (i.e., a small molecule).
- suitable molecule including, without limitation, proteins, peptides, proteins, poly- or oligo-saccharides, glycoproteins, lipids and lipoproteins, and nucleic acids, as well as synthetic organic or inorganic molecules having a defined bioactivity, such as an antibiotic, anti-inflammatory agent, an enzyme substrate, or a cell adhesion mediator (i.e., a small molecule).
- proteins that can be immobilized on the surfaces of the present invention include ligand-binding proteins, lectins, hormones, receptors, and enzymes.
- Representative proteins include antibodies (monoclonal, polyclonal, chimeric, single-chain or other recombinant forms) and fragments thereof, their protein/peptide antigens, protein-peptide hormones, streptavidin, avidin, protein A, proteins G, growth factors and their respective receptors, DNA-binding proteins, cell membrane receptors, endosomal membrane receptors, nuclear membrane receptors, neuron receptors, visual receptors, and muscle cell receptors.
- the target binding partner is an antibody, and the target molecule is an antigen against the antibody.
- the surface of the invention specifically binds to the antigen and resists non-specific protein adsorption.
- the target binding partner is a protein capable of promoting cell adhesion, and the target molecule is a cell.
- the surface of the invention specifically binds to the cell and resists non-specific protein adsorption and non-specific cell adhesion.
- the second layer has a recognition element binding level of about 200 to about 1500 ng/cm 2 .
- substrate surfaces can be rendered dual-functional using the materials and methods described herein.
- Representative surfaces that can be rendered dual-functional include metal and metal oxide surfaces, ceramic surfaces, synthetic and natural polymeric surfaces, glass surfaces, fiber glass surface, silicon/silica surfaces, carbon-based material surfaces, protein-based material surfaces, and cell surfaces.
- Representative natural polymeric surfaces include collagen, fibrins, and other carbohydrate surfaces suitable for the use of tissue engineering.
- Representative carbon-based material surfaces include carbon fiber, nanotube, and bulky ball surfaces.
- Suitable substrates include those substrates useful in medical diagnostic applications such as biosensors, bioprobes, and biomedical devices including in vivo devices; biomaterials and tissue engineering applications, such as membranes for bioprocesses or bioseparation, implantable devices, prosthetics, and tissue scaffolds; and drug delivery applications, such as particles and nanoparticles.
- the present invention provides a SPR sensor comprising a film of the invention.
- the films of the invention have been described as including (i.e., the film comprises) the stated components. It will be appreciated that in certain embodiments, the films of the invention described above include the stated components as well as other components that do not alter the novel and material characteristics properties of the film (i.e., the film consists essentially of). Components that alter the novel and material characteristics of the film include components that adversely affect the films ultra low fouling or the ability of the film to capture target molecules through its recognition elements. It will also be appreciated that in certain embodiments, the films of the invention described above include only the stated components (i.e., the film consists of).
- the method includes forming a first layer having a first layer density on a substrate; and forming a second layer on the first layer, the second layer having a second density, wherein the first layer density is greater than the second layer density.
- the film is a polymer film in which the first, second, or first and second layers comprise a plurality of polymers.
- the first layer is a nonfouling layer and the second layer is effective to specifically bind target agents.
- the first layer comprises a first polymer layer having a first polymer density, and the first polymer layer comprises a plurality of first polymers, wherein each first polymer is attached to a substrate; and the second layer comprises a second polymer layer having a second polymer density, wherein the second polymer layer comprises a plurality of second polymers, wherein each second polymer is attached to a first polymer.
- the first layer can be formed by grafting first polymers from the substrate. Grafting the first polymers from the substrate can be accomplished by any one of a variety polymerization methods (e.g., free radical polymerization, atom transfer radical polymerization (ATRP), reverse addition fragment transfer (RAFT), photoiniferter-mediated polymerization (PIMP), condensation/ring opening polymerization).
- ATRP atom transfer radical polymerization
- RAFT reverse addition fragment transfer
- PIMP photoiniferter-mediated polymerization
- condensation/ring opening polymerization condensation/ring opening polymerization
- the first layer can be formed by grafting first polymers to the substrate.
- the first polymer can be attached to the substrate by any one of a variety of coupling techniques.
- the first polymers are covalently coupled to the substrate by click chemistry.
- the first polymers are covalently coupled to the substrate by thiol-ene. It will be appreciated that any coupling technique requires suitably reactive second polymers and first layer components.
- the first polymer may be coupled to the substrate surface through alkylene linkers.
- the grafting of the polymers onto the surface of the substrate through the alkylene linkers may be via any one of a variety of polymerization methods as described herein.
- SAMs on substrate surfaces are an excellent platform for surface polymerization.
- a radical initiator-terminated self-assembly monolayer (SAM) comprising the alkylene linkers can be formed onto the substrate surface, and the polymers are grafted onto the surface through the radical initiator-terminated self-assembly monolayer.
- the substrate surface can be coated with the SAMs terminated with radical initiator, wherein the radical initiators are tethered to the surface through alkylene linkers.
- the alkylene linkers can be any substituted or unsubstituted alkylene. In one embodiment, the alkylene linker is a C2-C30 alkylene.
- Polymers are then formed onto the SAMs to provide a layer of nonfouling polymeric coating on the substrate surface. Atom transfer radical polymerization is initiated by the radical initiator at the SAMs terminus.
- a hydroxyl-terminated monolayer having alkylene linkers can be formed onto the substrate surface, which is subsequently converted to a radical initiator terminated monolayer.
- the second layer can be formed by grafting second polymers from the first layer. Grafting the second polymers from the first polymers can also be accomplished by any one of a variety polymerization methods (e.g., free radical polymerization, atom transfer radical polymerization (ATRP), reverse addition fragment transfer (RAFT), photoiniferter-mediated polymerization (PIMP), condensation/ring opening polymerization).
- a schematic illustration of representative methods for grafting second polymers to the first layer is shown in FIG. 1 .
- the second layer can be formed by grafting second polymers to the first layer.
- the second polymer can be attached to the first layer by any one of a variety of coupling techniques.
- the second polymers are covalently coupled to the first layer by click chemistry.
- the second polymers are covalently coupled to the first layer by thiol-ene. It will be appreciated that any coupling technique requires suitably reactive second polymers and first layer components.
- films with additional layers are within the scope of the invention.
- the additional layers can be formed on the two-layer film described herein.
- the third layer can be formed on the second layer (e.g., by “graft from” or “graft to” techniques). Subsequent layers can be similarly formed.
- the present invention provides methods for modifying the second layer to provide a surface having affinity toward a target molecule.
- the method for modifying a surface includes covalently coupling a plurality of target binding partners (i.e., recognition elements) to the second layer.
- a plurality of target binding partners i.e., recognition elements
- an amide linkage is formed between the polymers and the target binding partners.
- covalently coupling the plurality of target binding partners to the plurality of polymers includes converting a portion of carboxylic acid groups to activated esters and reacting the activated esters with target binding partners having amino groups.
- covalently coupling the plurality of target binding partners to the plurality of polymers includes converting a portion of carboxylic acid groups of the target binding partners to activated esters and reacting the activated esters with the polymers of the surface having available amino groups.
- the activated esters are N-hydroxysuccinimide esters.
- Suitable target binding partners include those described in detail above with regard to the films of the invention.
- the carboxylic acid groups of the polymers may be activated by forming activated intermediate groups for further coupling with the amino groups of the biomolecule.
- Any activated form of carboxylic acid groups may be used in the present invention.
- the representative activated intermediate groups include carbodiimides, carbonyldiimidazoles, uranium salts, isothiocyanates, isocyanates, acyl azides, N-succinimidyl esters (NHS esters), sulfonyl chloride, aldehydes, epoxides arylating groups, imido esters, and anhydrides.
- O—(N-succinimidyl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (TSTU) is used to convert the carboxylic acid groups on the polymers to activated uronium salts.
- TSTU O—(N-succinimidyl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
- EDC/NHS coupling chemistry are used to convert the carboxylic acid groups on the polymers to activated N-hydroxysuccinimide esters.
- the carboxylic acid groups were converted to activated NHS esters by treating the carboxylic acid groups with N-bromo succinimide (NHS) and N-ethyl-N′-(3-diethylaminopropyl) carbodiimide (EDC) under acidic conditions (e.g., pH 2.5 to 6).
- NHS N-bromo succinimide
- EDC N-ethyl-N′-(3-diethylaminopropyl) carbodiimide
- the activated NHS esters were coupled with the amino groups of the target binding partner forming amide bonds under basic conditions (e.g., pH 7.4 to 11).
- the invention provides methods for determining the presence of an analyte in a sample.
- the method utilizes film of the invention comprising a plurality of recognition elements.
- the method includes contacting a sample with a film of the invention comprising a plurality of recognition elements, wherein each recognition element has a specific binding affinity for the analyte; and interrogating the film to determine whether the analyte has bound to the film.
- the film can include one or more different recognition elements for the detection of one or more analytes.
- the film can be interrogated by any method that provides an indication of analyte binding to the film.
- the invention provides a polymer film having two layers (i.e., a hierarchical architecture) prepared from two distinct surface-initiated techniques. These “graft from” techniques are based on controlled “living” radical polymerizations and provide polymer brushes having controlled chemical composition, film thickness, and architecture. As shown in FIG. 1 , one film was prepared via surface initiated atom transfer radical polymerization (SI-ATRP) and the other film was prepared via surface initiated photoiniferter-mediated polymerization (SI-PIMP). In each film, the first layer was grown in a controlled manner to reach a high surface packing density. The second layer, with a lower surface packing density, was achieved through “termination” or “regeneration” of the living capped species at the polymer chain end for SI-ATRP and SI-PIMP, respectively.
- SI-ATRP surface initiated atom transfer radical polymerization
- SI-PIMP surface initiated photoiniferter-mediated polymerization
- pCB poly(carboxybetaine)
- SPR surface plasmon resonance
- fouling levels can be maintained following the immobilization of around 250 ng cm ⁇ 2 of antibody using conventional 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide and N-hydroxysuccinimide (EDC/NHS) coupling chemistry under biologically friendly conditions.
- this functionalization level only corresponds to an IgG monolayer.
- the pCB-based polymer films (platforms) of the invention with hierarchical structures on a SPR sensor surface provide sensitive quantification of IgG immobilization, antigen binding, and nonspecific protein adsorption.
- ATRP was combined with a “termination” approach for demonstrating the novel architecture.
- ATRP involves a dynamic equilibrium between activated propagating radicals and dormant halide end-capped polymer chains, yielding low polydispersity and controlled growth. This “living” characteristic enables re-initiation from macroinitiators for the synthesis of block copolymers.
- SI-ATRP a densely-packed first layer was grown from a gold coated SRP chip modified with an alkyl bromide terminated self-assembled monolayer (SAM).
- SAM alkyl bromide terminated self-assembled monolayer
- the macroinitiator density for re-growth of the second pCB layer was regulated via azide substitution of bromide species thus “terminating” the future growth of the corresponding chains during the second ATRP reaction.
- the density of the polymer chains can be controlled by the azide concentration and reaction time.
- a 2 hr submersion using an azide concentration of 0.1 M produced an optimal second layer polymer density for protein immobilization.
- water-accelerated polymerization with a solvent consisting of 50% water in methanol was employed to induce a high polydispersity of polymer chains.
- the resulting thickness of the structured film with azide substitution was higher than that without treatment. This is in agreement with previous reports showing rapid bimolecular termination at high initiator densities using aqueous ATRP whereas more dilute initiators enabled continued linear and controlled polymer growth.
- SI-PIMP releases capped species from the polymer chains during polymerization, primarily due to bimolecular termination. This irreversible termination significantly hampers future polymer growth. Therefore, in order to control the chain density of the second layer via SI-PIMP, a “regeneration” approach was adopted in which the addition of a deactivator, tetraethylthiuram disulfide (TED), was able to preserve the end-capped photoiniferter groups on the grafted polymers for re-growth of the second layer with controlled grafting density.
- TED tetraethylthiuram disulfide
- SPR gold substrates were first modified with the photoiniferter (N,N-(diethylamino)-dithiocarbamoylbenzyl(trimethyoxy)-thiol (DTCA)) to form SAMs.
- the photoiniferter N,N-(diethylamino)-dithiocarbamoylbenzyl(trimethyoxy)-thiol (DTCA)
- DTCA photoiniferter
- the first layer for SI-PIMP was also synthesized in 100% methanol to form a highly dense and thin film. Reactions were conducted using a 30 min UV irradiation and the resulting film thicknesses are shown in Table 1.
- the first layer thicknesses prepared with 2 ⁇ M TED was comparable to that without TED (11.1 ⁇ 0.6 nm).
- the films were re-initiated in a 90% water/methanol solution resulting in TED treated films with greater thicknesses than those made without, reflecting the ability of TED for preserving the reactive photoiniferter end groups and thereby maintaining the “living” characteristic of SI-PIMP.
- the functionalization levels were estimated as 195.9 ng cm ⁇ 2 and 417.0 ng cm ⁇ 2 for one-layer (“One”) and hierarchical (“HA”) films prepared via SI-ATRP; 253.0 ⁇ 14.8 and 792.7 ⁇ 54.7 ng cm ⁇ 2 for one-layer and hierarchical films from SI-PIMP.
- An increase in binding capacities for IgG molecules on pCB films was observed for the hierarchical architecture.
- the binding capacities were similar to that obtained with carboxyl-terminated SAMs.
- the protein fouling levels on one-layer films and hierarchical pCB films before and after IgG functionalization were tested by flowing undiluted blood serum or plasma ( FIG. 2B ). All fouling levels were very low as a result of the highly-packed first pCB layers serving as ultra low fouling backgrounds. As a comparison, the fouling level for a loose pCB one-layer film with a thickness of 12.3 nm prepared from 50% water in methanol by SI-PIMP was as high as 54.3 ng cm ⁇ 2 in the presence of serum.
- TSH binding capacities were 42.1 ⁇ 2.4 ng cm ⁇ 2 and 128.5 ⁇ 26.2 ng cm ⁇ 2 for one-layer and hierarchical pCB films from SI-PIMP, respectively.
- the corresponding bio-activities were 0.89 and 0.87.
- the one-layer and hierarchical pCB films made via SI-ATRP bound 30.4 ng cm ⁇ 2 and 74.7 ng cm ⁇ 2 of TSH, respectively, with bio-activities of 0.80 and 0.93, respectively.
- the binding capacity for antigens is well correlated to the degree of antibody immobilization and that the bio-activity of the film is not affected by the pCB hierarchical architecture.
- the invention provides a polymer film having two layers (i.e., a high density ultra low fouling first layer and a low density second layer suitable for presenting recognition elements) prepared via surface initiated photoiniferter-mediated polymerization (SI-PIMP) techniques.
- SI-PIMP surface initiated photoiniferter-mediated polymerization
- Zwitterionic polycarboxybetaine acrylamine (pCB)-based platforms with a two-layer structure for ultra low fouling and high protein loading properties were prepared.
- the first pCB layer with a high packing density prepared under a water-free condition serves as a protective layer to resist nonspecific adsorption from complex media.
- the second pCB layer with a low packing density is used to achieve high protein immobilization. Addition of tetraethylthiuram disulfide (TED) and the water content in the reaction were varied to regulate polymer chain density and length, respectively, for the second pCB layer.
- TED tetraethylthiuram disulfide
- TSH thyroid stimulating hormone
- the two-layer structured pCB film was prepared by (i) growing a densely-packed first pCB brush under a water-free polymerization condition, (ii) adjusting the surface density of the “living” capping moieties on the first pCB layer by adding the TED molecules, and (iii) promoting the chain growth of the second pCB layer via water-accelerated polymerization.
- the growth of polymer brushes was monitored using ellipsometer.
- the protein loading on the structured pCB films was investigated by conjugating anti-human thyroid stimulating hormone (TSH) antibodies through EDC/NHS coupling chemistry, followed by flowing the TSH antigens for estimating the bioactivities.
- TSH thyroid stimulating hormone
- the present invention provides a two-layer structured binding platform that incorporates a first highly dense pCB layer to achieve ultra-low fouling and a second “loose” pCB layer to achieve a high antibody binding capacity ( FIG. 5B ).
- Surface-initiated photoiniferter-mediated polymerization can be used for preparing surface-tethered pCB films.
- This polymerization technique poses advantages of simple experimental process, fast reaction rate, and large-scaled surface polymerization, which make an attractive approach for tailoring surface properties.
- this technique enables to control light exposure spatially and temporally for creating multidimensional structures regardless of types of monomers.
- the pCB chains were grown from a self-assembled monolayer comprising of thiolated photoiniferter (N,N-(diethylamino)-dithiocarbamoylbenzyl(trimethyoxy)thiol (DTCA)).
- the photoiniferters provide control over the reaction by maintaining equilibrium between activated propagating chains and dormant chains that are capped by deactivating species, resulting in controlled radical polymerization.
- the polymerization favors irreversible termination caused by bimolecular termination.
- the reduction of termination can be accomplished by adding deactivating species, tetraethylthiuram disulfide (TED), to the reaction medium ( FIG. 6 ). While irradiated with UV light, TED undergoes a homolytic cleavage, generating two dithiocarbamyl (DTC) radicals.
- TED tetraethylthiuram disulfide
- Representative films of the invention were prepared by: (i) growing a densely-packed first pCB brush under a water-free polymerization condition; (ii) adjusting the surface density of the “living” capping moieties on the first pCB layer by adding the TED molecules, and (iii) promoting the chain growth of the second pCB layer via water-accelerated polymerization.
- FIG. 7A the fouling tests with undiluted plasma, 1 mg mL ⁇ 1 fibrinogen and lysozyme dissolved in PBS for the first pCB film were monitored on SPR. After the buffer washing the fouling level was indicated as 3.9 ⁇ 0.8 nm for plasma and for fibrinogen and lysozyme, their fouling levels were both below the detection limit of the SPR sensor which is 0.3 ng cm ⁇ 2 . 21 Therefore, the first pCB layer was developed and ensured its efficient protection of the surface from protein adsorption.
- TED was added to regenerate the initiator during the polymerization for the growth of the first pCB layer in order to prevent the irreversible termination.
- concentration of TED was varied from 0 to 50 ⁇ M.
- the dry thickness of the first pCB layer deceased with the increased TED concentration.
- the results indicate that for the one-layer films and the two-layer films prepared from high TED concentration, it was difficult for IgG molecules to penetrate through the brushes owing to the steric hindrance and most likely conjugated on the outmost of pCB films.
- “water-accelerated” polymerization was used to increase the chain length of the second layer for providing large available binding sites for IgG conjugation.
- FIG. 8A after the re-initiation from the first layer prepared from 100% methanol containing 2 ⁇ M of TED, the thicknesses of the second layers were measured and found to increase with the water content relative to MeOH in the reaction solvent. The surfaces were subsequently reacted with EDC/NHS mixture for 7 min followed by flowing anti-TSH IgG solution for 20 min. The results show that the binding capacities were dependent on the thicknesses of the second layers ( FIG. 8A ).
- AFM in the tapping mode was used to examine the surface morphology of the two-layer pCB films before and after IgG functionalization.
- the image of the pristine pCB film with a scale of 1 ⁇ m ⁇ 1 ⁇ m showed featureless morphology, whereas there were enormous bumps observed on the IgG functionalized pCB, as an evidence of the high density of immobilized IgG molecules. Therefore, this approach to build up a hierarchical structure of pCB film enables the accommodation for a large amount of biomolecules through conventional EDC/NHS amine coupling chemistry and possesses possibility to manipulate the chain density of the second pCB layer for customizing specific requirements, such as considerations on ligand and antigen sizes.
- Functionalization of TSH IgG on both one-layer and two-layer binding platforms was conducted via EDC/NHS activation for 7 min and allowing the 20 min reaction with IgG molecules.
- the undiluted plasma was flowed over surfaces with and without the IgG functionalization for 10 min and then rinsed with PBS to remove unbound molecules.
- the fouling levels were both below 5 ng cm ⁇ 2 .
- the fouling resistance of the “two-layer” binding platform can be attributed to the excellent nonfouling capability of the densely packed first pCB layer.
- the binding capacities of the two-layer pCB films was evaluated for TSH antigens dissolved in PBS at a concentration of 1 ⁇ g mL ⁇ 1 and the bioactivity of conjugated IgG molecules, which is defined as the mole ratio of captured TSH antigens to immobilized IgG molecules.
- the binding platform with “one-layer” structure was present in parallel for a comparison.
- the TSH binding capacity on “two-layer” pCB films was increased by 3.1 with respect to that on “one-layer” film.
- the bioactivities on one-layer and two-layer films were quite comparable. This observation reflects the fact that the high surface density of the bound IgG molecules in pCB brushes did not significantly hamper the approach of antigens, which is consistent with works using 3D carboxymethylated dextran-based binding matrix.
- the invention provides a polymer film having two layers (i.e., a high density ultra low fouling first layer and a low density second layer suitable for presenting recognition elements) prepared via surface initiated atom transfer radical polymerization (SI-ATRP) techniques.
- SI-ATRP surface initiated atom transfer radical polymerization
- the two-layer architecture for films of the invention for sensing and detection in complex media is shown in FIG. 10 .
- SI-ATRP was used due to its ability to provide excellent control over polymer growth. Additionally, the “living” characteristic enabled by the reversible equilibrium between active and dormant species allows the formation of block copolymers due to the presence of initiating species, which cap the chain ends once the polymerization is stopped.
- deactivator e.g. CuBr 2
- the concentration of re-initiating groups (i.e., bromines) on the surface can be reduced by reacting with an aqueous sodium azide solution.
- This termination forms a stable azide group, which remains dormant and non-reactive as the second polymerization takes place.
- Both the concentration and reaction time of sodium azide will affect the degree of termination resulting in surfaces, which are low, moderately, or highly substituted with azide moieties. If the substitution is low then the most chains will just re-initiate and maintain the relative high density resulting in only monolayer antibody coverage. For the chains to grow vertically they need to be close enough together, if they are too dilute, then the chains will preferentially grow laterally in a mushroom configuration.
- the second layer is thin, consisting of a small number of long chains with minimal surface area for antibody immobilization, which also results in low loading. Therefore, in order to achieve high antibody binding capacity, a moderate amount of substitution is desired. In this scenario, the chains will be close enough to be obliged to grow vertically, but dilute enough so as to maximize the surface area for achieving high protein functionalization and enable sufficient diffusion to reactive NHS-esters. It is also important to note that a second layer with moderate substitution can actually grow longer than single layer with low substitution. This is due to a reduction in radical recombination in the former as a result of more space between the growing polymer chains.
- Thin (about 10 nm) and highly dense pCB films can be made via SI-ATRP from pure methanol as the solvent can maintain ultra low fouling properties to undiluted serum.
- the ability to minimize the final thickness of the two-layer film in a swollen in situ environment is crucial for SPR detection. This is due to a rapid decrease in sensitivity as the measured biomolecular interaction gets further from the SPR active gold layer. For this reason, pure methanol was chosen as the condition for the bottom layer. Different reaction times (0.5-24 hrs) were investigated for growing the second block, which used a 50/50 methanol/water solvent.
- the moderately diluted second layer has more surface area (i.e. more accessible NHS-esters) for protein attachment.
- the available surface area decreases along with the immobilization.
- the highest level of immobilization achieved was about 440 ng/cm 2 , which was more than twice than that achieved for a single layer film grown from pure methanol (about 200 ng/cm 2 ).
- the saturated antigen response for azide exposure times of 0, 60, and 120 min for films made using a 10% and 50% water second layer is shown in FIG. 12 .
- the relatively low antibody loading for the 10% water condition for all exposure times resulted in an effective monolayer of antibody and thus gave very similar responses.
- the lowest level of immobilization also provides the smallest amount of antigen binding.
- the result for 60 min is much less than that for 120 min despite the higher level of antibody binding for the former.
- PBS spike with 1 ⁇ g/mL TSH was flowed over the surface for 10 min.
- the 10 min was sufficient to nearly saturate the antigen binding.
- the non-specific protein adsorption from undiluted human serum as a function of azide exposure time is shown in FIG. 13 .
- All cases except the 1 hour azide time with a second layer grown from a 10% water solvent resulted in excellent functionalized and non-functionalized protein resistant properties with most being at or below ultra low fouling levels.
- the one exception with high fouling can be explained as a highly substituted film with long polymer chains.
- the SPR sensor-gram for this film shows a significant and rapid binding during the antibody immobilization step. However, contrary to the typical SPR sensor-grams for the two-layer films (50% water content), a much larger decrease was observed during the deactivation step.
- Zwitterionic pCB films take on a slight positive charge following EDC/NHS activation. This would force the long and dilute chains to extend from the surface due to charge-charge repulsion. At a pH of 7.5, anti-TSH maintains a partial negative charge. Thus, the charge interaction between the surface and protein result in an accumulation of antibody near the surface. But, the limited surface area of the dilute polymer chains prevents most of the protein from being covalently bound. Upon deactivation, the surface regains its zwitterionic backbone and as a result the proteins are washed away. This particular conformation of polymer chains can increase the hydrophobicity of the surface by exposure more of the polymer backbone and thereby lead to an increase in fouling.
- the concentration of water was varied from 0-90% for a one hour azide treatment (the condition which enabled the highest antibody immobilization).
- the functionalized and non-functionalized serum fouling, antibody immobilization, and antigen response are shown in FIG. 14 .
- a peak of the antibody immobilization was found for the 50% water condition.
- Further investigation of these films by calculating the polymer volume fraction (PVF) in PBS (i.e., the wet polymer density) found that this particular condition had an effective PVF of about 25% where as all others films except for the 0% water second layer, had a PVF of about 43%.
- PVF polymer volume fraction
- the corresponding second block film thicknesses for each condition are shown in Table 3.
- the two-layer films made from 20-50% water all resulted in excellent non-fouling properties, had the highest level of immobilization, and also had the highest thickness. It is believed that the two-layer films made from 0% water content grow a very small second layer due to the limited solubility of the highly dense first layer polymer brush in pure methanol resulting in few polymer chains actually being reinitiated. Additionally, the significantly low level of immobilization (about 100 ng/cm 2 ) indicates that very few functionalizable groups are accessible.
- the similar antigen response for the other water concentrations corresponds with the expected results from 2D surfaces, with the 50% case simply having a low rate of diffusion as discussed above.
- the two endpoints have the expected response for a 2D surface with low antibody immobilization.
- Second layer films thicknesses as a functional of the polymerization water concentration using a one hour azide treatment.
- Second Layer Thickness [nm] ATRP Water Content [%] (1 hr Azide) 0 0.9 ⁇ 0.3 10 1.7 ⁇ 0.1 20 13.2 ⁇ 1.0 40 11.8 ⁇ 1.0 50 13.8 ⁇ 0.4 60 2.9 ⁇ 1.3 90 1.1 ⁇ 0.1
- the films of the invention having two-layer architecture with zwitterionic dual-functional pCB were made via SI-ATRP. Exposing the dense bottom layer to a sodium azide solution to reduce the number of re-initiating sites was effective to double the antibody immobilization all while maintaining ultra low fouling properties to undiluted human serum. Changing the second block polymer density also resulted in a significant increase in the antigen response.
- These ideal properties of pCB integrated with the two-layer architecture offer the ability to significantly improve detection abilities from undiluted complex media.
- polycarboxybetaine (pCB) films prepared by SI-ATRP are described.
- the solution was quenched with CuBr 2 (275.87 mg) in methanol (4 mL) and then rinsed with methanol, water, and submerged in PBS.
- the second block was then grown via repeating the above procedure but using a nitrogen purged methanol:water (1:1) and reacting for 3 hours. Termination of bromine groups and replacement with non-reactive azide moieties for reducing the second block polymer density was achieved by submerging the single layer chips in an aqueous azide solution (0.1 M) for 2 hours, removing and rinsing with PBS, water, and then drying for ATRP.
- the DTCA photoiniferter was synthesized as described in T. Otsu, Journal of Polymer Science Part a—Polymer Chemistry 2000, 38, 2121-2136. SAMs on cleaned SPR chips (Z. Zhang, S. F. Chen, Y. Chang, S. Y. Jiang, J. Phys. Chem. B 2006, 110, 10799-10804) of the photoiniferter were formed by soaking overnight in THF containing DTCA (2 mM) followed by rinsing with THF and drying with a stream of air. For single layers, the photoiniferter modified chip was transferred to a quartz reaction tube along with 170 mg of CB monomer and placed under nitrogen.
- the thickness of the pCB films were determined using an ellipsometer (Model alpha-SE, J. A. Woollam, Lincoln, Nebr.) using the 380-900 nm wavelength range at an incidence angle of 70°. The results were fitted to a Cauchy module.
- SPR chips were made of a glass slide coated with titanium (2 nm) followed by gold (48 nm) using an electron beam evaporator.
- a 1 nm SPR wavelength shift corresponded to a change in the protein surface coverage of 17 ng cm ⁇ 2 , which was corrected to account for loss of sensitivity due to the polymer films using previously described methods (W. Yang, H. Xue, W. Li, J. L. Zhang, S. Y. Jiang, Langmuir 2009, 25, 11911-11916; J. Homola, Surface Plasmon Resonance Based Sensors.; Springer-Verlag: Berlin, Germany, 2006).
- undiluted human serum or plasma were injected (10 min, 40 ⁇ L min-1) and the wavelength shift between PBS baselines was converted to a surface coverage.
- Anti-TSH was immobilized by first injecting 10 mM sodium acetate (SA, pH 5) followed by EDC/NHS (0.2 M/0.05 M in water) for 7 min at 30 ⁇ L min-1.
- Anti-TSH 50 ⁇ g mL-1 in 10 mM HEPES pH 7.5
- Immobilization was calculated as the difference between SA baselines before IgG injection and after deactivation.
- TSH was antigen binding was then monitored by first injecting PBS and then antigen (1 ⁇ g mL ⁇ 1 in PBS at 40 ⁇ L min ⁇ 1 ) following by PBS.
- polycarboxybetaine (pCB) films prepared by SI-PIMP are described.
- Solvents including acetone, methanol (MeOH) and tetrahydrofuran (THF) at the highest available purity were obtained from Sigma-Aldrich (Milwaukee, Wis.).
- CB monomer and photoiniferter N,N-(diethylamino)-dithiocarbamoylbenzyl(trimethyoxy)thiol (DTCA) were synthesized by literature methods.
- Fibrinogen, lysozyme, tetraethylthiuram disulfide (TED), N-hydroxysuccinimide (NHS) and ethyl(dimethylaminopropyl) carbodiimide (EDC) were obtained from Sigma-Aldrich.
- Human thyroid stimulating hormone (TSH) antibody and antigen were from Thermo Scientific (Waltham, Mass.).
- Deionized water with minimum resistivity of 18.0 M ⁇ cm used in the experiment was from a Millipore water purification system (Billerica, Mass.).
- the buffers including 150 mM phosphate buffered saline (PBS) at pH 7.4, 10 mM sodium acetate buffer (SA) at pH 5.0, 10 mM sodium carbonate buffer (SC) with 300 mM NaCl at pH 10 and 10 mM HEPES at pH 7.5 were prepared for biomolecular conjugation and bioassay. The pH values were adjusted with HCl or NaOH. The buffers were degassed prior to use. Human plasma used for challenging the surface coatings were purchased from BioChemed Services (Winchester, Va.).
- the UV-ozone cleaned SPR chip was immersed in THF containing 2 mM DTCA at room temperature for 24 h in order to form a self-assembled monolayer (SAM) of photoiniferter, followed by intensive rinsing with THF and drying with a stream of filtered air.
- SAM self-assembled monolayer
- the photoiniferter modified chip was transferred to a quartz reaction tube containing 170 mg of CB monomers and TED molecules with different concentrations for growth of the first pCB layer.
- the reaction tube was placed under nitrogen protection, sealed with a rubber septum and wrapped with parafilm.
- the solvents used were deoxygenated with a continuous stream of dry nitrogen for more than 30 min, and then 5 mL of MeOH was transferred to the reaction tube using a syringe under nitrogen protection.
- the photo-polymerization was conducted by means of a UV lamp emitting light at 302 nm coupled with 280 nm cutoff filter in order to avoid the deterioration of thiol-gold bonds. 31 After the 30 min UV exposure, the chips were removed and rinsed with water and PBS to remove loosely bound polymers.
- the preparation method was the same as that for the first layer, but the TED was not needed and the water content in the solvents was adjusted to optimize the thickness of the films.
- the dry thicknesses (d) of pCB was determined using an ellipsometer (model alpha-SE, J. A. Woollam, Lincoln, Nebr.) with a light source with wavelengths ranging from 380 to 900 nm at a fixed incident angle of 70°. The thickness measurements were taken on six spots on each sample. The results were analyzed using a Cauchy model. The refractive index of polymer films was around 1.5.
- a four-channel SPR sensor was used (H. Vaisocherová, W. Yang, Z. Zhang, Z. Cao, G. Cheng, M. Piliarik, J. Homola, S. Jiang, Analytical Chem., 80, 7894 (2008)).
- the SPR sensor based on the Kretschman configuration, detects the changes of the refractive index arising from the molecular adsorption at the sensor chip surface.
- the sensor chip was washed with PBS and water and dried with a stream of air. On the glass side of the chip a drop of the refractive index matching liquid (Cargille, Cedar Grove, N.J.) was placed and then attached onto the base of the prism.
- the refractive index matching liquid Cargille, Cedar Grove, N.J.
- the flow cell was mounted on the chip and filled with the buffer by a peristaltic pump (Ismatec, Vernon Hills, Ill.).
- a baseline signal was established by flowing PBS at a flow rate of 30 ⁇ L min ⁇ 1 over the chip surface for 20 min.
- undiluted blood serum and plasma were flowed over the chip at a flow rate of 30 ⁇ L min ⁇ 1 for 10 min, followed by PBS washing.
- a 1 nm SPR wavelength shift represents a change in the protein surface coverage of 17 ng cm ⁇ 2 .
- the unreactive groups were hydrolyzed to recover to carboxyl acid groups by washing with basic SC buffer at a flow rate of 30 ⁇ L min ⁇ 1 for 10 min, followed by SA buffer.
- the binding capacity was estimated as the surface mass changes before the IgG injection and after hydrolysis in SA buffer.
- TSH antigens spiked in PBS at a concentration of 1 ⁇ g mL ⁇ 1 were performed after TSH IgG functionalization on pCB layers. Prior to and after the assay, PBS buffer was flowed over the polymer surfaces for 20 min. Samples containing TSH antigens were introduced into the channels of the flow cell at a flow rate of 30 ⁇ L min ⁇ 1 and flowed until the binding curve reached a plateau.
- the pCB films with and without IgG functionalization on SPR chips were dried with a stream of filter air and attached onto the AFM sample holder.
- the AFM secondographic images were taken in a taping mode using a Dimension 3100 AFM (Digital Instruments/Veeco, Woodbury, N.Y.).
- Noncontact silicon cantilevers with a resonant frequency of 315 kHz and a force constant of 48 N m ⁇ 1 (MikroMasch, Tallinn, Estonia) were used.
- polycarboxybetaine (pCB) films prepared by SI-ATRP are described.
- CBAA (3-Acryloylamino-propyl)-(2-carboxy-ethyl)-dimethyl-ammonium (CBAA) was synthesized by reacting 48 mL of DMAPA with 25 g of ⁇ -propiolactone in 400 mL of anhydrous acetone at 0° C. under nitrogen protection. After removing the ice bath at 20 minutes, the solution was allowed to warm up to room temperature. After 6 hours, the product was filtered, washed with ether, and allowed to dry under vacuum. The rough product, a white precipitate, was re-dissolved in a 30% (v/v) triethylamine in methanol solution and stirred overnight.
- SPR sensor chips coated with ATRP initiator self-assembled monolayers were prepared by soaking the gold-coated substrates into 1 mM mercaptoundecyl bromoisobutyrate in pure ethanol for 24 hours. The chips were then removed, rinsed with ethanol, THF, and ethanol, and the blown dry using filtered compressed air and placed into a custom glass tube reactor for ATRP. In a separate glass tube, 8.86 mg CuBr, 57.85 mg 2,2′-bipyridine (BPY), and 600 mg of CBAA were added. Both tubes were then placed under nitrogen protection. Nitrogen purged methanol (4 mL) was then added to the solids.
- BPY 2,2′-bipyridine
- the mixture was then transferred to the reactor tube under nitrogen protection and allowed to react for 24 hours at 25° C. in a shaker set to 120 rpm.
- the reaction was removed and quenched with a solution containing methanol (4 mL) and CuBr 2 (275.87) in order to maintain the maximum number of surface terminal bromine grown polymer chains.
- the chips were rinsed with methanol, water, and then submerged in PBS.
- the second polymer block was then grown by repeating the above ATRP procedure and adjusting only the solvent ratio between nitrogen purged methanol and water in the final reaction mixture.
- For the re-initiated polymerization was allowed to react for 3 hours at 25° C. in a shaker set to 120 rpm. Following the reaction the chips were rinsed with copious amounts of water and then submerged overnight in PBS. In order to terminate bromine groups on the surface and replace them with non-reactive azide moieties to further reduce the polymer density of the second block, the chips were submerged in an aqueous solution of sodium azide (6.5 mg/mL) and mixed at room temperature. After a specific time, the chips were removed, dipped in PBS, rinsed with water, dried, and the placed into the custom tube reactor for re-initiating ATRP.
- a laboratory SPR sensor developed at the Institute of Photonics and Electronics, Prague, Czech Republic was used as described in H. Vaisocherová, W. Yang, Z. Zhang, Z. Cao, G. Cheng, M. Piliarik, J. Homola, S. Jiang, Analytical Chem., 80, 7894 (2008).
- the SPR is based on the attenuated total reflection method and wavelength modulation. It is equipped with a four-channel flow-cell, temperature control, and uses a peristaltic pump for delivering samples.
- SPR sensor chips were made of a glass slide coated with an adhesion-promoting titanium film (about 2 mm) followed by a gold film (about 48 nm) using an electron beam evaporator. Because the SPR sensitivity depends on the distance of the binding event from the SPR active surface, the sensor response due to the polymer films was calibrated as described in H. Vaisocherová et al., 2008 (above).
- the non-specific protein adsorption of the pCBAA polymer films formed via SI-ATRP was determined with a SPR biosensor using a flow rate of 50 ⁇ L/min at 25° C. After first establishing a baseline using PBS, undiluted human serum was flowed for 10 minutes, followed by buffer to reestablish the baseline. Protein adsorption was quantified as the difference between buffer baselines and converted to a surface coverage using the appropriate sensitivity factor.
- the functionalization procedure was monitored step-by-step in real time using an SPR sensor at 25° C.
- Sodium acetate buffer (10 mM) at pH 5.0 (SA) was first injected at 30 ⁇ L/min to obtain a stable baseline.
- the carboxylate groups of the polymer surface were then activated by flowing a freshly prepared solution of 0.05 M NHS and 0.2 M EDC in water for 7 minutes.
- SA buffer a solution of anti-TSH (50 ⁇ g/mL) in HEPES buffer (pH 7.5) was flowed over the activated surface for 20 minutes at 20 ⁇ L/min.
- the pCBAA surface was washed with PBS buffer until a steady baseline was established at 50 ⁇ L/min and 25° C.
- undiluted human blood serum was then injected for 10 minutes followed by PBS for an additional 15 minutes.
- the net adsorption was calculated as the difference between buffer baselines and converted to a surface coverage.
- Specific antigen detection was compared by measuring the response at saturation for each polymer film. After establishing an initial buffer baseline, PBS spiked with TSH at 1000 ng/mL was flowed through sensor for 10 minutes followed by buffer. The saturated antigen binding was calculated as the difference between the original buffer baseline and the maximum response which was then converted to a surface coverage.
- Polymer brushes can theoretically be described via chain lengths and chain-to-chain distances. Practically, ellipsometry is often used to measure the film thickness, which has been correlated to ultra low fouling properties of polymer brushes to undiluted human blood plasma and serum. However, ellipsometry also calculates an additional parameter, the film refractive index (RI). This film RI can be used to characterize the polymer density, but is often overlooked in practice. The film RI may be an even more important parameter for identifying nonfouling polymer films.
- SI-ATRP surface-initiated atom transfer radical polymerization
- zwitterionic carboxybetaine protein resistance to undiluted human serum was determined to be strongly dependent on the film RI. A minimum value of about 1.5 RI units was necessary to achieve ⁇ 5 ng/cm 2 of protein adsorption, measured using a surface plasmon resonance biosensor.
- the swelling behavior of a film is one approach to study polymer density. Tightly packed polymer brushes in a good solvent will swell less than lower density brushes. These tightly packed films have high extension in the dry state and significant further extension is limited upon swelling. Ellipsometry also calculates an additional parameter, the film refractive index (RI).
- RI film refractive index
- This film RI can be used to characterize the polymer density, but is often overlooked in practice. Because the RI measurements of films account for two factors, the medium (e.g., air, RI of about 1.0) as well as the material itself (e.g., proteins, RI of about 1.53), the RI of a polymer film will increase with density. Importantly, the RI can be measured in the dry state, thus offering a convenient and simple approach for film characterization.
- SI-ATRP was used to investigate a parameter capable of characterizing and predicting ultra low fouling properties of pCBAA films.
- SI-ATRP is a controlled radical polymerization that enables the formation of polymer brushes with low polydispersity, high density, and a desired thickness. It is based on the equilibrium reaction between activated propagating chains and those that have been capped by a deactivating complex.
- the highly localized and low concentration of immobilized initiators in SI-ATRP (relative to solution ATRP) is a major challenge for achieving control due to the low concentration of persistent deactivator which can trap the propagating radical.
- the rate of polymerization is highly dependent upon the ratio of activator to deactivator; reduction in the latter leads to fast and uncontrolled growth.
- Ultra low fouling properties of pCBAA films formed via SI-ATRP was investigated using surface plasmon resonance (SPR) biosensors. Protein resistance to undiluted human serum was studied as a function of the polymer thickness and dry refractive index, the latter representing the polymer density. The results indicated that the nonfouling properties of pCBAA films were not affected much by the polymer thickness, but instead were strongly dependent on the RI.
- SPR surface plasmon resonance
- UV cleaned SPR sensor chips coated with ATRP initiator self-assembled monolayers were prepared by soaking in 0.1 mM mercaptoundecyl bromoisobutyrate in pure ethanol for 24 hours. The chips were then removed, rinsed with ethanol, THF, and ethanol, and the blown dry using filtered air and placed into a custom glass tube reactor. In a separate glass tube, 8.86 mg CuBr, 57.85 mg 2,2′-bipyridine, and 600 mg of CBAA were added. Both tubes were then placed under nitrogen protection. Appropriate volumes of nitrogen purged methanol and water were then added (total volume was 4 mL) to the solids according to the necessary solvent ratio.
- the mixture was then transferred to the reactor tube under nitrogen protection and allowed to react for 3 hours at 25° C. in a shaker set to 120 rpm. Following the reaction the chips were rinsed with water and then submerged overnight in PBS.
- SPR sensor developed at the Institute of Photonics and Electronics, Prague, Czech Republic was used as described above. This custom built SPR is based on the Kretschmann geometry of the attenuated total reflection method with wavelength modulation and is equipped with a four-channel flow-cell, temperature control, and uses a peristaltic pump for delivering samples. SPR sensor chips were made of a glass slide coated with an adhesion-promoting titanium film (about 2 nm) followed by a gold film (about 48 nm) using an electron beam evaporator. Because SPR sensitivity depends on the distance of the binding event from the SPR active surface, the sensor response due to the polymer films was calibrated using methods described above.
- RI dry and wet film thickness and refractive index
- a multi-wavelength ellipsometer J. A. Woollam Co., Inc., Model alpha-SE.
- a liquid cell with a volume of 0.5 mL supplied by the manufacturer was used for obtaining the wet measurements.
- the data was analyzed via fitting a Cauchy model for a bare SPR substrate which enables the film thickness and refractive index to be simultaneously determined without using predetermined or assumed Cauchy coefficients.
- the wet and dry refractive index measurements were then used with the effective medium approximation for calculating the wet polymer density (i.e., film polymer volume fraction (PVF). See Equation 1.
- the wet polymer density (PVF) in PBS of pCBAA films made via SI-ATRP using 0%, 10%, 50% and 90% water (v/v) was calculated using Equation 1 as described above.
- Nonspecific protein adsorption of the pCBAA polymer films was determined with a SPR biosensor using a flow rate of 50 ⁇ L/min at 25° C. After first establishing a baseline using PBS, undiluted human serum was flowed for 10 minutes, followed by buffer. Protein adsorption was quantified as the difference between buffer baselines and converted to a surface coverage using the appropriate sensitivity factor.
- the pCBAA films were achieved by varying the SI-ATRP water content from 0-90% (v/v) using a fixed reaction time.
- the corresponding dry film thicknesses (8-40 nm), dry RI values (1.48-1.56 RI units (RIU)), and protein adsorption to undiluted human serum indicated a maximum value for both the thickness and RI as the polymerization rate was varied. All films except for those made using 90% water (v/v) enabled ultra low fouling properties. Thus it appears that thickness does not play a significant role in protein resistance. Because the dry film RI is proportional to the polymer density, the relatively high fouling for the films made from 90% water is likely due to its lower polymer density with a correspondingly reduced hydration, the primary mechanism of protein resistance.
- the thickness as well as the polymer density are simultaneously changing.
- the thickness can still serve as an indirect measure for achieving nonfouling surfaces.
- the results here illustrate that the polymer density may be the direct and more important parameter for reflecting protein resistance. This enables one to achieve ultra low fouling with a densely packed thin film.
- a minimum RI value (about 1.5) was observed, representing a minimum polymer density for achieving ultra low fouling properties with pCBAA films.
- the pCBAA film had a peak thickness at about 40 nm using 20% water (v/v).
- the ATRP reaction rate has been shown to be significantly affected by the concentration of water. As the water content increases, the rate of polymerization increases primarily due to loss of deactivator. For example, polymer films grown using 0% water enable a relatively slow reaction with low polydispersity. Under this condition, the final thickness is likely limited by the maximum solubility of the dense brushes in methanol. Here, the solvation ability of methanol gradually changes from good to bad as the chain length increases and the solubility approaches saturation.
- the RI measurements have a similar trend to the film thicknesses. Because the dry film RI is proportional to polymer density, these results indicate that the density initially increases and then rapidly decreases with the rate of the ATRP reaction.
- the films made from 0% and 90% water had the lowest densities in air, despite the former being made under the most controlled conditions (i.e., water-free) which would be expected to yield a very high density polymer brush.
- the films made using 10%-60% water had the highest polymer densities. These are attributed to changes in surface morphology and packing structure of the film due to the increased polydispersity allowing for ion-pair interactions of the loose chains, which collapse onto the surface in the presence of air, similar to a multilayer polyelectrolyte film.
- the low value achieved for the film made from 0% water is due to the highly uniform and monodisperse brush containing few collapsed chains.
- the result for the film made with 90% water (v/v) was likely caused by excessive radical termination reactions which occur under this condition, thus creating little pockets for air thereby reducing the density. This is supported by the rapid decrease in thickness for films made from high water concentrations.
- the wet polymer density (polymer volume fraction (PVF)) in PBS of several films was also studied.
- a low wet density will have a large amount of solvent relative to polymer material thus enabling a large degree of swelling, corresponding to a “loose” polymer structure.
- the films made using 0%, 10%, 50%, and 90% water had wet densities of 62%, 48%, 35%, and 73%, respectively.
- the initial decrease follows the expected increase in polydispersity for the faster polymerizations, such as with high water concentrations. Therefore, because the films made using 90% water elicit widespread termination events, as indicated by the rapid decrease in thickness, it is believed that such significant chain-end recombination restricted the polymer from swelling yielding a high wet density.
- the data revealed a RI range of 1.50-1.56 RIU with wet polymer densities from 62-35% PVF that allowed zwitterionic pCBAA films to achieve ⁇ 5 ng/cm 2 of nonspecific protein adsorption from undiluted human serum.
- the results enable a model of the polymer structure as a function of water content (polymerization rate) and protein resistance to be developed.
- the water free scenario results in thin but uniform and dense polymer brushes with low polydispersity and ultra low fouling properties. As the water concentration increases, the polydispersity increases but the amount of termination is not excessive enough to significantly suppress film growth.
- the continued propagation enabled by the lack of recombination provides for a similarly dense base-layer to form and thus ultra low fouling properties can be achieved.
- the scenario for high water content occurs with very fast and uncontrolled reactions in which radical recombination frequently occurs. This restricts polymer growth and reduces the polymer density thereby affecting the film hydration and subsequent protein resistance.
- Polymer brushes based on dual-function poly(carboxybetaine acrylamide) (pCB) were prepared via surface-initiated photoiniferter-mediated polymerization to determine the effects of the chain packing density on the protein resistant properties of surface-initiated polymer brushes.
- pCB poly(carboxybetaine acrylamide)
- the resulting pCB film thicknesses in air and physiological buffer were measured and correlated with the non-fouling properties to undiluted human serum and plasma.
- Human thyroid stimulating hormone (TSH) detection using SPR integrated with a highly packed and thin pCB film as a binding platform demonstrated remarkable sensitivity and specificity.
- the SI polymerization was carried out in the mixture of ethanol and water with a volume ratio of 75:25 with a monomer concentration of 0.15 M.
- the thickness (d) and swelling ratio (G) of prepared pCB films was measured using an ellipsometer and analyzed as a function of the UV radiation time.
- the thicknesses of pCB films in air and PBS increased with the UV radiation time.
- the swelling ratio showed the opposite trend, declining from 3.6 to 2.8 for the 30 min UV radiation time.
- a pCB film with a thin thickness and high packing density was prepared through changing the solvent content in the polymerization.
- the UV radiation time and monomer concentration remained constant at 30 min and 0.15 M, respectively, and the volume ratio of methanol to water in solution was changed from 50% to 100%.
- Film thicknesses in air and in PBS decreased with the ratio of methanol, as well as their swelling ratio, which dropped from 3.7 to 2.5.
- the surface resistance to fouling from serum and plasma on pCB samples indicates that with increasing methanol content during photo-polymerization, non-specific adsorption on surfaces tends to decrease, reaching the ultra low fouling level.
- Functionalizable pCB was applied to a binding platform in SPR for in situ detection of TSH antigens in undiluted serum.
- Experiments were performed on pCB films fabricated from the solvents with MeOH:H 2 O ratios of 50:50, 70:30 and 100:0 under 30 min UV radiation, and the wet thicknesses of resulting films were 93.7 ⁇ 1.5 nm, 67.8 ⁇ 1.2 nm, and 22.8 ⁇ 2.3 nm, respectively.
- those samples were denoted pCB-94, pCB-68, and pCB-23, respectively, according to their wet thicknesses.
- the surfaces were functionalized with anti-TSH antibodies through EDC/NHS coupling chemistry and the resulting binding capacities were 422.7 ⁇ 8.2 ng cm ⁇ 2 , 396.2 ⁇ 13.6 ng cm ⁇ 2 , and 262.5 ⁇ 0.8 ng cm 2 on pCB-94, pCB-68 and pCB-23, respectively.
- undiluted blood serum containing 1 ⁇ g mL-1 TSH antigens was flowed over the surfaces in contact with conjugated IgG molecules and, additionally, in the other channel the serum without antigen was parallel tested as a control experiment.
- the signals obtained from TSH-containing channels were subtracted from the signals of control channels.
- the net sensor responses to TSH binding on pCB films indicated that the strengths of responses increased with decrease in film thicknesses.
- the evanescent wave-based biosensor such as SPR, exhibits a strength profile of a probing field exponentially decaying from the interface.
- the penetration depth of the probing field is typically around 200 nm, beyond which the binding event cannot be detected.
- pCB-23 with high chain packing density was prepared under a water-free condition. Compared to the films prepared from water-rich solutions, the pCB-23 represents very high sensor responses to TSH binding in complex media due to its ultra-low fouling properties and thin thickness although its antibody loading was the lowest. Therefore, the high resistance to non-specific adsorption and the effective use of probing field allow enhancing dramatically the specificity and sensitivity of biosensors.
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Materials For Medical Uses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
Hierarchical films with structurally regulated functionalities through the integration of two-dimensional and three-dimensional structures to achieve ultra low nonspecific binding and high loading of molecular recognition elements, and methods for making and using the films.
Description
- This application is a continuation of U.S. application Ser. No. 13/747,290, filed Jan. 22, 2013, which claims the benefit of U.S. Provisional Application No. 61/588,785, filed Jan. 20, 2012, the disclosures of which are expressly incorporated by reference herein.
- This invention was made with Government support under HDTRA1-10-1-0074 awarded by the Defense Threat Reduction Agency and under N000140910137 awarded by the Office of Naval Research. The Government has certain rights in the invention.
- Surface chemistries for biosensors, implantable medical devices, targeted drug/gene delivery carriers, tissue scaffolds, and targeted molecular imaging probes in complex media remain a great challenge due to high nonspecific adsorption and low binding capacity of molecular recognition elements. Currently, few materials have been developed to reduce nonspecific protein adsorption, including poly(ethylene glycol) (PEG), mannitol tetraglyme, and zwitterionic polymers. The effectiveness of protein resistant materials relies on their high surface packing densities. Unfortunately, highly dense two-dimensional (2D) polymer films elicit the limitation of a low ligand-binding capacity. At the same time, a three-dimensional (3D) carboxymethylated dextran-based hydrogel binding matrix was previously developed, enabling very high protein loading due to an open polymer structure. However, this open structure only provides weak surface resistance to nonspecific protein adsorption, particularly in complex media such as blood.
- Despite the advances in the development polymer films noted above, there is a need for polymer films with precisely controlled architecture for achieving advantageous properties for a variety of applications. The present invention seeks to fulfill this need and provides further related advantages.
- In one aspect, the invention provides hierarchical films.
- In one embodiment, the film comprises a first layer having a first layer density, wherein the first layer is attached to a substrate; and a second layer having a second layer density, wherein the second layer is attached to the first layer, wherein the first layer density is greater than the second layer density.
- In another embodiment, the film comprises a first nonfouling layer (low level of fibrinogen or lysozyme non-specific binding), wherein the first layer is attached to a substrate; and a second layer that can be functionalized to include recognition elements, wherein the second layer is attached to the first layer.
- In certain embodiments, the second layer of the films of the invention further comprises a plurality of recognition elements. Representative recognition elements include peptides, proteins, nucleic acids, and small molecules. In certain embodiments, the recognition element is an antibody or antibody fragment, or a DNA or an RNA.
- In certain embodiments, the first layer comprises a plurality of polymers. In one embodiment, the first layer is a polymer brush. In certain embodiments, the first layer is a nonfouling layer. In certain embodiments, the first layer has a fibrinogen binding level less than about 30 ng/cm2. In other embodiments, the first layer has a lysozyme binding level less than about 30 ng/cm2. In certain embodiments, the first layer comprises a first polymer layer having a first polymer density, and the first polymer layer comprises a plurality of first polymers, each of the first polymers having a first end and a second end, wherein each first polymer is attached to a substrate through its first end. In certain embodiments, the first polymers are grafted from the substrate. In other embodiments, the first polymers are grafted to the substrate.
- In certain embodiments, the second layer comprises a plurality of polymers. In certain of these embodiments, the second layer is a crosslinked layer (e.g., a hydrogel). In certain embodiments, the second layer comprises a second polymer layer having a second polymer density, wherein the second polymer layer comprises a plurality of second polymers, each of the second polymers having a first end and a second end, wherein each second polymer is attached to a first polymer through its first end. In certain embodiments, the second polymers are grafted from the first polymers. In other embodiments, the second polymers are grafted to the first polymers.
- The first or second polymers are independently selected from charged polymers and copolymers and non-charged polymers and copolymers. Representative charged polymers and copolymers include zwitterionic polymers and copolymers and mixed charge copolymers. Representative zwitterionic polymers include polysulfobetaines, polycarboxybetaines, polyphosphobetaines, peptides, and peptoids. Representative non-charged polymers include alkylene oxide polymers and copolymers (e.g., PEGs), polysaccharide polymers and copolymers (e.g., dextrans), acrylamide polymers and copolymers (e.g., acrylamide and methacrylamide polymers and copolymers), and hydroxy-terminal polymers and copolymers (e.g., HEMA and HPMA).
- In certain embodiments, the films of the invention include one or more additional layers attached to the second layer.
- In the films of the invention, the first layer is attached to a substrate surface. Suitable surfaces include metal and metal oxide surfaces, ceramic surfaces, synthetic and natural polymeric surfaces, glass surfaces, fiber glass surfaces, silicon/silica surfaces, carbon-based material surfaces, cell surfaces, and macromolecule surfaces (e.g., protein, DNAs, lipids). Representative substrates include diagnostic devices, medical devices, separation devices, targeting delivery carriers, tissue scaffolds, and marine devices.
- In another aspect, methods for making the films of the invention are provided. In one embodiment, the method includes forming a first layer having a first layer density on a substrate; and forming a second layer on the first layer, the second layer having a second density, wherein the first layer density is greater than the second layer density. In certain embodiments, the method further comprises attaching a plurality of recognition elements to the second layer. In other embodiments, the method further comprises attaching one or more additional layers to the second layer.
- In certain embodiments, forming the first layer comprises grafting first polymers from the substrate. In other embodiments, forming the first layer comprises grafting first polymers to the substrate.
- In certain embodiments, forming the second layer comprises grafting the second polymers from the first polymers. In other embodiments, forming the second layer comprises grafting the second polymers to the first polymers.
- In a further aspect, the invention provides methods for determining the presence of an analyte in a sample. In one embodiment, the method comprises contacting a sample with a film of the invention comprising one or more recognition elements, wherein the recognition element has a specific binding affinity for the analyte, and interrogating the film to determine whether the analyte has bound to the film.
- The foregoing aspects and many of the attendant advantages of this invention will become more readily appreciated as the same become better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings.
-
FIG. 1 is a schematic illustration of a representative polymer film of the invention having an ultra low fouling first layer and high-loading second layer. -
FIGS. 2A-2C compare IgG functionalization levels (2A), fouling levels in the presence of undiluted serum or plasma, before and after IgG functionalization (2B), and antigen detection (2C) on films with one-layer (One) and hierarchical (HA) structures prepared via SI-ATRP and SI-PIMP. -
FIG. 3 is an SPR sensorgram for a fouling test in the presence of undiluted blood plasma or serum on a representative hierarchical pCB film of the invention. -
FIG. 4 is an SPR sensorgram for a fouling test on a representative hierarchical pCB film of the invention following modification with TSH IgG, deactivation with SC buffer, and then used for TSH antigen detection. -
FIGS. 5A and 5B are schematic illustrations of conventional platforms.FIG. 5A illustrates a single layer 2D pCB platform having excellent nonfouling properties, but low antibody loading (left panel) and a commercial dextran platform having high antibody loading, but poor nonfouling properties (right panel).FIG. 5B is a schematic illustration of a representative two-layer film of the invention having a first dense pCB layer to resist nonspecific adsorption and a second loose (less dense) pCB layer to achieve high antibody loading. -
FIG. 6 is a schematic illustration of a photoiniferter-mediated polymerization of surface-tethered pCB brushes in the presence of TED deactivator. -
FIG. 7A compares SPR sensorgrams for fouling tests on pCB films prepared from 100% MeOH without TED addition in contact with undiluted plasma (●), fibrinogen (♦), lysozyme (⋄). -
FIG. 7B compares film thickness and IgG binding capacity of pCB films as a function of the TED concentration. The dry film thicknesses were measured using ellipsometer. IgG molecules were chemically conjugated on binding platforms with one- and two-layer pCB structures and their binding capacities were estimated using SPR. -
FIG. 8A compares IgG binding capacity and dry thickness of the second layer as a function of the water content in the polymerization for the second layer. -
FIG. 8B compares IgG binding capacity versus EDC/NHS activation time. -
FIG. 9A compares SPR sensorgrams for fouling tests with undiluted blood plasma on the two-layer structured pCB films with and without IgG functionalization. -
FIG. 9B compares TSH binding capacity and surface bioactivity on pCB films with one-layer and two-layer structures. -
FIG. 10A is a schematic illustration of the preparation of representative films of the invention for sensing and detection in undiluted complex media using a two-layer architecture integrated with zwitterionic dual-functional pCB. -
FIG. 10B is a schematic illustration of the preparation of representative films of the invention. -
FIG. 11 compares antibody immobilization versus azide exposure time for second layer pCB films grown from 10% and 50% water content. -
FIG. 12 compares antigen response versus azide exposure time for second layers made using 10% and 50% water content. For 10% SI-ATRP water content, all responses were very similar with surfaces resulting in antigen-antibody saturation. For 50% water content, both the 0 min and the 120 min conditions resulted in saturation. However, despite the 60 min condition having the highest level of antibody immobilization, the response was low due to the restricted ability of the antigen to diffuse through the polymer film thus taking longer to saturate binding. The antigen solution was flowed for a fixed time of 10 min. -
FIG. 13 compares fouling to undiluted human serum versus azide exposure time for second layer films made using 10% and 50% water content. -
FIG. 14 compares the effect of solvent water concentration on the second layer polymerization using a one hour azide treatment. -
FIG. 15A compares thicknesses and swelling ratios of pCB films with dry thicknesses of about 10 nm. The thicknesses in air (full squares) and PBS (full circles) and the swelling ratio (hollow squares) were measured using an ellipsometer. -
FIG. 15B compares the fouling tests for pCB films from (a) with serum (darker bars) and plasma (lighter bars) were determined using a SPR sensor. -
FIG. 16 compares serum fouling versus dry film refractive index and illustrates a minimum packing density that is necessary to achieving ultra low fouling properties. - The present invention provides hierarchical films with structurally regulated functionalities through the integration of two-dimensional and three-dimensional structures to achieve ultra low nonspecific binding and high loading of molecular recognition elements. Methods for making and using the films are also provided.
- As used herein, the term “hierarchical” refers to the layered architecture of the films, where the individual layers have specific functions and properties.
- The present invention provides dual-functional nonfouling films, methods for making dual-functional nonfouling films, and devices that include dual-functional nonfouling films. The dual-functional films of the invention are films that are nonfouling (e.g., ultra low-fouling) surfaces that resist non-specific protein adsorption and cell adhesion. The dual-functional films of the invention also include covalently coupled recognition elements (e.g., target binding partners) that impart specific binding activity to the surfaces. Because the dual-functional films of the invention are nonfouling and include immobilized recognition elements, these films are useful in any method or device that requires sensitive specific binding or specific binding measurement and at the same time requires resistance to non-specific protein binding and cell adhesion. The dual-functional films of the invention are useful in medical diagnostic applications, biomaterials and tissue engineering, and drug delivery.
- Dual-Functional Films
- In one aspect, the invention provides a film that includes two layers: a first layer having a first layer density and attached to a substrate; and a second layer having second density and attached to the first layer. In certain embodiments, the density of the first layer is greater than the density of the second layer. In other embodiments, the film comprises a first nonfouling layer (low level of fibrinogen or lysozyme non-specific binding as described below), wherein the first layer is attached to a substrate; and a second layer that can be functionalized to include recognition elements, wherein the second layer is attached to the first layer. In preferred embodiments, the second layer of the films of the invention includes a plurality of recognition elements.
- The terms “film,” “coating,” and “surface coating” are used interchangeably and refer the constructs of the invention having two layers as described above.
- In certain embodiments, the first layer is a nonfouling layer. As used herein, the terms “nonfouling” and “ultra low fouling” refers to layers and films of the invention that resist or prevent non-specific protein adsorption and cell adhesion. Non-specific protein adsorption can be measured by determining the level of protein (e.g., fibrinogen or lysozyme) adsorption that adsorbs to the surface per unit area.
- The first layer of the films of the invention adsorb less than about 30 ng/cm2 fibrinogen or lysozyme. In one embodiment, the first layer has a fibrinogen or lysozyme adsorption less than about 10 ng/cm2; in one embodiment, the fibrinogen or lysozyme adsorption is less than about 5 ng/cm2; in one embodiment, the fibrinogen or lysozyme adsorption is less than about 3 ng/cm2; and in one embodiment, the fibrinogen or lysozyme adsorption is less than about 0.3 ng/cm2.
- The nonfouling function of the film is imparted to the first layer by the materials of the first layer coupled to the surface. These materials include zwitterionic materials. Suitable materials useful in making the surfaces include the polymers and copolymers described in U.S. Pat. No. 7,879,444 (Superlow-Fouling Sulfobetaine and Carboxybetaine Materials and Related Methods) and US 20090259015 (Mixed Charge Copolymers and Hydrogels), each expressly incorporated herein by reference in its entirety. Methods for measuring protein adsorption (fibrinogen) are described in U.S. Pat. No. 7,879,444, expressly incorporated herein by reference.
- The thickness of the first layer of the film of the invention can vary depending on the intended use of the film. In certain embodiments, the first layer has a thickness from about 1 to about 100 nm. In certain other embodiments, the first layer has a thickness from about 1 to about 20 nm.
- The second layer of the films of the invention is attached to the film's first layer and has a density less than the density of the first layer. In certain embodiments, recognition elements are attached to the second layer to render the films dual-functional films. In these embodiments, the second layer includes materials having a functional group or groups suitably reactive to immobilize recognition elements (e.g., proteins such as antibodies). Representative functional groups for these dual-functional materials include carboxylic acid groups and amino groups, among others. As described in detail below, in one embodiment, the dual-functional materials are zwitterionic materials that can be attached (e.g., covalently coupled) to a surface and that have terminal carboxylic acid groups. These terminal carboxylic acid groups can be activated for coupling to one or more amino groups present in a biomolecule. In this embodiment, the carboxylic acid groups may be converted to active esters (e.g., N-hydroxysuccinimide esters) and then reacted with one or more amino groups (e.g., amino group of a lysine residue of a protein) to form an amide bond thereby immobilizing the protein to the surface to provide a dual-functional film of the invention.
- In the second layer, the materials can include carboxylic acid groups and certain of these carboxylic acid groups are available for further chemical reaction, specifically the immobilization of recognition elements (i.e., target binding partners) to the materials and, therefore, the film. In certain embodiments, recognition elements having available amino groups (—NH2) can be covalently coupled to the materials' available carboxylic acid groups to immobilize the recognition element through stable amide linkages (—CONH—). In the practice of the invention, a portion of the materials having available carboxylic acid groups are activated for coupling and then covalently coupled to the recognition elements to provide immobilized recognition elements. The extent of recognition elements immobilized to the films of the invention can be readily controlled through the reaction conditions (e.g., extent of carboxyl group activation and concentration and amount of recognition elements exposed to the activated layer for immobilization. Schematic illustrations of representative nonfouling films of the invention having immobilized recognition elements are shown in
FIGS. 1, 10A, and 10B . It will be appreciated that in certain circumstances, due to the difference in densities between the second and first layers and the nature of the first layer, recognition elements may be attached to the first layer. - The thickness of the second layer of the film of the invention can also vary depending on the intended use of the film. In certain embodiments, the second layer has a thickness from about 10 nm to about 300 μm. In certain other embodiments, the second layer has a thickness from about 100 nm to about 100 μm.
- It will be appreciated that films with additional layers (e.g., third, fourth, fifth layers) are within the scope of the invention. The additional layers can be formed on the two-layer film described herein. For example, the third layer can be formed on the second layer (e.g., by “graft from” or “graft to” techniques). Subsequent layers can be similarly formed.
- Polymer Films
- Representative films of the invention include polymer films. As used herein, the term “polymer film” refers to a film of the invention in which the first layer is a polymer layer, the second layer is a polymer layer, or the first and second layers are polymer layers.
- In certain embodiments, the first layer comprises a plurality of polymers. For these embodiments, the first layer is a polymer layer. Suitable polymers layers include polymer brushes. As used herein, the term “polymer brush” refers to an assembly of polymer chains in which an end of each polymer chain is attached to a substrate surface.
- The second layer may also comprise a plurality of polymers. For these embodiments, the second layer is a polymer layer. In certain of these embodiments, the second layer is a crosslinked polymer layer and, in certain of these embodiments, the second layer is a hydrogel.
- As noted above, in certain embodiments, the films of the invention, the density of the first layer is greater than the density of the second layer.
- As noted above, in certain embodiments, the first layer of the films of the invention have a density greater than the density of the second layer. As used herein, the term “density” has its common meaning: mass per unit volume. The greater density of the first layer of films of the invention is readily apparent from the schematic illustrations of representative films in
FIG. 10A . Referring toFIG. 10A , because not every first polymer in the first layer is attached to a second polymer in the second layer, the density of the second layer is necessarily less than the density of the first layer. - The density of layers can be determined by refractive index or swelling ratio as described herein. Representative films of the invention have a dry film refractive index from about 1.40 to about 1.57 RIU. In one embodiment, the dry film refractive index is greater than about 1.45 RIU. In another embodiment, the dry film refractive index is greater than about 1.48 RIU. In a further embodiment, the dry film refractive index is greater than about 1.50 RIU. Dry film refractive index is measured as described in Example 4. See also
FIG. 16 . Representative films of the invention have a swelling ratio from about 1 to about 5. In one embodiment, the swelling ratio is less than about 4. In another embodiment, the swelling ratio is less than about 3. In a further embodiment, the swelling ratio is less than about 2.5. Swelling ratio is measured as described in Example 5. SeeFIGS. 15A and 15B . - In other embodiments, the film comprises a first nonfouling layer (low level of fibrinogen or lysozyme non-specific binding), wherein the first layer is attached to a substrate; and a second layer that can be functionalized to include recognition elements, wherein the second layer is attached to the first layer. In this embodiment, the first layer need not have a density that is greater than the second layer.
- For certain polymer films of the invention, the first layer comprises a first polymer layer having a first polymer density, and the first polymer layer comprises a plurality of first polymers, each of the first polymers having a first end and a second end, wherein each first polymer is attached to a substrate through its first end.
- Similarly, for certain polymer films of the invention, the second layer comprises a second polymer layer having a second polymer density, and the second polymer layer comprises a plurality of second polymers, each of the second polymers having a first end and a second end, wherein each second polymer is attached to a first polymer's second end through the second polymer's first end.
- In certain embodiments, the polymer film of the invention includes a first layer comprising a first polymer layer having a first polymer density, the first polymer layer comprising a plurality of first polymers, each of the first polymers having a first end and a second end, wherein each first polymer is attached to a substrate through its first end; and a second layer comprising a second polymer layer having a second polymer density, wherein the second polymer layer comprises a plurality of second polymers, each of the second polymers having a first end and a second end, wherein each second polymer is attached to a first polymer's second end through the second polymer's first end.
- As described above, the polymers are attached end to end (first polymer first end attached to the substrate, and first polymer second end attached to second polymer first end), it will be appreciated that the polymers need not be attached end to end. In certain embodiments the polymers can be attached through attachment sites that are not at the polymer end (terminus). The attachment sites can be near the polymer end or, for example, near the middle of the polymer.
- In certain embodiments, the first polymers are grafted from the substrate surface. As used herein, the term “grafted from” refers to an attachment method in which the polymer is formed from the substrate. In this embodiment, each of the first polymers are formed by polymerization from the substrate. Suitable polymerization methods include free radical polymerization, atom transfer radical polymerization (ATRP), reverse addition fragment transfer (RAFT), photoiniferter-mediated polymerization (PIMP), and condensation/ring opening polymerization.
- In other embodiments, the first polymers are grafted to the substrate surface. As used herein, the term “grafted to” refers to an attachment method in which the first polymer is attached to the substrate surface. In this embodiment, each of the first polymers are first formed and then attached to the substrate surface. The nature of the attachment of the first polymer to the substrate surface is not critical; the attachment site of each of the first polymer and substrate is suitably reactive to the other. In certain embodiments, the first polymer is attached to the substrate surface by click chemistry. See, for example, http://onlinelibrary.wiley.com/doi/10.1002/1521-3773(20010601)40:11%3C2004::AID-ANIE2004%3E3.0.CO;2-5/full. In other embodiments, the first polymer is attached to the substrate surface by thiol-ene chemistry. See, for example, http://onlinelibrary.wiley.com/doi/10.1002/anie.200903924/full. In certain embodiments, non-covalent association (e.g., ionic, hydrophobic, hydrogen bonding, or mechanical methods such as entanglement) are effective graft to methods.
- In certain embodiments, the second polymers are grafted from the first polymers. This refers to an attachment method in which the second polymer is formed from the first polymer. In this embodiment, each of the second polymers are formed by polymerization from a first polymer. Suitable polymerization methods include free radical polymerization, atom transfer radical polymerization (ATRP), reverse addition fragment transfer (RAFT), photoiniferter-mediated polymerization (PIMP), and condensation/ring opening polymerization.
- In other embodiments, the second polymers are grafted to the first polymers. This refers to an attachment method in which the second polymer is attached to the first polymer. In this embodiment, each of the second polymers are first formed and then attached to a first polymer. The nature of the attachment of the second polymer to the first polymer is not critical; the attachment site of each of the first and second polymers is suitably reactive to the other. In certain embodiments, the second polymer is attached to the first polymer by click chemistry. In other embodiments, the second polymer is attached to the first polymer by thiol-ene chemistry. As noted above, in certain embodiments, non-covalent association (e.g., ionic, hydrophobic, hydrogen bonding, or mechanical methods such as entanglement) are effective graft to methods.
- In the above methods, the second polymer may be attached to the first polymer by covalent coupling the second polymer to the first polymer.
- Graft from ATRP and PIMP methods for making films of the invention are described below and in Examples 1-3.
- The specific polymers making up the first and second layers is not critical so long as the properties of each layer are maintained as described above. Suitable first and second polymers include charged polymers and copolymers and non-charged polymers and copolymers. Suitable charged polymers include zwitterionic polymers and copolymers and mixed charge copolymers. Suitable non-charged polymers and copolymers include alkylene oxide polymers and copolymers, polysaccharide polymers and copolymers (dextrans), acrylamide polymers and copolymers, and hydroxy-terminal polymers and copolymers (HEMA). Representative zwitterionic polymers useful in the first and second layers include polysulfobetaines, polycarboxybetaines, polyphosphobetaines, peptides, and peptoids. Representative zwitterionic polymers useful in the second layer include polycarboxybetaines and mixed charge peptides.
- In some embodiments, the first polymers are selected from polysulfobetaines, polycarboxybetaines, polyphosphobetaines, and peptides, and the second polymers are selected from polycarboxybetaines and peptides. In other embodiments, the first polymers are polycarboxybetaines and the second polymers are polycarboxybetaines.
- In certain embodiments, the first and/or second polymers of the first and second layers of the polymer film of the invention are zwitterionic polymers. In the practice of the invention, these polymers may be prepared by polymerization of a zwitterionic (or latent zwitterionic) monomer.
- Representative zwitterionic first or second polymers have the formula:
-
PB-[L1-(N+(R2)(R3))-L2-AO2 −X−]n(M+)n - wherein
- PB is the polymer backbone having n pendant zwitterionic groups;
- R2 and R3 are independently selected from the group consisting of hydrogen, alkyl, and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
- L1 is a linker that covalently couples the cationic center [N+(R5)(R6)] to the polymer backbone;
- L2 is a linker that covalently couples the anionic center [A(═O)—O−] to the cationic center;
- A is C, S, SO, P, or PO;
- M+ is an optional counter ion associated with the (A=O)O− anionic center;
- X− is an optional counter ion associated with the cationic center; and
- n is an integer from 1 to about 10,000.
- Representative zwitterionic first or second polymers comprise a plurality of repeating units, each repeating unit having the formula:
- wherein
- R1 is selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C1-C6 alkyl, and C6-C12 aryl groups;
- R2 and R3 are independently selected from the group consisting of hydrogen, alkyl, and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
- L1 is a linker that covalently couples the cationic center [N+(R5)(R6)] to the polymer backbone [—(CH2—CR4)n—];
- L2 is a linker that covalently couples the anionic center [A(═O)—O−] to the cationic center;
- A is C, S, SO, P, or PO;
- M+ is an optional counter ion associated with the (A=O)O− anionic center;
- X− is an optional counter ion associated with the cationic center; and
- n is an integer from 1 to about 10,000.
- In one embodiment, the polymer is a polycarboxybetaine. Suitable polycarboxybetaines can be prepared from one or more monomers selected from the group consisting of carboxybetaine acrylates, carboxybetaine acrylamides, carboxybetaine vinyl compounds, carboxybetaine epoxides, and mixtures thereof. In one embodiment, the monomer is carboxybetaine methacrylate. Representative monomers for making carboxybetaine polymers useful in the invention include carboxybetaine methacrylates, such as 2-carboxy-N,N-dimethyl-N-(2′-methacryloyloxyethyl) ethanaminium inner salt; carboxybetaine acrylates; carboxybetaine acrylamides; carboxybetaine vinyl compounds; carboxybetaine epoxides; and other carboxybetaine compounds with hydroxyl, isocyanates, amino, or carboxylic acid groups. In one embodiment, the polymer is a poly(carboxybetaine methacrylate) (poly(CBMA)). In another embodiment, the polymer is a poly(carboxybetaine acrylate) (poly(CBAA)).
- In other embodiments, the first and/or second polymers of the first and second layers of the polymer film of the invention are mixed charge copolymers.
- As used herein, the term “mixed charge copolymer” refers to a copolymer having a polymer backbone, a plurality of positively charged repeating units, and a plurality of negatively charged repeating units.
- The mixed charge copolymer includes a plurality of positively charged repeating units, and a plurality of negatively charged repeating units. In one embodiment, the mixed charge copolymer is substantially electronically neutral. As used herein, the term “substantially electronically neutral” refers to a copolymer that imparts advantageous nonfouling properties to the copolymer. In one embodiment, a substantially electronically neutral copolymer is a copolymer having a net charge of substantially zero (i.e., a copolymer about the same number of positively charged repeating units and negatively charged repeating units). In one embodiment, the ratio of the number of positively charged repeating units to the number of the negatively charged repeating units is from about 1:1.1 to about 1:0.5. In one embodiment, the ratio of the number of positively charged repeating units to the number of the negatively charged repeating units is from about 1:1.1 to about 1:0.7. In one embodiment, the ratio of the number of positively charged repeating units to the number of the negatively charged repeating units is from about 1:1.1 to about 1:0.9. In the practice of the invention, these copolymers may be prepared by polymerization of an ion-pair comonomer.
- In one embodiment, the copolymers are prepared by copolymerization of suitable polymerizable ion pair comonomers.
- Representative ion-pair comonomers useful in the invention have the formulas:
-
CH2═C(R4)-L3-N+(R6)(R7)(R8)X− -
CH2═C(R5)-L4-A2(═O)—O−M+ - Representative mixed charge first or second polymers have the formula:
-
PB-[L3-(N+(R6)(R7)(R8)X−]n[L4-A2O2 −M+]p - wherein
- PB is the polymer backbone having n pendant cationic groups and p pendant anionic groups;
- R6, R7, and R8 are independently selected from hydrogen, alkyl, and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
- A(═O)—OM) is an anionic center, wherein A is C, S, SO, P, or PO, and M+ is an optional counter ion;
- L3 is a linker that covalently couples the cationic center [N+(R6)(R7)(R8)] to the polymer backbone;
- L4 is a linker that covalently couples the anionic center [A(═O)—OM] to the polymer backbone;
- X− is an optional counter ion associated with the cationic center;
- n is an integer from 1 to about 10,000; and
- p is an integer from 1 to about 10,000.
- Representative mixed charge first or second polymers comprise a plurality of repeating units, the copolymer having the formula:
- wherein
- R4 and R5 are independently selected from hydrogen, fluorine, trifluoromethyl, C1-C6 alkyl, and C6-C12 aryl groups;
- R6, R7, and R8 are independently selected from hydrogen, alkyl, and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
- A(═O)—OM) is an anionic center, wherein A is C, S, SO, P, or PO, and M+ is an optional counterion;
- L3 is a linker that covalently couples the cationic center [N+(R6)(R7)(R8)] to the polymer backbone;
- L4 is a linker that covalently couples the anionic center [A(═O)—OM] to the polymer backbone;
- X− is an optional counter ion associated with the cationic center;
- n is an integer from 1 to about 10,000; and
- p is an integer from 1 to about 10,000.
- As noted above, in certain embodiments, M+ and X− are optional as the cationic center and the anionic center provide an inner salt.
- For the above formulas illustrating polymer repeating units, * represents the point at which each repeating unit is covalently linked to the next.
- In the above formulas, the polymer backbone (PB) may be any one of a variety of backbones known to those of skill in the art (e.g., acrylic acid, alkylacrylic acid, such as methacrylic acid; acrylamide, alkylacrylamide such as methacrylamide). The nature of the polymer backbone is not critical. Suitable backbones include vinyl backbones (i.e., —C(R′)(R″)—C(R′″)(R″″)—, where R′, R″, R′″, and R′″ are independently selected from hydrogen, alkyl, and aryl) derived from vinyl monomers (e.g., acrylate, methacrylate, acrylamide, methacrylamide, styrene). Other suitable backbones include polyamide backbones, such as poly(amino acid) backbones.
- In the above formulas, N+ is the cationic center. In certain embodiments, the cationic center is a quaternary ammonium (e.g., N bonded to L1, R2, R3, and L2). In addition to ammonium, other useful cationic centers (e.g., R2 and R3 taken together with N) include imidazolium, triazaolium, pyridinium, morpholinium, oxazolidinium, pyrazinium, pyridazinium, pyrimidinium, piperazinium, and pyrrolidinium.
- R1-R8 are independently selected from hydrogen, alkyl, and aryl groups. Representative alkyl groups include C1-C10 straight chain and branched alkyl groups. In certain embodiments, the alkyl group is further substituted with one of more substituents including, for example, an aryl group (e.g., —CH2C6H5, benzyl). In one embodiment, R2 and R3, and R6, R7, and R8, are methyl. In one embodiment, R1—R8 are methyl. Representative aryl groups include C6-C12 aryl groups including, for example, phenyl. For certain embodiments of the above formulas, R2 and R3, and/or R6, R7, and R8 are taken together with N+ form the cationic center. In one embodiment, R7 and R8 are C1-C3 alkyl. In another embodiment, R6, R7, and R8 are C1-C3 alkyl.
- L1 is a linker that covalently couples the cationic center to the polymer backbone. In certain embodiments, L1 includes a functional group (e.g., ester or amide) that couples the remainder of L1 to the polymer backbone (or polymerizable moiety for the monomers). In addition to the functional group, L1 can include an C1-C20 alkylene chain. Representative L1 groups include —C(═O)O—(CH2)n— and —C(═O)NH—(CH2)n—, where n is 1-20 (e.g., n=2).
- L2 is a linker that covalently couples the cationic center to the anionic group. L2 can be a C1-C20 alkylene chain. Representative L2 groups include —(CH2)n—, where n is 1-20 (e.g., 1, 3, or 5).
- L3 is a linker that covalently couples the cationic center to the polymer backbone. In certain embodiments, L3 includes a functional group (e.g., ester or amide) that couples the remainder of L3 to the polymer backbone (or polymerizable moiety for the monomers). In addition to the functional group, L3 can include an C1-C20 alkylene chain. Representative L3 groups include —C(═O)O—(CH2)n— and —C(═O)NH—(CH2)n—, where n is 1-20 (e.g., n=2). In certain embodiments, L3 is —C(═O)O—(CH2)n—, wherein n is 1-6.
- L4 is a linker that covalently couples the anionic group to the polymer backbone. In certain embodiments, L4 is a C1-C20 alkylene chain. Representative L4 groups include —(CH2)n—, where n is 1-20 (e.g., 1, 3, or 5).
- Representative alkyl groups include C1-C30 straight chain and branched alkyl groups. In certain embodiments, the alkyl group is further substituted with one of more substituents including, for example, an aryl group (e.g., —CH2C6H5, benzyl).
- Representative aryl groups include C6-C12 aryl groups including, for example, phenyl including substituted phenyl groups (e.g., benzoic acid).
- X− is the counter ion associated with the cationic center. The counter ion can be the counter ion that results from the synthesis of the cationic polymers or the monomers (e.g., Cl−, Br−, I−). The counter ion that is initially produced from the synthesis of the cationic center can also be exchanged with other suitable counter ions. Representative hydrophobic counter ions include carboxylates, such as benzoic acid and fatty acid anions (e.g., CH3(CH2)CO2 − where n=1-19); alkyl sulfonates (e.g., CH3(CH2)SO3 − where n=1-19); salicylate; lactate; bis(trifluoromethylsulfonyl)amide anion (N−(SO2CF3)2); and derivatives thereof. Other counter ions also can be chosen from chloride, bromide, iodide, sulfate; nitrate; perchlorate (ClO4); tetrafluoroborate (BF4); hexafluorophosphate (PF6); trifluoromethylsulfonate (SO3CF3); and derivatives thereof. Other suitable counter ions include salicylic acid (2-hydroxybenzoic acid), benzoate, and lactate.
- In certain embodiments, A is C or SO.
- In certain embodiments, n is an integer from 5 to about 5,000.
- In one embodiment, R4, R5, R6, R7, and R8 are methyl, L3 is —C(═O)O—(CH2)2—, and L4 is —CH2—, A1 is C or SO, and n is an integer from 5 to about 5,000.
- For the zwitterionic polymers and mixed charge copolymers useful in the invention, the degree of polymerization (DP or n), number average molecular weight (Mn), and the ratio of weight average and number average molecular weights (Mw/Mn.), also known as polydispersity index, can vary. In one embodiment, the polymers have a degree of polymerization (n) from 1 to about 10,000. In one embodiment, n is from about 10 to about 5,000. In another embodiment, n is from about 100 to about 3,500. In one embodiment, the polymers have a number average molecular weight (M) of from about 200 to about 2,000,000 Da. In one embodiment, Mn is from about 2,000 to about 100,000 Da. In another embodiment, Mn is from about 20,000 to about 80,000 Da. In one embodiment, the polymers have a ratio of weight average and number average molecular weight (Mw/Mn.) of from about 1.0 to about 2.0. In one embodiment, Mw/Mn. is from about 1.1 to about 1.5. In another embodiment, Mw/Mn. is from about 1.2 to about 2.0.
- Recognition Elements
- As noted above, in the films of the invention, the second layer includes a plurality of recognition elements. The terms “recognition elements” and “target binding partners” are used interchangeably.
- The binding affinity of a target molecule toward to the surface results from the target binding partners immobilized on the surface. The target binding partner and the target molecule, each termed a binding pair member, form a binding pair. Each binding pair member is a molecule that specifically binds the other member. In one embodiment, the target binding partner has affinity to a target molecule with Kd less than about 10−8.
- A binding pair member can be any suitable molecule including, without limitation, proteins, peptides, proteins, poly- or oligo-saccharides, glycoproteins, lipids and lipoproteins, and nucleic acids, as well as synthetic organic or inorganic molecules having a defined bioactivity, such as an antibiotic, anti-inflammatory agent, an enzyme substrate, or a cell adhesion mediator (i.e., a small molecule).
- Examples of proteins that can be immobilized on the surfaces of the present invention include ligand-binding proteins, lectins, hormones, receptors, and enzymes. Representative proteins include antibodies (monoclonal, polyclonal, chimeric, single-chain or other recombinant forms) and fragments thereof, their protein/peptide antigens, protein-peptide hormones, streptavidin, avidin, protein A, proteins G, growth factors and their respective receptors, DNA-binding proteins, cell membrane receptors, endosomal membrane receptors, nuclear membrane receptors, neuron receptors, visual receptors, and muscle cell receptors. Representative oligonucleotides that can be immobilized on the surfaces of the present invention include DNA (genomic or cDNA), RNA, antisense, ribozymes, and external guide sequences for RNAase P, and can range in size from short oligonucleotide primers up to entire genes.
- Other target binding partners that bind specifically to a target compound include poly- or oligosaccharides on glycoproteins that bind to receptors, for example, the carbohydrate on the ligand for the inflammatory mediators P-selectin and E-selectin, and nucleic acid sequences that bind to complementary sequences, such as ribozymes, antisense, external guide sequences for RNAase P, and aptamers.
- In one embodiment, the target binding partner is an antibody, and the target molecule is an antigen against the antibody. In this embodiment, the surface of the invention specifically binds to the antigen and resists non-specific protein adsorption. In one embodiment, the target binding partner is a protein capable of promoting cell adhesion, and the target molecule is a cell. In this embodiment, the surface of the invention specifically binds to the cell and resists non-specific protein adsorption and non-specific cell adhesion.
- In certain embodiments, the second layer has a recognition element binding level of about 200 to about 1500 ng/cm2.
- Film Substrates
- A variety of substrate surfaces can be rendered dual-functional using the materials and methods described herein. Representative surfaces that can be rendered dual-functional include metal and metal oxide surfaces, ceramic surfaces, synthetic and natural polymeric surfaces, glass surfaces, fiber glass surface, silicon/silica surfaces, carbon-based material surfaces, protein-based material surfaces, and cell surfaces. Representative natural polymeric surfaces include collagen, fibrins, and other carbohydrate surfaces suitable for the use of tissue engineering. Representative carbon-based material surfaces include carbon fiber, nanotube, and bulky ball surfaces.
- Suitable substrates include those substrates useful in medical diagnostic applications such as biosensors, bioprobes, and biomedical devices including in vivo devices; biomaterials and tissue engineering applications, such as membranes for bioprocesses or bioseparation, implantable devices, prosthetics, and tissue scaffolds; and drug delivery applications, such as particles and nanoparticles.
- In one embodiment, the present invention provides a SPR sensor comprising a film of the invention.
- It will be appreciated that the films of the invention have been described as including (i.e., the film comprises) the stated components. It will be appreciated that in certain embodiments, the films of the invention described above include the stated components as well as other components that do not alter the novel and material characteristics properties of the film (i.e., the film consists essentially of). Components that alter the novel and material characteristics of the film include components that adversely affect the films ultra low fouling or the ability of the film to capture target molecules through its recognition elements. It will also be appreciated that in certain embodiments, the films of the invention described above include only the stated components (i.e., the film consists of).
- Methods for Making Films
- In another aspect of the invention, methods for making the films of the invention are provided. In one embodiment, the method includes forming a first layer having a first layer density on a substrate; and forming a second layer on the first layer, the second layer having a second density, wherein the first layer density is greater than the second layer density. In certain embodiments, further includes a plurality of recognition elements to the second layer.
- As noted above, in certain embodiments, the film is a polymer film in which the first, second, or first and second layers comprise a plurality of polymers. In certain embodiments, the first layer is a nonfouling layer and the second layer is effective to specifically bind target agents. In certain embodiments, the first layer comprises a first polymer layer having a first polymer density, and the first polymer layer comprises a plurality of first polymers, wherein each first polymer is attached to a substrate; and the second layer comprises a second polymer layer having a second polymer density, wherein the second polymer layer comprises a plurality of second polymers, wherein each second polymer is attached to a first polymer.
- The first layer can be formed by grafting first polymers from the substrate. Grafting the first polymers from the substrate can be accomplished by any one of a variety polymerization methods (e.g., free radical polymerization, atom transfer radical polymerization (ATRP), reverse addition fragment transfer (RAFT), photoiniferter-mediated polymerization (PIMP), condensation/ring opening polymerization).
- Alternatively, the first layer can be formed by grafting first polymers to the substrate. In these methods, the first polymer can be attached to the substrate by any one of a variety of coupling techniques. In one embodiment, the first polymers are covalently coupled to the substrate by click chemistry. In another embodiment, the first polymers are covalently coupled to the substrate by thiol-ene. It will be appreciated that any coupling technique requires suitably reactive second polymers and first layer components.
- For embodiments in which the film is a polymer film, the first polymer may be coupled to the substrate surface through alkylene linkers. The grafting of the polymers onto the surface of the substrate through the alkylene linkers may be via any one of a variety of polymerization methods as described herein. SAMs on substrate surfaces are an excellent platform for surface polymerization. In one embodiment, a radical initiator-terminated self-assembly monolayer (SAM) comprising the alkylene linkers can be formed onto the substrate surface, and the polymers are grafted onto the surface through the radical initiator-terminated self-assembly monolayer. In this method, the substrate surface can be coated with the SAMs terminated with radical initiator, wherein the radical initiators are tethered to the surface through alkylene linkers. The alkylene linkers can be any substituted or unsubstituted alkylene. In one embodiment, the alkylene linker is a C2-C30 alkylene. Polymers are then formed onto the SAMs to provide a layer of nonfouling polymeric coating on the substrate surface. Atom transfer radical polymerization is initiated by the radical initiator at the SAMs terminus.
- In one embodiment, a hydroxyl-terminated monolayer having alkylene linkers can be formed onto the substrate surface, which is subsequently converted to a radical initiator terminated monolayer.
- Materials and methods for making a single layer polycarboxybetaine film having nonfouling properties and the ability to specifically bind target agents is described in US 2010/0099160 (Dual-Functional Nonfouling Surfaces and Materials), expressly incorporated herein by reference in its entirety.
- The second layer can be formed by grafting second polymers from the first layer. Grafting the second polymers from the first polymers can also be accomplished by any one of a variety polymerization methods (e.g., free radical polymerization, atom transfer radical polymerization (ATRP), reverse addition fragment transfer (RAFT), photoiniferter-mediated polymerization (PIMP), condensation/ring opening polymerization). A schematic illustration of representative methods for grafting second polymers to the first layer is shown in
FIG. 1 . - Alternatively, the second layer can be formed by grafting second polymers to the first layer. In these methods, the second polymer can be attached to the first layer by any one of a variety of coupling techniques. In one embodiment, the second polymers are covalently coupled to the first layer by click chemistry. In another embodiment, the second polymers are covalently coupled to the first layer by thiol-ene. It will be appreciated that any coupling technique requires suitably reactive second polymers and first layer components.
- It will be appreciated that films with additional layers (e.g., third, fourth, or fifth layers) are within the scope of the invention. The additional layers can be formed on the two-layer film described herein. For example, the third layer can be formed on the second layer (e.g., by “graft from” or “graft to” techniques). Subsequent layers can be similarly formed.
- The present invention provides methods for modifying the second layer to provide a surface having affinity toward a target molecule. In one embodiment, the method for modifying a surface, includes covalently coupling a plurality of target binding partners (i.e., recognition elements) to the second layer. In certain embodiments, an amide linkage is formed between the polymers and the target binding partners. For polymer films that include carboxylic acid groups (e.g., polycarboxybetaines), covalently coupling the plurality of target binding partners to the plurality of polymers includes converting a portion of carboxylic acid groups to activated esters and reacting the activated esters with target binding partners having amino groups. For polymers that have been modified to include available amino groups, covalently coupling the plurality of target binding partners to the plurality of polymers includes converting a portion of carboxylic acid groups of the target binding partners to activated esters and reacting the activated esters with the polymers of the surface having available amino groups. In one embodiment, the activated esters are N-hydroxysuccinimide esters. Suitable target binding partners include those described in detail above with regard to the films of the invention.
- As noted above, the carboxylic acid groups of the polymers may be activated by forming activated intermediate groups for further coupling with the amino groups of the biomolecule. Any activated form of carboxylic acid groups may be used in the present invention. The representative activated intermediate groups include carbodiimides, carbonyldiimidazoles, uranium salts, isothiocyanates, isocyanates, acyl azides, N-succinimidyl esters (NHS esters), sulfonyl chloride, aldehydes, epoxides arylating groups, imido esters, and anhydrides. In one embodiment, O—(N-succinimidyl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (TSTU) is used to convert the carboxylic acid groups on the polymers to activated uronium salts. In another embodiment, carbodiimides and N-hydroxysuccinimide (EDC/NHS coupling chemistry) are used to convert the carboxylic acid groups on the polymers to activated N-hydroxysuccinimide esters.
- In one embodiment, the carboxylic acid groups were converted to activated NHS esters by treating the carboxylic acid groups with N-bromo succinimide (NHS) and N-ethyl-N′-(3-diethylaminopropyl) carbodiimide (EDC) under acidic conditions (e.g., pH 2.5 to 6). The activated NHS esters were coupled with the amino groups of the target binding partner forming amide bonds under basic conditions (e.g., pH 7.4 to 11).
- The preparation of representative films of the invention is described in Examples 1-3.
- Methods for measuring refractive index and swelling ratio for representative films of the invention are described in Examples 4 and 5, respectively.
- Methods for Detecting the Presence of an Analyte Using the Film of the Invention
- In another aspect, the invention provides methods for determining the presence of an analyte in a sample. The method utilizes film of the invention comprising a plurality of recognition elements. In one embodiment, the method includes contacting a sample with a film of the invention comprising a plurality of recognition elements, wherein each recognition element has a specific binding affinity for the analyte; and interrogating the film to determine whether the analyte has bound to the film. The film can include one or more different recognition elements for the detection of one or more analytes. The film can be interrogated by any method that provides an indication of analyte binding to the film.
- Representative films and methods for making and using the films are described below.
- Representative Polymer Films
- In one aspect, the invention provides a polymer film having two layers (i.e., a hierarchical architecture) prepared from two distinct surface-initiated techniques. These “graft from” techniques are based on controlled “living” radical polymerizations and provide polymer brushes having controlled chemical composition, film thickness, and architecture. As shown in
FIG. 1 , one film was prepared via surface initiated atom transfer radical polymerization (SI-ATRP) and the other film was prepared via surface initiated photoiniferter-mediated polymerization (SI-PIMP). In each film, the first layer was grown in a controlled manner to reach a high surface packing density. The second layer, with a lower surface packing density, was achieved through “termination” or “regeneration” of the living capped species at the polymer chain end for SI-ATRP and SI-PIMP, respectively. - Due to the dual functionality of poly(carboxybetaine) (pCB) films, a surface plasmon resonance (SPR) biosensor with a pCB film was used for demonstrating the novel hierarchical architecture. Surface-tethered pCB brushes formed by both SI-ATRP and SI-PIMP achieve excellent resistance to nonspecific protein adsorption in the presence of complex media, such undiluted human blood serum and plasma, to fouling levels below 5 ng cm−2. These fouling levels can be maintained following the immobilization of around 250 ng cm−2 of antibody using conventional 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide and N-hydroxysuccinimide (EDC/NHS) coupling chemistry under biologically friendly conditions. However, this functionalization level only corresponds to an IgG monolayer. The pCB-based polymer films (platforms) of the invention with hierarchical structures on a SPR sensor surface provide sensitive quantification of IgG immobilization, antigen binding, and nonspecific protein adsorption.
- As shown in
FIG. 1 , ATRP was combined with a “termination” approach for demonstrating the novel architecture. ATRP involves a dynamic equilibrium between activated propagating radicals and dormant halide end-capped polymer chains, yielding low polydispersity and controlled growth. This “living” characteristic enables re-initiation from macroinitiators for the synthesis of block copolymers. To achieve hierarchical pCB films possessing ultra low fouling and high loading properties via SI-ATRP, a densely-packed first layer was grown from a gold coated SRP chip modified with an alkyl bromide terminated self-assembled monolayer (SAM). The chips were then submerged in a methanolic solution containing 2,2′-bipyridine, CuBr, and CB monomer under nitrogen protection and allowed to react overnight. The resulting thickness was 7.6±0.3 nm (Table 1). Importantly, these conditions enabled a highly dense yet thin film to be grown. While the high density is key for achieving low fouling, a thin film is desired for many sensing applications, such as SPR, as the signal intensity/sensitivity decays exponentially from surface of the metal substrate. To establish a hierarchically structured pCB film for increasing the binding capacity, the macroinitiator density for re-growth of the second pCB layer was regulated via azide substitution of bromide species thus “terminating” the future growth of the corresponding chains during the second ATRP reaction. The density of the polymer chains can be controlled by the azide concentration and reaction time. A 2 hr submersion using an azide concentration of 0.1 M produced an optimal second layer polymer density for protein immobilization. For the growth of the second pCB layer, water-accelerated polymerization with a solvent consisting of 50% water in methanol was employed to induce a high polydispersity of polymer chains. The resulting thickness of the structured film with azide substitution was higher than that without treatment. This is in agreement with previous reports showing rapid bimolecular termination at high initiator densities using aqueous ATRP whereas more dilute initiators enabled continued linear and controlled polymer growth. - In contrast to SI-ATRP, SI-PIMP releases capped species from the polymer chains during polymerization, primarily due to bimolecular termination. This irreversible termination significantly hampers future polymer growth. Therefore, in order to control the chain density of the second layer via SI-PIMP, a “regeneration” approach was adopted in which the addition of a deactivator, tetraethylthiuram disulfide (TED), was able to preserve the end-capped photoiniferter groups on the grafted polymers for re-growth of the second layer with controlled grafting density. SPR gold substrates were first modified with the photoiniferter (N,N-(diethylamino)-dithiocarbamoylbenzyl(trimethyoxy)-thiol (DTCA)) to form SAMs. Similarly to SI-ATRP, the first layer for SI-PIMP was also synthesized in 100% methanol to form a highly dense and thin film. Reactions were conducted using a 30 min UV irradiation and the resulting film thicknesses are shown in Table 1. The first layer thicknesses prepared with 2 μM TED was comparable to that without TED (11.1±0.6 nm). Subsequently, the films were re-initiated in a 90% water/methanol solution resulting in TED treated films with greater thicknesses than those made without, reflecting the ability of TED for preserving the reactive photoiniferter end groups and thereby maintaining the “living” characteristic of SI-PIMP.
- The thicknesses of representative films prepared via SI-ATRP and SI-PIMP with and without treatment to capped species are compared in Table 1.
-
TABLE 1 Film thickness with and without treatment to capped species. SI-ATRP SI-PIMP Thickness (nm) Thickness (nm) First Layer 7.6 ± 0.3 10.8 ± 0.8 Re-growth (without 13.2 ± 0.3 32.1 ± 0.6 treatment) Re-growth (with treatment) 17.5 ± 0.9 46.1 ± 1.6 - Functionalization and fouling tests were monitored in situ using a custom-built SPR sensor with wavelength modulation (see representative sensorgrams in
FIGS. 3 and 4 ). For antibody immobilization, the films were activated using EDC/NHS coupling chemistry followed by injecting an anti-human thyroid stimulating hormone (anti-TSH) IgG solution. The unreacted NHS esters were then hydrolyzed back into the original carboxylate groups using 10 mM sodium carbonate buffer with 300 mM NaCl atpH 10. As shown inFIG. 2A , the functionalization levels were estimated as 195.9 ng cm−2 and 417.0 ng cm−2 for one-layer (“One”) and hierarchical (“HA”) films prepared via SI-ATRP; 253.0±14.8 and 792.7±54.7 ng cm−2 for one-layer and hierarchical films from SI-PIMP. An increase in binding capacities for IgG molecules on pCB films was observed for the hierarchical architecture. For the IgG functionalized one-layer films, the binding capacities were similar to that obtained with carboxyl-terminated SAMs. Although pCB provides abundant carboxyl groups for biomolecule conjugation, highly-packed polymer brushes hamper the penetration of molecules due to steric hindrance and therefore modification only takes place at the accessible functional groups on the topmost layer of the pCB films. However, for the hierarchical films, the chain densities of the second layer were controlled via the termination and regeneration approaches. Constructed from highly dense first layers, the loose second layers allowed diffusion of antibodies thus enabling conjugation with NHS esters throughout the entire second layer. The control experiments using the structured films without treatment of capped species were also conducted. IgG immobilization levels were reduced by 30% and 64% for SI-ATRP and SI-PIMP, respectively, compared to the corresponding treated hierarchical pCB films. This evidence indicates that a sufficient number of accessible binding groups for protein modification, made apparent by the larger second-layer film thicknesses of the treated films, are a determining factor of the ligand loading capacity. - The protein fouling levels on one-layer films and hierarchical pCB films before and after IgG functionalization were tested by flowing undiluted blood serum or plasma (
FIG. 2B ). All fouling levels were very low as a result of the highly-packed first pCB layers serving as ultra low fouling backgrounds. As a comparison, the fouling level for a loose pCB one-layer film with a thickness of 12.3 nm prepared from 50% water in methanol by SI-PIMP was as high as 54.3 ng cm−2 in the presence of serum. These results indicate that the high performance of pCB for effective resistance against non-specific adsorption and high ligand loading is established on the basis of control over the polymer architecture. - Solutions containing TSH antigen were flowed over the functionalized surfaces to evaluate the antigen detection ability (
FIG. 2C ) and the bio-activities (molar ratios of antigen to antibody) of the binding platforms. TSH binding capacities were 42.1±2.4 ng cm−2 and 128.5±26.2 ng cm−2 for one-layer and hierarchical pCB films from SI-PIMP, respectively. The corresponding bio-activities were 0.89 and 0.87. The one-layer and hierarchical pCB films made via SI-ATRP bound 30.4 ng cm−2 and 74.7 ng cm−2 of TSH, respectively, with bio-activities of 0.80 and 0.93, respectively. Thus, the binding capacity for antigens is well correlated to the degree of antibody immobilization and that the bio-activity of the film is not affected by the pCB hierarchical architecture. - SI-PIMP Methods
- In one embodiment, the invention provides a polymer film having two layers (i.e., a high density ultra low fouling first layer and a low density second layer suitable for presenting recognition elements) prepared via surface initiated photoiniferter-mediated polymerization (SI-PIMP) techniques.
- Zwitterionic polycarboxybetaine acrylamine (pCB)-based platforms with a two-layer structure for ultra low fouling and high protein loading properties were prepared. The first pCB layer with a high packing density prepared under a water-free condition serves as a protective layer to resist nonspecific adsorption from complex media. The second pCB layer with a low packing density is used to achieve high protein immobilization. Addition of tetraethylthiuram disulfide (TED) and the water content in the reaction were varied to regulate polymer chain density and length, respectively, for the second pCB layer. The in situ modification of pCB films with anti-human thyroid stimulating hormone (TSH) IgG molecules and the detection of TSH antigens were employed to demonstrate high protein immobilization and high antigen detection capabilities of this two-layer structure. Undiluted blood plasma was used to test the nonfouling properties of this system. Nonspecific and specific interactions were monitored by a surface plasmon resonance sensor.
- In one embodiment, the two-layer structured pCB film was prepared by (i) growing a densely-packed first pCB brush under a water-free polymerization condition, (ii) adjusting the surface density of the “living” capping moieties on the first pCB layer by adding the TED molecules, and (iii) promoting the chain growth of the second pCB layer via water-accelerated polymerization. The growth of polymer brushes was monitored using ellipsometer. The protein loading on the structured pCB films was investigated by conjugating anti-human thyroid stimulating hormone (TSH) antibodies through EDC/NHS coupling chemistry, followed by flowing the TSH antigens for estimating the bioactivities. The non-fouling properties of the platforms before and after antibody functionalization were realized by challenging with undiluted human blood plasma.
- Although this pCB platform has shown great success to resist nonspecific protein adsorption from complex media, relatively low antibody loading, similar to all 2-dimensional (2D) surface platforms, limits the sensor response to analyte binding. Owing to the high packing density of the brush film, such surfaces can merely achieve an antibody binding capacity of only 250 ng cm−2 (corresponding to an IgG monolayer) (
FIG. 5A , left panel). A three-dimensional (3D) carboxymethylated dextran-based SPR chip fabricated via a “graft-to” approach has a high protein binding capacity of more than 1000 ng cm−2. However, this high loading accompanies high nonspecific protein adsorption on unprotected substrate surfaces during detection primarily due to the “loose” polymeric structure (FIG. 5B , right panel). - In one embodiment, the present invention provides a two-layer structured binding platform that incorporates a first highly dense pCB layer to achieve ultra-low fouling and a second “loose” pCB layer to achieve a high antibody binding capacity (
FIG. 5B ). - Surface-initiated photoiniferter-mediated polymerization can be used for preparing surface-tethered pCB films. This polymerization technique poses advantages of simple experimental process, fast reaction rate, and large-scaled surface polymerization, which make an attractive approach for tailoring surface properties. In addition, this technique enables to control light exposure spatially and temporally for creating multidimensional structures regardless of types of monomers. The pCB chains were grown from a self-assembled monolayer comprising of thiolated photoiniferter (N,N-(diethylamino)-dithiocarbamoylbenzyl(trimethyoxy)thiol (DTCA)). The photoiniferters provide control over the reaction by maintaining equilibrium between activated propagating chains and dormant chains that are capped by deactivating species, resulting in controlled radical polymerization. However, due to a low concentration of the deactivating radicals, the polymerization favors irreversible termination caused by bimolecular termination. To preserve the “living” capability of the pCB films, the reduction of termination can be accomplished by adding deactivating species, tetraethylthiuram disulfide (TED), to the reaction medium (
FIG. 6 ). While irradiated with UV light, TED undergoes a homolytic cleavage, generating two dithiocarbamyl (DTC) radicals. As the concentration of the deactivating species increases, the capability of re-initiation is enhanced. Representative films of the invention (two-layer pCB films) were prepared by: (i) growing a densely-packed first pCB brush under a water-free polymerization condition; (ii) adjusting the surface density of the “living” capping moieties on the first pCB layer by adding the TED molecules, and (iii) promoting the chain growth of the second pCB layer via water-accelerated polymerization. - The densely-packed first pCB layer was fabricated via photoiniferter-mediated polymerization in 100% methanol. After 30 min UV exposure, the resulting thickness of the pCB was d1st=10.9±0.7 nm. In
FIG. 7A , the fouling tests with undiluted plasma, 1 mg mL−1 fibrinogen and lysozyme dissolved in PBS for the first pCB film were monitored on SPR. After the buffer washing the fouling level was indicated as 3.9±0.8 nm for plasma and for fibrinogen and lysozyme, their fouling levels were both below the detection limit of the SPR sensor which is 0.3 ng cm−2. 21 Therefore, the first pCB layer was developed and ensured its efficient protection of the surface from protein adsorption. - In order to re-initiate the second layer of pCB, TED was added to regenerate the initiator during the polymerization for the growth of the first pCB layer in order to prevent the irreversible termination. The concentration of TED was varied from 0 to 50 μM. The growth of the second layers was accomplished with the CB monomer concentration of 0.15 M in the mixed solvent of MeOH:H2O=50:50 for 30 min. In
FIG. 7B , the dry thickness of the first pCB layer deceased with the increased TED concentration. However, the thickness of the second pCB layer increased from d2nd=2.7±0.8 nm to 9.8±0.4 nm. This indicates that the presence of TED in the polymerization shifts the equilibrium of the surface-tethered radicals toward the dormant state as shown by decreased thicknesses in the first pCB layers with the TED concentration. As a result, the TED addition slowed the monomer conversion rate and to inhibit generation of radicals. At the same time, the re-growth of the second pCB layer was promoted due to the high surface concentration of iniferter species. - The IgG modification was conducted through EDC/NHS coupling chemistry and the corresponding binding capacities of surfaces were measured using a SPR sensor.
FIG. 7B shows that the maximum binding capacity occurred on the two-layer pCB film prepared from the TED concentration of 2 μM, which was F=546.2±71.4 ng cm−2. The one-layer pCB films prepared from the TED concentrations of 0 and 50 μM, the binding capacities for IgG molecules were significantly lower than any two-layer structured films. For instance, on the one-layer film prepared from 50 μM TED, the binding capacity was merely F=116.0±65.6 ng cm−2. The results indicate that for the one-layer films and the two-layer films prepared from high TED concentration, it was difficult for IgG molecules to penetrate through the brushes owing to the steric hindrance and most likely conjugated on the outmost of pCB films. - To further increase the binding capacity, “water-accelerated” polymerization was used to increase the chain length of the second layer for providing large available binding sites for IgG conjugation. As seen in
FIG. 8A , after the re-initiation from the first layer prepared from 100% methanol containing 2 μM of TED, the thicknesses of the second layers were measured and found to increase with the water content relative to MeOH in the reaction solvent. The surfaces were subsequently reacted with EDC/NHS mixture for 7 min followed by flowing anti-TSH IgG solution for 20 min. The results show that the binding capacities were dependent on the thicknesses of the second layers (FIG. 8A ). Moreover, the degree of conversion from carboxyl groups to NHS esters in pCB brushes was mediated by the EDC/NHS reaction time (FIG. 8B ). The binding capacity for IgG on the two-layer structured pCB film increased to 1312.2 ng cm−2 after 30 min activation, which is more than five times more than that on the one-layer pCB film. - AFM in the tapping mode was used to examine the surface morphology of the two-layer pCB films before and after IgG functionalization. The image of the pristine pCB film with a scale of 1 μm×1 μm showed featureless morphology, whereas there were enormous bumps observed on the IgG functionalized pCB, as an evidence of the high density of immobilized IgG molecules. Therefore, this approach to build up a hierarchical structure of pCB film enables the accommodation for a large amount of biomolecules through conventional EDC/NHS amine coupling chemistry and possesses possibility to manipulate the chain density of the second pCB layer for customizing specific requirements, such as considerations on ligand and antigen sizes.
- For biosensor applications, an appropriate design of bio-interfaces should be capable of improving the sensitivity and specificity of detection. In the following description, the film with “one-layer” structure is referred to the one fabricated in 100% MeOH without TED addition (d1st=10.9±0.7 nm; F=262.5±0.8 ng cm−2
FIG. 7B ). For the “two-layer” binding platform, the first layer was prepared from 100% MeOH with 2 μM TED and the second layer was re-grown in the solvent with a volume ratio of MeOH:H2O=10:90 with 30 min UV radiation (d1st=11.1±0.6 nm; d2nd=35.7±1.3 nm; F=773.2±55.9 ng cm−2,FIG. 8A ). Functionalization of TSH IgG on both one-layer and two-layer binding platforms was conducted via EDC/NHS activation for 7 min and allowing the 20 min reaction with IgG molecules. To verify to the performance of the constructed “two-layer” pCB binding platform for biosensing in complex media, the undiluted plasma was flowed over surfaces with and without the IgG functionalization for 10 min and then rinsed with PBS to remove unbound molecules. As shown inFIG. 9A , the fouling levels were both below 5 ng cm−2. Again, the fouling resistance of the “two-layer” binding platform can be attributed to the excellent nonfouling capability of the densely packed first pCB layer. The binding capacities of the two-layer pCB films was evaluated for TSH antigens dissolved in PBS at a concentration of 1 μg mL−1 and the bioactivity of conjugated IgG molecules, which is defined as the mole ratio of captured TSH antigens to immobilized IgG molecules. The binding platform with “one-layer” structure was present in parallel for a comparison. InFIG. 9B , the TSH binding capacity on “two-layer” pCB films was increased by 3.1 with respect to that on “one-layer” film. The bioactivities on one-layer and two-layer films were quite comparable. This observation reflects the fact that the high surface density of the bound IgG molecules in pCB brushes did not significantly hamper the approach of antigens, which is consistent with works using 3D carboxymethylated dextran-based binding matrix. - SI-ATRP Methods
- In another embodiment, the invention provides a polymer film having two layers (i.e., a high density ultra low fouling first layer and a low density second layer suitable for presenting recognition elements) prepared via surface initiated atom transfer radical polymerization (SI-ATRP) techniques.
- The two-layer architecture for films of the invention for sensing and detection in complex media is shown in
FIG. 10 . SI-ATRP was used due to its ability to provide excellent control over polymer growth. Additionally, the “living” characteristic enabled by the reversible equilibrium between active and dormant species allows the formation of block copolymers due to the presence of initiating species, which cap the chain ends once the polymerization is stopped. The use of solvent conditions, which provide high density polymer brushes with minimal chain-chain termination and quenching (spiking the reaction solution with a high concentration of deactivator (e.g. CuBr2), provides the maximum number of re-initiating sites near the outermost surface of the swollen layer, which is highly desired for obtaining sufficient control over the polymer density of the second block. - As shown in
FIG. 10 , the concentration of re-initiating groups (i.e., bromines) on the surface can be reduced by reacting with an aqueous sodium azide solution. This termination forms a stable azide group, which remains dormant and non-reactive as the second polymerization takes place. Both the concentration and reaction time of sodium azide will affect the degree of termination resulting in surfaces, which are low, moderately, or highly substituted with azide moieties. If the substitution is low then the most chains will just re-initiate and maintain the relative high density resulting in only monolayer antibody coverage. For the chains to grow vertically they need to be close enough together, if they are too dilute, then the chains will preferentially grow laterally in a mushroom configuration. In this highly substituted and very dilute case, the second layer is thin, consisting of a small number of long chains with minimal surface area for antibody immobilization, which also results in low loading. Therefore, in order to achieve high antibody binding capacity, a moderate amount of substitution is desired. In this scenario, the chains will be close enough to be obliged to grow vertically, but dilute enough so as to maximize the surface area for achieving high protein functionalization and enable sufficient diffusion to reactive NHS-esters. It is also important to note that a second layer with moderate substitution can actually grow longer than single layer with low substitution. This is due to a reduction in radical recombination in the former as a result of more space between the growing polymer chains. - Thin (about 10 nm) and highly dense pCB films can be made via SI-ATRP from pure methanol as the solvent can maintain ultra low fouling properties to undiluted serum. The ability to minimize the final thickness of the two-layer film in a swollen in situ environment is crucial for SPR detection. This is due to a rapid decrease in sensitivity as the measured biomolecular interaction gets further from the SPR active gold layer. For this reason, pure methanol was chosen as the condition for the bottom layer. Different reaction times (0.5-24 hrs) were investigated for growing the second block, which used a 50/50 methanol/water solvent. It was found that a 24 hour reaction resulted in the thickest second layer, the highest antibody immobilization, and excellent functionalized and non-functionalized protein resistance to undiluted serum. The response to antigen was similar for all reactions greater than 1 hour, with bioactivity ratios (i.e., the molar ratio of antigen to antibody) all being about 1.0. The 24 hours reaction enabled the same level of antibody immobilization achieved from a single layer grown from a 50% methanol solution. However, the post-functionalized serum non-fouling of the two-layer film (<5 ng/cm2) was better than the single layer film (about 15 ng/cm2) proving the effectiveness of the two-layer architecture. A first layer made using 50% water was also prepared. However, this condition was very difficult to control, even with short reaction times on the order of a few minutes, resulting in the final second layer polymer structure being mostly determined by the rapid polymerization of the bottom layer. Furthermore, simply spiking solutions grown from a first layer of either 50% water or in pure methanol with a high concentration of monomer dissolved in pure water was also not found to be effective.
- The affect of azide treatment on the second layer polymer thickness and corresponding antibody immobilization for two different solvent conditions is shown in Table 2 and
FIG. 11 , respectively. Due to the significant influence of water content on the polymer density of SI-ATRP films, two conditions were used for evaluation of azide exposure time. A 10% and 50% water content was chosen for slower (more controlled) and faster (less controlled but more polydisperse) polymerizations, respectively. Both conditions resulted in the expected trends as discussed above forFIG. 10 . Reducing the concentration of re-initiating species lead to an increase in the film thickness which then decreased as the chains became more and more dilute. It was observed that as the second layer thickness increased, the antibody immobilization also increased. This indicates that the moderately diluted second layer has more surface area (i.e. more accessible NHS-esters) for protein attachment. However, as the chains become more dilute, the available surface area decreases along with the immobilization. As shown in theFIG. 11 , the highest level of immobilization achieved was about 440 ng/cm2, which was more than twice than that achieved for a single layer film grown from pure methanol (about 200 ng/cm2). -
TABLE 2 Effect of azide treatment on the second layer polymer thickness for second blocks grown from 10% and 50% water content. Azide Second Layer Thickness Exposure Time Second Layer Thickness [nm] [nm] [min] (10% Water) (50% Water) 0 4.6 ± 1.7 5.6 ± 1.1 15 8.8 ± 1.5 3.4 ± 0.4 30 3.1 ± 0.5 6.8 ± 0.1 60 1.7 ± 0.1 13.8 ± 0.4 120 2.5 ± 0.5 9.9 ± 0.7 - The saturated antigen response for azide exposure times of 0, 60, and 120 min for films made using a 10% and 50% water second layer is shown in
FIG. 12 . The relatively low antibody loading for the 10% water condition for all exposure times resulted in an effective monolayer of antibody and thus gave very similar responses. As expected for the two layer films made using a 50% water content second layer, the lowest level of immobilization also provides the smallest amount of antigen binding. However, the result for 60 min is much less than that for 120 min despite the higher level of antibody binding for the former. For these experiments, PBS spike with 1 μg/mL TSH was flowed over the surface for 10 min. For all experiments except this 60 min one, the 10 min was sufficient to nearly saturate the antigen binding. Thus, while the result for this case shown inFIG. 12 does not represent the saturated value, which would likely be larger, it does indicate that the polymer density of the second block is higher relative to the 120 min exposure time. This indicates that the ability of the antigen to diffuse through the film was more restricted compared to the 120 min film, which would be expected as the azide substitution reaction time increases. - The non-specific protein adsorption from undiluted human serum as a function of azide exposure time is shown in
FIG. 13 . All cases except the 1 hour azide time with a second layer grown from a 10% water solvent resulted in excellent functionalized and non-functionalized protein resistant properties with most being at or below ultra low fouling levels. This also indicates that the azide moiety itself does not affect the protein resistant properties of the film. The one exception with high fouling can be explained as a highly substituted film with long polymer chains. The SPR sensor-gram for this film (second layer 10% water content) shows a significant and rapid binding during the antibody immobilization step. However, contrary to the typical SPR sensor-grams for the two-layer films (50% water content), a much larger decrease was observed during the deactivation step. Zwitterionic pCB films take on a slight positive charge following EDC/NHS activation. This would force the long and dilute chains to extend from the surface due to charge-charge repulsion. At a pH of 7.5, anti-TSH maintains a partial negative charge. Thus, the charge interaction between the surface and protein result in an accumulation of antibody near the surface. But, the limited surface area of the dilute polymer chains prevents most of the protein from being covalently bound. Upon deactivation, the surface regains its zwitterionic backbone and as a result the proteins are washed away. This particular conformation of polymer chains can increase the hydrophobicity of the surface by exposure more of the polymer backbone and thereby lead to an increase in fouling. However, these long and dilute chains also lead to very fast antibody saturation of the surface due to the ease of accessibility. Regardless, the combined result of the significant increase in the antigen response for films made using 50% water, with ultra low fouling properties, indicates that this architecture could dramatically positive influence on diagnostic devices. - Due to the ability of the water concentration to significantly affect the polymer density of the ATRP reaction, the concentration of water was varied from 0-90% for a one hour azide treatment (the condition which enabled the highest antibody immobilization). The functionalized and non-functionalized serum fouling, antibody immobilization, and antigen response are shown in
FIG. 14 . A peak of the antibody immobilization was found for the 50% water condition. Further investigation of these films by calculating the polymer volume fraction (PVF) in PBS (i.e., the wet polymer density) found that this particular condition had an effective PVF of about 25% where as all others films except for the 0% water second layer, had a PVF of about 43%. - The corresponding second block film thicknesses for each condition are shown in Table 3. The two-layer films made from 20-50% water all resulted in excellent non-fouling properties, had the highest level of immobilization, and also had the highest thickness. It is believed that the two-layer films made from 0% water content grow a very small second layer due to the limited solubility of the highly dense first layer polymer brush in pure methanol resulting in few polymer chains actually being reinitiated. Additionally, the significantly low level of immobilization (about 100 ng/cm2) indicates that very few functionalizable groups are accessible. This could mean that physically absorbed polymer is covering the surface, interacting via charged intermolecular interactions, resulting in a significant presence of the hydrophobic acrylamide backbone being exposed on the surface. The 60% water condition resulted in a similar SPR response as for the 10% water case, thus likely being described by the same phenomena (long and dilute chains), but also with an increase in chain-chain termination reactions which reduced the effective area for immobilization and also lead to exposure of the hydrophobic backbone of the polymer. The 90% water result is likely attributed to a significant presence of radical recombination reactions with the same negative consequences as for the film made using 60% water. With an exception of the two extreme endpoints (0% and 90% water), the similar antigen response for the other water concentrations corresponds with the expected results from 2D surfaces, with the 50% case simply having a low rate of diffusion as discussed above. The two endpoints have the expected response for a 2D surface with low antibody immobilization.
-
TABLE 3 Second layer films thicknesses as a functional of the polymerization water concentration using a one hour azide treatment. Second Layer Thickness [nm] ATRP Water Content [%] (1 hr Azide) 0 0.9 ± 0.3 10 1.7 ± 0.1 20 13.2 ± 1.0 40 11.8 ± 1.0 50 13.8 ± 0.4 60 2.9 ± 1.3 90 1.1 ± 0.1 - In certain embodiments, the films of the invention having two-layer architecture with zwitterionic dual-functional pCB were made via SI-ATRP. Exposing the dense bottom layer to a sodium azide solution to reduce the number of re-initiating sites was effective to double the antibody immobilization all while maintaining ultra low fouling properties to undiluted human serum. Changing the second block polymer density also resulted in a significant increase in the antigen response. These ideal properties of pCB integrated with the two-layer architecture offer the ability to significantly improve detection abilities from undiluted complex media.
- Each references cited is incorporated by reference in its entirety.
- As used here the term “about” means±5 percent of the recited value.
- The following examples are provided for the purpose of illustrating, not limiting, the invention.
- In this example, the preparation, characterization, and properties of representative polymer films of the invention, polycarboxybetaine (pCB) films prepared by SI-ATRP, are described.
- Materials.
- Copper (I) bromide (99.999%), 2,2′-bipyridine (BPY, 99%), tetrahydrofuran (THF), tetraethylthiuram disulfide (TED), methanol, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and phosphate buffered saline (PBS, 0.01 M phosphate, 0.138 M sodium chloride, 0.0027 M potassium chloride, pH 7.4) were purchased from Sigma-Aldrich (St. Louis, Mo.). Ethanol (200 Proof) was purchased from Decon Laboratories (King of Prussia, Pa.). Sodium carbonate anhydrous was purchased from EMD Chemicals (Darmstadt, Germany). Sodium chloride (NaCl) and ether were purchased from J. T. Baker (Phillipsburg, N.J.). Sodium acetate anhydrous was purchased from Fluka (subsidiary of Sigma Aldrich, St. Louis, Mo.). 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) were purchased from Acros Organics (Geel, Belgium). Pooled human serum was purchased from Biochemed Services (Winchester, Va.). Antibody to thyroid stimulating hormone (anti-TSH) and the TSH antigen were purchased from ThermoFisher Scientific (Waltham, Mass.). Water used in the experiments was purified using a Millipore water purification system with a minimum resistivity of 18.2 MΩ cm.
- Preparation of pCB Films Via SI-ATRP.
- Mercaptoundecyl bromoisobutyrate (SI-ATRP initiator) and carboxybetaine acrylamide (CB) monomer were synthesized as described in J. E. Krause, N. D. Brault, L. Y. Li, H. Xue, Y. B. Zhou, S. Y. Jiang, Macromolecules 2011, 44, 9213-9220, and Z. Zhang, H. Vaisocherova, G. Cheng, W. Yang, H. Xue, S. Y. Jiang,
Biomacromolecules 2008, 9, 2686-2692. SAMs on cleaned SPR chips (Z. Zhang, S. F. Chen, Y. Chang, S. Y. Jiang, J. Phys. Chem. B 2006, 110, 10799-10804) of ATRP initiator were formed by soaking overnight in ethanol (0.1 mM). Upon removal, the chips were rinsed with ethanol, THF, ethanol, and then dried and placed in a custom glass tube reactor under nitrogen. In a separate glass tube, CuBr (8.86 mg), 2,2′-bipyridine (57.85 mg), and CB (600 mg) were added and placed under nitrogen. The solids were dissolved in nitrogen purged methanol (4 mL) and transferred to the chips and reacted for 24 hours at 25° C. in a shaker bath. For single layer films, the chips were rinsed with water and stored overnight in PBS. For hierarchical films, the solution was quenched with CuBr2 (275.87 mg) in methanol (4 mL) and then rinsed with methanol, water, and submerged in PBS. The second block was then grown via repeating the above procedure but using a nitrogen purged methanol:water (1:1) and reacting for 3 hours. Termination of bromine groups and replacement with non-reactive azide moieties for reducing the second block polymer density was achieved by submerging the single layer chips in an aqueous azide solution (0.1 M) for 2 hours, removing and rinsing with PBS, water, and then drying for ATRP. - The DTCA photoiniferter was synthesized as described in T. Otsu, Journal of Polymer Science Part a—Polymer Chemistry 2000, 38, 2121-2136. SAMs on cleaned SPR chips (Z. Zhang, S. F. Chen, Y. Chang, S. Y. Jiang, J. Phys. Chem. B 2006, 110, 10799-10804) of the photoiniferter were formed by soaking overnight in THF containing DTCA (2 mM) followed by rinsing with THF and drying with a stream of air. For single layers, the photoiniferter modified chip was transferred to a quartz reaction tube along with 170 mg of CB monomer and placed under nitrogen. Nitrogen purged methanol (5 mL) containing TED (2 μM) was transferred to the reaction tube. The photo-polymerization was then conducted for 30 min using a UV lamp (302 nm) coupled with a 280 nm cutoff filter for preventing deterioration of thiol-gold bonds. Following the reaction, the chips were removed and rinsed with water, PBS, and then submerged in PBS. For the hierarchical films, the single layer film was re-initiated using the identical procedure except for the using nitrogen purged methanol:water (10:90) in the absence of TED.
- Ellipsometry.
- The thickness of the pCB films were determined using an ellipsometer (Model alpha-SE, J. A. Woollam, Lincoln, Nebr.) using the 380-900 nm wavelength range at an incidence angle of 70°. The results were fitted to a Cauchy module.
- Non-Specific Protein Adsorption, Antibody Modification, and Antigen Detection.
- The non-specific adsorption, antibody immobilization, and antigen detection was monitored using a four-channel SPR sensor with the Kretschmann configuration and wavelength modulation as described in H. Vaisocherova, W. Yang, Z. Zhang, Z. Q. Cao, G. Cheng, M. Piliarik, J. Homola, S. Y. Jiang, Anal. Chem. 2008, 80, 7894-7901. SPR chips were made of a glass slide coated with titanium (2 nm) followed by gold (48 nm) using an electron beam evaporator. A 1 nm SPR wavelength shift corresponded to a change in the protein surface coverage of 17 ng cm−2, which was corrected to account for loss of sensitivity due to the polymer films using previously described methods (W. Yang, H. Xue, W. Li, J. L. Zhang, S. Y. Jiang,
Langmuir 2009, 25, 11911-11916; J. Homola, Surface Plasmon Resonance Based Sensors.; Springer-Verlag: Berlin, Germany, 2006). For fouling experiments, undiluted human serum or plasma were injected (10 min, 40 μL min-1) and the wavelength shift between PBS baselines was converted to a surface coverage. Anti-TSH was immobilized by first injecting 10 mM sodium acetate (SA, pH 5) followed by EDC/NHS (0.2 M/0.05 M in water) for 7 min at 30 μL min-1. Anti-TSH (50 μg mL-1 in 10 mM HEPES pH 7.5) was injected (20 min, 20 μL min-1) followed by deactivating with 10 mM sodium carbonate containing 300 mM sodium chloride (pH 10) for 10 min and the SA both at 30 μL min-1. Immobilization was calculated as the difference between SA baselines before IgG injection and after deactivation. TSH was antigen binding was then monitored by first injecting PBS and then antigen (1 μg mL−1 in PBS at 40 μL min−1) following by PBS. - In this example, the preparation, characterization, and properties of representative polymer films of the invention, polycarboxybetaine (pCB) films prepared by SI-PIMP, are described.
- Materials.
- Solvents including acetone, methanol (MeOH) and tetrahydrofuran (THF) at the highest available purity were obtained from Sigma-Aldrich (Milwaukee, Wis.). CB monomer and photoiniferter (N,N-(diethylamino)-dithiocarbamoylbenzyl(trimethyoxy)thiol (DTCA)) were synthesized by literature methods. Fibrinogen, lysozyme, tetraethylthiuram disulfide (TED), N-hydroxysuccinimide (NHS) and ethyl(dimethylaminopropyl) carbodiimide (EDC) were obtained from Sigma-Aldrich. Human thyroid stimulating hormone (TSH) antibody and antigen were from Thermo Scientific (Waltham, Mass.). Deionized water with minimum resistivity of 18.0 MΩ cm used in the experiment was from a Millipore water purification system (Billerica, Mass.). The buffers including 150 mM phosphate buffered saline (PBS) at pH 7.4, 10 mM sodium acetate buffer (SA) at pH 5.0, 10 mM sodium carbonate buffer (SC) with 300 mM NaCl at
10 and 10 mM HEPES at pH 7.5 were prepared for biomolecular conjugation and bioassay. The pH values were adjusted with HCl or NaOH. The buffers were degassed prior to use. Human plasma used for challenging the surface coatings were purchased from BioChemed Services (Winchester, Va.).pH - Preparation of Polymer Brushes Via Photoiniferter-Mediated Polymerization (PIMP).
- The UV-ozone cleaned SPR chip was immersed in THF containing 2 mM DTCA at room temperature for 24 h in order to form a self-assembled monolayer (SAM) of photoiniferter, followed by intensive rinsing with THF and drying with a stream of filtered air. The photoiniferter modified chip was transferred to a quartz reaction tube containing 170 mg of CB monomers and TED molecules with different concentrations for growth of the first pCB layer. The reaction tube was placed under nitrogen protection, sealed with a rubber septum and wrapped with parafilm. The solvents used were deoxygenated with a continuous stream of dry nitrogen for more than 30 min, and then 5 mL of MeOH was transferred to the reaction tube using a syringe under nitrogen protection. The photo-polymerization was conducted by means of a UV lamp emitting light at 302 nm coupled with 280 nm cutoff filter in order to avoid the deterioration of thiol-gold bonds. 31 After the 30 min UV exposure, the chips were removed and rinsed with water and PBS to remove loosely bound polymers. For the re-growth of pCB for the second layer, the preparation method was the same as that for the first layer, but the TED was not needed and the water content in the solvents was adjusted to optimize the thickness of the films.
- Ellipsometry.
- The dry thicknesses (d) of pCB was determined using an ellipsometer (model alpha-SE, J. A. Woollam, Lincoln, Nebr.) with a light source with wavelengths ranging from 380 to 900 nm at a fixed incident angle of 70°. The thickness measurements were taken on six spots on each sample. The results were analyzed using a Cauchy model. The refractive index of polymer films was around 1.5.
- SPR Measurements.
- A four-channel SPR sensor was used (H. Vaisocherová, W. Yang, Z. Zhang, Z. Cao, G. Cheng, M. Piliarik, J. Homola, S. Jiang, Analytical Chem., 80, 7894 (2008)). Briefly, the SPR sensor, based on the Kretschman configuration, detects the changes of the refractive index arising from the molecular adsorption at the sensor chip surface. The sensor chip was washed with PBS and water and dried with a stream of air. On the glass side of the chip a drop of the refractive index matching liquid (Cargille, Cedar Grove, N.J.) was placed and then attached onto the base of the prism. The flow cell was mounted on the chip and filled with the buffer by a peristaltic pump (Ismatec, Vernon Hills, Ill.). A baseline signal was established by flowing PBS at a flow rate of 30 μL min−1 over the chip surface for 20 min. For the fouling test, undiluted blood serum and plasma were flowed over the chip at a flow rate of 30 μL min−1 for 10 min, followed by PBS washing. For quantitative estimation of surface mass coverage with the SPR sensor operating at a resonant wavelength of around 750 nm, a 1 nm SPR wavelength shift represents a change in the protein surface coverage of 17 ng cm−2. The signal calibration and the estimation for surface mass coverage (F) are described in Yang, W.; Xue, H.; Li, W.; Zhang, J. L.; Jiang, S. Y.
Langmuir 2009, 25, 11911; and Vaisocherova, H.; Zhang, Z.; Yang, W.; Cao, Z. Q.; Cheng, G.; Taylor, A. D.; Piliarik, M.; Homola, J.; Jiang, S. Y. Biosens. Bioelectron. 2009, 24, 1924. - Protein Modification and Bioassay for TSH Hormone.
- The functionalization of pCB layers with TSH antibodies through EDC/NHS coupling chemistry was in situ monitored by means of the SPR sensor. SA buffer was flowed over the surface to swell the polymer and to establish the baseline for 20 min. The activation reagent, EDC/NHS mixture in water with a molar ratio of 0.2 M/0.05 M, was introduced at a flow rate of 30 μL min−1 for 7 min, followed by 5 min flushing of SA buffer to flow away unreacted EDC/NHS chemicals. HEPES buffer spiked with TSH antibodies at a concentration of 50 μg mL−1 was flowed through the channel at a flow rate of 20 μL min−1 for 20 min. Afterwards, the unreactive groups were hydrolyzed to recover to carboxyl acid groups by washing with basic SC buffer at a flow rate of 30 μL min−1 for 10 min, followed by SA buffer. The binding capacity was estimated as the surface mass changes before the IgG injection and after hydrolysis in SA buffer.
- The detections for TSH antigens spiked in PBS at a concentration of 1 μg mL−1 were performed after TSH IgG functionalization on pCB layers. Prior to and after the assay, PBS buffer was flowed over the polymer surfaces for 20 min. Samples containing TSH antigens were introduced into the channels of the flow cell at a flow rate of 30 μL min−1 and flowed until the binding curve reached a plateau.
- Atomic Force Microscopy (AFM) Imaging.
- The pCB films with and without IgG functionalization on SPR chips were dried with a stream of filter air and attached onto the AFM sample holder. The AFM secondographic images were taken in a taping mode using a Dimension 3100 AFM (Digital Instruments/Veeco, Woodbury, N.Y.). Noncontact silicon cantilevers with a resonant frequency of 315 kHz and a force constant of 48 N m−1 (MikroMasch, Tallinn, Estonia) were used.
- In this example, the preparation, characterization, and properties of representative polymer films of the invention, polycarboxybetaine (pCB) films prepared by SI-ATRP, are described.
- Materials.
- Copper (I) bromide (99.999%), 2,2′-bipyridine (BPY, 99%), tetrahydrofuran (THF), methanol, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and phosphate buffered saline (PBS, 0.01 M phosphate, 0.138 M sodium chloride, 0.0027 M potassium chloride, pH 7.4) were purchased from Sigma-Aldrich (St. Louis, Mo.). Ethanol (200 Proof) was purchased from Decon Laboratories (King of Prussia, Pa.). Sodium carbonate anhydrous and sodium azide were purchased from EMD Chemicals (Darmstadt, Germany). Sodium chloride (NaCl) and ether were purchased from J. T. Baker (Phillipsburg, N.J.). Sodium acetate anhydrous was purchased from Fluka (subsidiary of Sigma Aldrich, St. Louis, Mo.). 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) were purchased from Acros Organics (Geel, Belgium). Pooled human serum was purchased from Biochemed Services (Winchester, Va.). Antibody to thyroid stimulating hormone (anti-TSH) and the TSH antigen were purchased from ThermoFisher Scientific (Waltham, Mass.). Water used in the experiments was purified using a Millipore water purification system with a minimum resistivity of 18.2 MΩ cm.
- Synthesis of Carboxybetaine Acrylamide (CBAA) Monomer.
- (3-Acryloylamino-propyl)-(2-carboxy-ethyl)-dimethyl-ammonium (CBAA) was synthesized by reacting 48 mL of DMAPA with 25 g of β-propiolactone in 400 mL of anhydrous acetone at 0° C. under nitrogen protection. After removing the ice bath at 20 minutes, the solution was allowed to warm up to room temperature. After 6 hours, the product was filtered, washed with ether, and allowed to dry under vacuum. The rough product, a white precipitate, was re-dissolved in a 30% (v/v) triethylamine in methanol solution and stirred overnight. After concentrating the solution, the CBAA was precipitated with acetone and then filtered. The solids were suspended in acetone and ether, for 1 hour each, dried under vacuum, and then stored at 4° C. Yield: 61%. 1H NMR (
Bruker 500 MHz, DMSO-d6): 8.61 (t, 1H, N—H), 6.28 (t, 1H, CHH═CH), 6.13 (t, 1H, CHH═CH), 5.61 (t, 1H, CHH═CH), 3.44 (t, 2H, N-CH2-CH2-COO), 3.21 (m, 4H, NH-CH2-CH2-CH2), 2.97 (s, 6H, N—(CH3)2), 2.25 (t, 2H, CH2-COO), 1.87 (t, 2H, NH-CH2-CH2-CH2). - Preparation of Two-Layer PolvCBAA Films.
- SPR sensor chips coated with ATRP initiator self-assembled monolayers were prepared by soaking the gold-coated substrates into 1 mM mercaptoundecyl bromoisobutyrate in pure ethanol for 24 hours. The chips were then removed, rinsed with ethanol, THF, and ethanol, and the blown dry using filtered compressed air and placed into a custom glass tube reactor for ATRP. In a separate glass tube, 8.86 mg CuBr, 57.85
2,2′-bipyridine (BPY), and 600 mg of CBAA were added. Both tubes were then placed under nitrogen protection. Nitrogen purged methanol (4 mL) was then added to the solids. Once completely dissolved (about 15 min), the mixture was then transferred to the reactor tube under nitrogen protection and allowed to react for 24 hours at 25° C. in a shaker set to 120 rpm. The reaction was removed and quenched with a solution containing methanol (4 mL) and CuBr2 (275.87) in order to maintain the maximum number of surface terminal bromine grown polymer chains. After mixing for two minutes, the chips were rinsed with methanol, water, and then submerged in PBS.mg - The second polymer block was then grown by repeating the above ATRP procedure and adjusting only the solvent ratio between nitrogen purged methanol and water in the final reaction mixture. For the re-initiated polymerization was allowed to react for 3 hours at 25° C. in a shaker set to 120 rpm. Following the reaction the chips were rinsed with copious amounts of water and then submerged overnight in PBS. In order to terminate bromine groups on the surface and replace them with non-reactive azide moieties to further reduce the polymer density of the second block, the chips were submerged in an aqueous solution of sodium azide (6.5 mg/mL) and mixed at room temperature. After a specific time, the chips were removed, dipped in PBS, rinsed with water, dried, and the placed into the custom tube reactor for re-initiating ATRP.
- SPR Sensor, Chips, and Calibration of the Surface Sensitivity.
- A laboratory SPR sensor developed at the Institute of Photonics and Electronics, Prague, Czech Republic was used as described in H. Vaisocherová, W. Yang, Z. Zhang, Z. Cao, G. Cheng, M. Piliarik, J. Homola, S. Jiang, Analytical Chem., 80, 7894 (2008). The SPR is based on the attenuated total reflection method and wavelength modulation. It is equipped with a four-channel flow-cell, temperature control, and uses a peristaltic pump for delivering samples. SPR sensor chips were made of a glass slide coated with an adhesion-promoting titanium film (about 2 mm) followed by a gold film (about 48 nm) using an electron beam evaporator. Because the SPR sensitivity depends on the distance of the binding event from the SPR active surface, the sensor response due to the polymer films was calibrated as described in H. Vaisocherová et al., 2008 (above).
- Determination of Polymer Film Thickness, Refractive Index, and Polymer Density.
- Dry and wet film thickness and refractive index (RI) measurements were determined using a multi-wavelength ellipsometer (J. A. Woollam Co., Inc., Model alpha-SE). A liquid cell with a volume of 0.5 mL supplied by the manufacturer was used for obtaining the wet measurements. The data was analyzed via fitting a Cauchy model for a bare SPR substrate which enables the film thickness and refractive index to be simultaneously determined without using predetermined or assumed Cauchy coefficients. The wet and dry refractive index measurements were then used with the effective medium approximation for calculating the film polymer volume fraction, PVF, (i.e., the wet polymer density)
- Measurements of Non-Specific Protein Adsorption by SPR.
- The non-specific protein adsorption of the pCBAA polymer films formed via SI-ATRP was determined with a SPR biosensor using a flow rate of 50 μL/min at 25° C. After first establishing a baseline using PBS, undiluted human serum was flowed for 10 minutes, followed by buffer to reestablish the baseline. Protein adsorption was quantified as the difference between buffer baselines and converted to a surface coverage using the appropriate sensitivity factor.
- In Situ Functionalization of pCB Polymer Surfaces.
- The functionalization procedure was monitored step-by-step in real time using an SPR sensor at 25° C. Sodium acetate buffer (10 mM) at pH 5.0 (SA) was first injected at 30 μL/min to obtain a stable baseline. The carboxylate groups of the polymer surface were then activated by flowing a freshly prepared solution of 0.05 M NHS and 0.2 M EDC in water for 7 minutes. Followed by a brief injection of SA buffer, a solution of anti-TSH (50 μg/mL) in HEPES buffer (pH 7.5) was flowed over the activated surface for 20 minutes at 20 μL/min. Subsequent washing of the functionalized surface for 10 minutes with 10 mM sodium carbonate (pH 10) containing 0.3 M NaCl (SC) at 30 μL/min removed non-covalently bound ligands and deactivated residual NHS-esters. SA buffer was then used to reestablish a stable baseline. The amount of immobilized antibodies was determined as the different between the SA injection following EDC/NHS activation and the final baseline.
- Measurements of Post-Functionalized Non-Fouling and Specific Protein Activity.
- Following antibody immobilization, the pCBAA surface was washed with PBS buffer until a steady baseline was established at 50 μL/min and 25° C. For post-functionalized non-fouling, undiluted human blood serum was then injected for 10 minutes followed by PBS for an additional 15 minutes. The net adsorption was calculated as the difference between buffer baselines and converted to a surface coverage. Specific antigen detection was compared by measuring the response at saturation for each polymer film. After establishing an initial buffer baseline, PBS spiked with TSH at 1000 ng/mL was flowed through sensor for 10 minutes followed by buffer. The saturated antigen binding was calculated as the difference between the original buffer baseline and the maximum response which was then converted to a surface coverage.
- In this example, the effects of chain packing density on protein resistance properties of surface-initiated polymer brushes as measured by refractive index are described.
- Polymer brushes can theoretically be described via chain lengths and chain-to-chain distances. Practically, ellipsometry is often used to measure the film thickness, which has been correlated to ultra low fouling properties of polymer brushes to undiluted human blood plasma and serum. However, ellipsometry also calculates an additional parameter, the film refractive index (RI). This film RI can be used to characterize the polymer density, but is often overlooked in practice. The film RI may be an even more important parameter for identifying nonfouling polymer films. By varying the water content in the surface-initiated atom transfer radical polymerization (SI-ATRP) of zwitterionic carboxybetaine, protein resistance to undiluted human serum was determined to be strongly dependent on the film RI. A minimum value of about 1.5 RI units was necessary to achieve <5 ng/cm2 of protein adsorption, measured using a surface plasmon resonance biosensor.
- The swelling behavior of a film, determined as the ratio of wet and dry thicknesses, is one approach to study polymer density. Tightly packed polymer brushes in a good solvent will swell less than lower density brushes. These tightly packed films have high extension in the dry state and significant further extension is limited upon swelling. Ellipsometry also calculates an additional parameter, the film refractive index (RI). This film RI can be used to characterize the polymer density, but is often overlooked in practice. Because the RI measurements of films account for two factors, the medium (e.g., air, RI of about 1.0) as well as the material itself (e.g., proteins, RI of about 1.53), the RI of a polymer film will increase with density. Importantly, the RI can be measured in the dry state, thus offering a convenient and simple approach for film characterization.
- SI-ATRP was used to investigate a parameter capable of characterizing and predicting ultra low fouling properties of pCBAA films. SI-ATRP is a controlled radical polymerization that enables the formation of polymer brushes with low polydispersity, high density, and a desired thickness. It is based on the equilibrium reaction between activated propagating chains and those that have been capped by a deactivating complex. The highly localized and low concentration of immobilized initiators in SI-ATRP (relative to solution ATRP) is a major challenge for achieving control due to the low concentration of persistent deactivator which can trap the propagating radical. The rate of polymerization is highly dependent upon the ratio of activator to deactivator; reduction in the latter leads to fast and uncontrolled growth. This increases the film polydispersity as well as the probability of irreversible chain-chain termination events thereby affecting the polymer density. For aqueous ATRP, the water content has been shown to sharply affect the rate of reaction due to a significant loss of deactivator, among other side reactions. This has previously enabled the use of SI-ATRP with 2-hydroxyethylmethacrylate (HEMA) to obtain a peak film thickness at some medium water concentration. Because the polydispersity of a film is related to its polymer density, varying the content of water during SI-ATRP enables a convenient approach for studying the effect of film thickness and polymer density on the nonfouling properties of pCBAA brushes.
- Ultra low fouling properties of pCBAA films formed via SI-ATRP was investigated using surface plasmon resonance (SPR) biosensors. Protein resistance to undiluted human serum was studied as a function of the polymer thickness and dry refractive index, the latter representing the polymer density. The results indicated that the nonfouling properties of pCBAA films were not affected much by the polymer thickness, but instead were strongly dependent on the RI.
- Materials.
- All chemicals were purchased from Sigma-Aldrich (St. Louis, Mo.) and Decon Laboratories (King of Prussia, Pa.). Pooled human serum was purchased from Biochemed Services (Winchester, Va.).
- Preparation of pCBAA Films.
- UV cleaned SPR sensor chips coated with ATRP initiator self-assembled monolayers were prepared by soaking in 0.1 mM mercaptoundecyl bromoisobutyrate in pure ethanol for 24 hours. The chips were then removed, rinsed with ethanol, THF, and ethanol, and the blown dry using filtered air and placed into a custom glass tube reactor. In a separate glass tube, 8.86 mg CuBr, 57.85
2,2′-bipyridine, and 600 mg of CBAA were added. Both tubes were then placed under nitrogen protection. Appropriate volumes of nitrogen purged methanol and water were then added (total volume was 4 mL) to the solids according to the necessary solvent ratio. After dissolving the solids (about 15 min), the mixture was then transferred to the reactor tube under nitrogen protection and allowed to react for 3 hours at 25° C. in a shaker set to 120 rpm. Following the reaction the chips were rinsed with water and then submerged overnight in PBS.mg - SPR Sensor, Chips, and Calibration of the Surface Sensitivity.
- A laboratory SPR sensor developed at the Institute of Photonics and Electronics, Prague, Czech Republic was used as described above. This custom built SPR is based on the Kretschmann geometry of the attenuated total reflection method with wavelength modulation and is equipped with a four-channel flow-cell, temperature control, and uses a peristaltic pump for delivering samples. SPR sensor chips were made of a glass slide coated with an adhesion-promoting titanium film (about 2 nm) followed by a gold film (about 48 nm) using an electron beam evaporator. Because SPR sensitivity depends on the distance of the binding event from the SPR active surface, the sensor response due to the polymer films was calibrated using methods described above.
- Determination of Polymer Film Thickness, Refractive Index, and Polymer Density.
- Dry and wet film thickness and refractive index (RI) measurements were determined using a multi-wavelength ellipsometer (J. A. Woollam Co., Inc., Model alpha-SE). A liquid cell with a volume of 0.5 mL supplied by the manufacturer was used for obtaining the wet measurements. The data was analyzed via fitting a Cauchy model for a bare SPR substrate which enables the film thickness and refractive index to be simultaneously determined without using predetermined or assumed Cauchy coefficients. The wet and dry refractive index measurements were then used with the effective medium approximation for calculating the wet polymer density (i.e., film polymer volume fraction (PVF). See
Equation 1. -
- The wet polymer density (PVF) in PBS of pCBAA films made via SI-ATRP using 0%, 10%, 50% and 90% water (v/v) was calculated using
Equation 1 as described above. - Measurements of Nonspecific Protein Adsorption by SPR.
- Nonspecific protein adsorption of the pCBAA polymer films was determined with a SPR biosensor using a flow rate of 50 μL/min at 25° C. After first establishing a baseline using PBS, undiluted human serum was flowed for 10 minutes, followed by buffer. Protein adsorption was quantified as the difference between buffer baselines and converted to a surface coverage using the appropriate sensitivity factor.
- Results.
- The pCBAA films were achieved by varying the SI-ATRP water content from 0-90% (v/v) using a fixed reaction time. The corresponding dry film thicknesses (8-40 nm), dry RI values (1.48-1.56 RI units (RIU)), and protein adsorption to undiluted human serum indicated a maximum value for both the thickness and RI as the polymerization rate was varied. All films except for those made using 90% water (v/v) enabled ultra low fouling properties. Thus it appears that thickness does not play a significant role in protein resistance. Because the dry film RI is proportional to the polymer density, the relatively high fouling for the films made from 90% water is likely due to its lower polymer density with a correspondingly reduced hydration, the primary mechanism of protein resistance. In the initial stages of polymerization for a given reaction, the thickness as well as the polymer density are simultaneously changing. Thus, the thickness can still serve as an indirect measure for achieving nonfouling surfaces. However, the results here illustrate that the polymer density may be the direct and more important parameter for reflecting protein resistance. This enables one to achieve ultra low fouling with a densely packed thin film.
- A minimum RI value (about 1.5) was observed, representing a minimum polymer density for achieving ultra low fouling properties with pCBAA films. The pCBAA film had a peak thickness at about 40 nm using 20% water (v/v). The ATRP reaction rate has been shown to be significantly affected by the concentration of water. As the water content increases, the rate of polymerization increases primarily due to loss of deactivator. For example, polymer films grown using 0% water enable a relatively slow reaction with low polydispersity. Under this condition, the final thickness is likely limited by the maximum solubility of the dense brushes in methanol. Here, the solvation ability of methanol gradually changes from good to bad as the chain length increases and the solubility approaches saturation. This leads to confinement of the growing chain end, limiting the access of free monomer as well as the catalyst complex thus preventing further propagation. Increasing the amount of water leads to both an increase in the accessibility of the chain end due to the super-hydrophilicity of zwitterionic carboxybetaine materials and an increase in the polymerization rate, resulting in larger film thicknesses. However, this comes at the expense of more polydispersity (i.e., loss of control) and more frequent irreversible chain-chain radical termination events. If such recombination events occur too often, as in the case of very high water concentrations, the film thickness can decrease. Therefore, increasing the water content should initially lead to larger film thicknesses until sufficient recombination occurs.
- The RI measurements have a similar trend to the film thicknesses. Because the dry film RI is proportional to polymer density, these results indicate that the density initially increases and then rapidly decreases with the rate of the ATRP reaction. The films made from 0% and 90% water had the lowest densities in air, despite the former being made under the most controlled conditions (i.e., water-free) which would be expected to yield a very high density polymer brush. The films made using 10%-60% water had the highest polymer densities. These are attributed to changes in surface morphology and packing structure of the film due to the increased polydispersity allowing for ion-pair interactions of the loose chains, which collapse onto the surface in the presence of air, similar to a multilayer polyelectrolyte film. The low value achieved for the film made from 0% water is due to the highly uniform and monodisperse brush containing few collapsed chains. The result for the film made with 90% water (v/v) was likely caused by excessive radical termination reactions which occur under this condition, thus creating little pockets for air thereby reducing the density. This is supported by the rapid decrease in thickness for films made from high water concentrations.
- The wet polymer density (polymer volume fraction (PVF)) in PBS of several films was also studied. A low wet density will have a large amount of solvent relative to polymer material thus enabling a large degree of swelling, corresponding to a “loose” polymer structure. The films made using 0%, 10%, 50%, and 90% water had wet densities of 62%, 48%, 35%, and 73%, respectively. The initial decrease follows the expected increase in polydispersity for the faster polymerizations, such as with high water concentrations. Therefore, because the films made using 90% water elicit widespread termination events, as indicated by the rapid decrease in thickness, it is believed that such significant chain-end recombination restricted the polymer from swelling yielding a high wet density.
- In summary, the data revealed a RI range of 1.50-1.56 RIU with wet polymer densities from 62-35% PVF that allowed zwitterionic pCBAA films to achieve <5 ng/cm2 of nonspecific protein adsorption from undiluted human serum.
- The results enable a model of the polymer structure as a function of water content (polymerization rate) and protein resistance to be developed. The water free scenario results in thin but uniform and dense polymer brushes with low polydispersity and ultra low fouling properties. As the water concentration increases, the polydispersity increases but the amount of termination is not excessive enough to significantly suppress film growth. The continued propagation enabled by the lack of recombination provides for a similarly dense base-layer to form and thus ultra low fouling properties can be achieved. The scenario for high water content occurs with very fast and uncontrolled reactions in which radical recombination frequently occurs. This restricts polymer growth and reduces the polymer density thereby affecting the film hydration and subsequent protein resistance.
- In this example, the effects of chain packing density on protein resistance properties of surface-initiated polymer brushes as measured by swelling ratio are described.
- Polymer brushes based on dual-function poly(carboxybetaine acrylamide) (pCB) were prepared via surface-initiated photoiniferter-mediated polymerization to determine the effects of the chain packing density on the protein resistant properties of surface-initiated polymer brushes. By adjusting the UV radiation time and solvent polarity, films with different thicknesses and packing densities were characterized via ellipsometry under both dry and wet conditions. Non-specific protein adsorption from undiluted human plasma and serum was then measured with a surface plasmon resonance (SPR) biosensor. The results indicated that the dry film thickness alone is not a sufficient characterization for evaluating non-fouling properties and the chain packing density must be considered. Based on this study, highly-packed and ultra-thin pCB films were developed and applied to the detection of human thyroid stimulating hormone (TSH) in serum by SPR with high sensitivity and specificity.
- Previous studies have identified the optimized “dry” thicknesses of pCB brushes for ultra-low fouling properties as being in the range of 20-30 nm. In bio-applications, the films are typically used in an aqueous environment. Hence, the “wet” thickness of the polymer brush films should be taken into account when determining the effects of thickness on non-fouling properties. The ratio of stretched and collapsed polymer film thicknesses was used to determine a swelling ratio as a means to characterize the effects of chain packing density on protein resistance. The packing density and film thickness of tethered pCB brushes prepared via SI photoiniferter-mediated polymerization were varied by adjusting the UV radiation time and solvent polarity. The resulting pCB film thicknesses in air and physiological buffer were measured and correlated with the non-fouling properties to undiluted human serum and plasma. Human thyroid stimulating hormone (TSH) detection using SPR integrated with a highly packed and thin pCB film as a binding platform demonstrated remarkable sensitivity and specificity.
- Growth and Non-Fouling Properties of pCB Films.
- The SI polymerization was carried out in the mixture of ethanol and water with a volume ratio of 75:25 with a monomer concentration of 0.15 M. The thickness (d) and swelling ratio (G) of prepared pCB films was measured using an ellipsometer and analyzed as a function of the UV radiation time. The thicknesses of pCB films in air and PBS increased with the UV radiation time. After 30 min of UV exposure, the film grew to thicknesses of ddry=22.1±1.1 nm and dwet=62.0±3.1 nm in air and PBS, respectively. However, the swelling ratio showed the opposite trend, declining from 3.6 to 2.8 for the 30 min UV radiation time. For the fouling test with undiluted blood serum and plasma, the fouling level decreased with increasing UV radiation time. As the film grew to ddry=22.1±1.1 nm and σ=2.8, it exhibited ultra-low fouling properties, which is in agreement with those observed on pCB and poly(hydroxypropyl methacrylate) previously prepared via SI-ATRP.
- A steep increase in thickness was observed at the beginning of polymerization, which was more pronounced for the “wet” thickness. The non-linear growth rate of pCB provides evidence that surface-tethered free radicals are lost during the course of polymerization. This observation confirms the feature of the initial rapid growth in photoiniferter-mediated photo-polymerization. The stretching of polymers decreased with UV radiation time. The rapid growth and termination of tethered polymers rendered the film sparse and the polymer chains coiled, giving rise to a “mushroom” conformation, manifested in the high swelling ratio. As the “living” polymer chains continue to grow, the chains interact with each other and, hence, stretch to become a “brush” conformation. The film thickness and chain packing density synergistically affect the non-fouling properties.
- Solvent Effects on Brush Packing Density and Non-Fouling Properties.
- In order to solidify the correlation between chain packing density and non-fouling properties, a pCB film with a thin thickness and high packing density was prepared through changing the solvent content in the polymerization. The UV radiation time and monomer concentration remained constant at 30 min and 0.15 M, respectively, and the volume ratio of methanol to water in solution was changed from 50% to 100%. Film thicknesses in air and in PBS decreased with the ratio of methanol, as well as their swelling ratio, which dropped from 3.7 to 2.5. The surface resistance to fouling from serum and plasma on pCB samples indicates that with increasing methanol content during photo-polymerization, non-specific adsorption on surfaces tends to decrease, reaching the ultra low fouling level. Furthermore, two samples were prepared from MeOH:H2O ratios of 50:50 and 70:30 for shorter radiation time, which exhibited similar dry film thicknesses but swelling ratios distinct from those prepared by the 100% methanol condition (
FIG. 15A ). Clearly, although these films have similar film thicknesses, the pCB films with high swelling rations or highly loose chain densities show significantly higher fouling levels than that with low swelling ratio or highly packed density (FIG. 15B ). These findings indicate that the high chain packing density namely contributes to excellent non-fouling performance, as long as a sufficient thickness is obtained (dwet=about 23 nm in this case). - The solvent effect was taken into consideration for investigating chain packing density and subsequent resistance to protein adsorption. Water and methanol were chosen as solvents for the super hydrophilic CB monomer due to their high polarity indices, which are 9.0 and 5.1, respectively. Higher methanol content leads to more controllable polymerization. These results for the first time reveal the correlation among non-fouling properties, growth rate and packing density of polymer films prepared via SI photo-polymerization approach, and point out the importance of the internal architecture of polymer brush for delicate design of desirable surface properties.
- SPR Detection for TSH Hormone Antigen.
- Functionalizable pCB was applied to a binding platform in SPR for in situ detection of TSH antigens in undiluted serum. Experiments were performed on pCB films fabricated from the solvents with MeOH:H2O ratios of 50:50, 70:30 and 100:0 under 30 min UV radiation, and the wet thicknesses of resulting films were 93.7±1.5 nm, 67.8±1.2 nm, and 22.8±2.3 nm, respectively. For convenience, those samples were denoted pCB-94, pCB-68, and pCB-23, respectively, according to their wet thicknesses. The surfaces were functionalized with anti-TSH antibodies through EDC/NHS coupling chemistry and the resulting binding capacities were 422.7±8.2 ng cm−2, 396.2±13.6 ng cm−2, and 262.5±0.8 ng cm2 on pCB-94, pCB-68 and pCB-23, respectively. After the establishment of baseline, undiluted blood serum containing 1 μg mL-1 TSH antigens was flowed over the surfaces in contact with conjugated IgG molecules and, additionally, in the other channel the serum without antigen was parallel tested as a control experiment. In order to compare the net responses upon antigen binding on three surfaces, the signals obtained from TSH-containing channels were subtracted from the signals of control channels. The net sensor responses to TSH binding on pCB films indicated that the strengths of responses increased with decrease in film thicknesses.
- The evanescent wave-based biosensor, such as SPR, exhibits a strength profile of a probing field exponentially decaying from the interface. For the regular SPR, the penetration depth of the probing field is typically around 200 nm, beyond which the binding event cannot be detected. pCB-23 with high chain packing density was prepared under a water-free condition. Compared to the films prepared from water-rich solutions, the pCB-23 represents very high sensor responses to TSH binding in complex media due to its ultra-low fouling properties and thin thickness although its antibody loading was the lowest. Therefore, the high resistance to non-specific adsorption and the effective use of probing field allow enhancing dramatically the specificity and sensitivity of biosensors.
- While illustrative embodiments have been illustrated and described, it will be appreciated that various changes can be made therein without departing from the spirit and scope of the invention.
Claims (23)
1. A surface-anchored polymer assembly, comprising:
(a) a nonfouling first layer having a first layer density, wherein the first layer comprises a plurality of first polymers, wherein each is attached to a substrate; and
(b) a second layer having a second layer density, wherein the second layer comprises a plurality of second polymers and a plurality of recognition elements attached to the second polymers, wherein the recognition elements are attached throughout the entire second layer, wherein the second layer is attached to the first layer,
wherein the first layer density is greater than the second layer density.
2. (canceled)
3. The polymer assembly of claim 1 further comprising one or more additional layers attached to the second layer.
4-5. (canceled)
6. The polymer assembly of claim 1 , wherein the first layer has a fibrinogen binding level less than about 30 ng/cm2.
7. The polymer assembly of claim 1 , wherein the first layer has a lysozyme binding level less than about 30 ng/cm2.
8-9. (canceled)
10. The polymer assembly of claim 1 , wherein the second layer is a crosslinked layer.
11. The polymer assembly of claim 1 , wherein the first polymers are grafted from the substrate.
12. The polymer assembly of claim 1 , wherein the first polymers are grafted to the substrate.
13. The polymer assembly of claim 1 , wherein the second polymers are grafted from the first polymers.
14. (canceled)
15. The polymer assembly of claim 1 , wherein the first and second polymers are independently selected from the group consisting of charged polymers and copolymers and non-charged polymers and copolymers.
16. The polymer assembly of claim 1 , wherein the first and second polymers are independently selected from zwitterionic polymers and copolymers and mixed charge copolymers.
17. The polymer assembly of claim 1 , wherein the first and second polymers are independently selected from the group consisting of polysulfobetaines, polycarboxybetaines, polyphosphobetaines, peptides, and peptoids.
18. The polymer assembly of claim 1 , wherein the first and second polymers are independently selected from alkylene oxide polymers and copolymers, polysaccharide polymers and copolymers, acrylamide polymers and copolymers, or hydroxy-terminal polymers and copolymers.
19. The polymer assembly of claim 1 , wherein the first polymers or the second polymers are zwitterionic polymers having the formula:
PB-[L1-(N+(R2)(R3))-L2-AO2 −-]n(X−)n(M+)n
PB-[L1-(N+(R2)(R3))-L2-AO2 −-]n(X−)n(M+)n
wherein
PB is the polymer backbone having n pendant zwitterionic groups;
R2 and R3 are independently selected from the group consisting of hydrogen, alkyl, and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
L1 is a linker that covalently couples the cationic center [N+(R5)(R6)] to the polymer backbone;
L2 is a linker that covalently couples the anionic center [A(═O)—O−] to the cationic center;
A is C, S, SO, P, or PO;
M+ is an optional counter ion associated with the (A=O)O− anionic center;
X− is an optional counter ion associated with the cationic center; and
n is an integer from 1 to about 10,000.
20. The polymer assembly of claim 1 , wherein the first polymers or the second polymers are mixed charge copolymers having the formula:
PB-[L3-(N+(R6)(R7)(R8)X−]n[L4-A2O2 −M+]p
PB-[L3-(N+(R6)(R7)(R8)X−]n[L4-A2O2 −M+]p
wherein
PB is the polymer backbone having n pendant cationic groups and p pendant anionic groups;
R6, R7, and R8 are independently selected from hydrogen, alkyl, and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
A(═O)—OM) is an anionic center, wherein A is C, S, SO, P, or PO, and M+ is an optional counter ion;
L3 is a linker that covalently couples the cationic center [N+(R6)(R7)(R8)] to the polymer backbone;
L4 is a linker that covalently couples the anionic center [A(═O)—OM] to the polymer backbone;
X− is an optional counter ion associated with the cationic center;
n is an integer from 1 to about 10,000; and
p is an integer from 1 to about 10,000.
21. The polymer assembly of claim 1 , wherein the substrate is selected from metal and metal oxide surfaces, ceramic surfaces, synthetic and natural polymeric surfaces, glass surfaces, fiber glass surfaces, silicon/silica surfaces, carbon-based material surfaces, cell surfaces, or macromolecule surfaces.
22. The polymer assembly of claim 1 , wherein the substrate is the surface of a diagnostic device, a medical device, a separation device, a targeting delivery carrier, a scaffold, or a marine coating.
23. A method for making a surface-anchored polymer assembly, comprising:
(a) forming a first layer having a first layer density on a substrate; and
(b) forming a second layer on the first layer, the second layer having a second density,
wherein the first layer density is greater than the second layer density.
24. The method of claim 23 further comprising attaching a plurality of recognition elements to the second layer.
25. A method for determining the presence of an analyte in a sample, comprising:
(a) contacting a sample with a polymer assembly of claim 1 , wherein the recognition element has a specific binding affinity for the analyte; and
(b) interrogating the polymer assembly to determine whether the analyte has bound to the film.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/042,883 US20190154683A1 (en) | 2012-01-20 | 2018-07-23 | Hierarchical films having ultra low fouling and high recognition element loading properties |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261588785P | 2012-01-20 | 2012-01-20 | |
| US13/747,290 US10031138B2 (en) | 2012-01-20 | 2013-01-22 | Hierarchical films having ultra low fouling and high recognition element loading properties |
| US16/042,883 US20190154683A1 (en) | 2012-01-20 | 2018-07-23 | Hierarchical films having ultra low fouling and high recognition element loading properties |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/747,290 Continuation US10031138B2 (en) | 2012-01-20 | 2013-01-22 | Hierarchical films having ultra low fouling and high recognition element loading properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20190154683A1 true US20190154683A1 (en) | 2019-05-23 |
Family
ID=49157976
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/747,290 Active 2033-11-08 US10031138B2 (en) | 2012-01-20 | 2013-01-22 | Hierarchical films having ultra low fouling and high recognition element loading properties |
| US16/042,883 Abandoned US20190154683A1 (en) | 2012-01-20 | 2018-07-23 | Hierarchical films having ultra low fouling and high recognition element loading properties |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/747,290 Active 2033-11-08 US10031138B2 (en) | 2012-01-20 | 2013-01-22 | Hierarchical films having ultra low fouling and high recognition element loading properties |
Country Status (1)
| Country | Link |
|---|---|
| US (2) | US10031138B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020263516A1 (en) * | 2019-06-28 | 2020-12-30 | Rhodia Operations | Use of polyphenol compounds and hydrophilic polymers for reducing or preventing colloids adhesion and/or fouling on a substrate |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008083390A2 (en) | 2006-12-29 | 2008-07-10 | University Of Washington | Dual-functional nonfouling surfaces and materials |
| US10031138B2 (en) | 2012-01-20 | 2018-07-24 | University Of Washington Through Its Center For Commercialization | Hierarchical films having ultra low fouling and high recognition element loading properties |
| CN111118121B (en) | 2013-12-05 | 2024-07-19 | 生捷科技控股公司 | Preparation of patterned arrays |
| US10597715B2 (en) | 2013-12-05 | 2020-03-24 | Centrillion Technology Holdings | Methods for sequencing nucleic acids |
| CN105940024B (en) * | 2013-12-05 | 2019-03-15 | 生捷科技控股公司 | modified surface |
| US11060139B2 (en) | 2014-03-28 | 2021-07-13 | Centrillion Technology Holdings Corporation | Methods for sequencing nucleic acids |
| CZ2015313A3 (en) | 2015-05-07 | 2016-07-07 | Ústav makromolekulární chemie AV ČR, v. v. i. | Polymeric brushes resistant to deposition of biological media components, process for their preparation and their use |
| US20170188905A1 (en) * | 2015-12-30 | 2017-07-06 | Dexcom, Inc. | Biointerface layer for analyte sensors |
| CZ2016361A3 (en) | 2016-06-17 | 2017-11-22 | Ústav Fotoniky A Elektroniky Av Čr, V. V. I. | A method of preparing a surface of a substrate comprising carboxybetaine functional groups |
| CN110770570A (en) * | 2017-07-28 | 2020-02-07 | 富士胶片株式会社 | Sensor with a sensor element |
| WO2019070594A1 (en) * | 2017-10-03 | 2019-04-11 | Massachusetts Institute Of Technology | Materials that resist fouling and methods for identifying same |
| TWI730352B (en) | 2018-08-06 | 2021-06-11 | 英商伊路米納劍橋有限公司 | Flow cells and sequencing systems and methods of preparing substrates therefor |
| JP7048946B2 (en) * | 2019-02-13 | 2022-04-06 | 大日精化工業株式会社 | Surface-treated membranes, their manufacturing methods, and articles |
| US11199778B2 (en) | 2019-03-12 | 2021-12-14 | International Business Machines Corporation | Polymer brush adhesion promoter with UV cleavable linker |
| CZ309314B6 (en) | 2020-05-14 | 2022-08-17 | Fyzikální Ústav Av Čr, V. V. I. | Polymer brush containing terpolymer for use against non-specific adsorption of substances from biological media |
| EP4423198A4 (en) * | 2021-11-18 | 2025-10-15 | Aculon Inc | Coated substrates with superhydrophilicity for use as medical devices |
| CN120835992A (en) * | 2023-03-02 | 2025-10-24 | 道达尔能源一技术公司 | Device for detecting BTEX using a polymer having fluorobenzyl groups |
Family Cites Families (216)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3671502A (en) | 1970-11-12 | 1972-06-20 | Kendall & Co | Betaine copolymers with hydroxyalkylacrylates and hydroxyalkylmethacrylates |
| US4138446A (en) | 1974-12-19 | 1979-02-06 | Sumitomo Chemical Company, Limited | Water-soluble high polymers and their preparation |
| GB1510689A (en) | 1974-12-19 | 1978-05-10 | Sumitomo Chemical Co | Preparation of water-soluble cationic high polymer |
| US4415388A (en) | 1981-06-22 | 1983-11-15 | Johnson & Johnson | Method of making absorbent bearing products |
| US4493926A (en) | 1984-01-04 | 1985-01-15 | General Electric Company | Dissociating ionically cross-linked siloxane polymers |
| US5204060A (en) | 1986-01-07 | 1993-04-20 | Berol Kemi Ab | Method for disinfection |
| DE3622993A1 (en) | 1986-07-09 | 1988-01-21 | Behringwerke Ag | DISPERSION POLYMERS, BIOLOGICALLY ACTIVE DISPERSION POLYMERS, METHOD FOR THE PRODUCTION THEREOF AND USE AS A DIAGNOSTIC MEANS |
| JPS63234007A (en) | 1987-03-23 | 1988-09-29 | Kohjin Co Ltd | Highly water-soluble cationic polymer |
| US4985023A (en) | 1988-05-09 | 1991-01-15 | Dow Corning Corporation | Antimicrobial superabsorbent articles |
| US4931328A (en) | 1988-08-19 | 1990-06-05 | Hewlett-Packard Company | Capillary tube with reduced protein interactions and controllable electroosmotic flow |
| JPH03110473A (en) | 1989-09-26 | 1991-05-10 | Tokuyama Soda Co Ltd | Method and device for automatic decision of blood type |
| KR920008095A (en) | 1990-10-01 | 1992-05-27 | 원본미기재 | Polymers suitable for use as absorbents of aqueous electrolyte solutions |
| SU1780673A1 (en) | 1991-04-19 | 1992-12-15 | Tashk Farmatsevticheskij I | Fungicide agent |
| US5233453A (en) | 1992-04-29 | 1993-08-03 | International Business Machines Corporation | Space-division switched waveguide array filter and method using same |
| US5905028A (en) | 1994-05-17 | 1999-05-18 | Gamma Biologicals, Inc. | Method and apparatus useful for detecting bloodgroup antigens and antibodies |
| US5604592A (en) | 1994-09-19 | 1997-02-18 | Textron Defense Systems, Division Of Avco Corporation | Laser ultrasonics-based material analysis system and method using matched filter processing |
| US5624711A (en) | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
| US7119337B1 (en) | 1997-08-04 | 2006-10-10 | Ion Optics, Inc. | Infrared radiation sources, sensors and source combinations, and methods of manufacture |
| US5633724A (en) | 1995-08-29 | 1997-05-27 | Hewlett-Packard Company | Evanescent scanning of biochemical array |
| US5714360A (en) | 1995-11-03 | 1998-02-03 | Bsi Corporation | Photoactivatable water soluble cross-linking agents containing an onium group |
| US6174424B1 (en) | 1995-11-20 | 2001-01-16 | Cirrex Corp. | Couplers for optical fibers |
| US5804453A (en) | 1996-02-09 | 1998-09-08 | Duan-Jun Chen | Fiber optic direct-sensing bioprobe using a phase-tracking approach |
| US5854863A (en) | 1996-03-15 | 1998-12-29 | Erb; Judith | Surface treatment and light injection method and apparatus |
| US5781284A (en) | 1996-04-24 | 1998-07-14 | Infante; David A. | System for detecting impurities contained in a fluid medium |
| US5925552A (en) | 1996-04-25 | 1999-07-20 | Medtronic, Inc. | Method for attachment of biomolecules to medical devices surfaces |
| EP0822401A3 (en) | 1996-07-30 | 1999-05-06 | Bayer Corporation | Hydraulic system for a hematology analytical instrument |
| US5840585A (en) | 1996-09-17 | 1998-11-24 | Baylor College Of Medicine | Rh blood group antigen compositions and methods of use |
| US5776711A (en) | 1996-11-12 | 1998-07-07 | The Regents Of The University Of California | Simultaneous human ABO and RH(D) blood typing or antibody screening by flow cytometry |
| US5818860A (en) | 1996-11-27 | 1998-10-06 | David Sarnoff Research Center, Inc. | High power semiconductor laser diode |
| EP0856539A1 (en) | 1997-01-30 | 1998-08-05 | Mitsui Chemicals, Inc. | Cross-linked polymer |
| US5838870A (en) | 1997-02-28 | 1998-11-17 | The United States Of America As Represented By The Secretary Of The Air Force | Nanometer-scale silicon-on-insulator photonic componets |
| US7056532B1 (en) | 1997-06-13 | 2006-06-06 | Univ. Nebraska Bd. of Regents | Compositions for delivery of biological agents and methods for the preparation thereof |
| US7547445B2 (en) | 1998-03-19 | 2009-06-16 | Surmodics, Inc. | Crosslinkable macromers |
| WO2000036715A1 (en) | 1998-11-25 | 2000-06-22 | The University Of New Mexico | Precisely wavelength-tunable and wavelength-switchable narrow linewidth lasers |
| US6361768B1 (en) | 1998-12-29 | 2002-03-26 | Pmd Holdings Corp. | Hydrophilic ampholytic polymer |
| US6330388B1 (en) | 1999-01-27 | 2001-12-11 | Northstar Photonics, Inc. | Method and apparatus for waveguide optics and devices |
| CA2371011C (en) * | 1999-04-28 | 2009-12-22 | Eidgenossisch Technische Hochschule Zurich | Polyionic coatings in analytic and sensor devices |
| PT1189553E (en) | 1999-06-24 | 2004-09-30 | Abbott Vascular Devices Ltd | EXPANSIVE BALLOON ENDOVASCULAR PROTESE |
| US6831938B1 (en) | 1999-08-30 | 2004-12-14 | California Institute Of Technology | Optical system using active cladding layer |
| US20060194008A1 (en) | 1999-09-22 | 2006-08-31 | Princeton University | Devices with multiple surface functionality |
| US6781696B1 (en) | 1999-10-06 | 2004-08-24 | The Board Of Regents For Oklahoma State University | Apparatus and method for a microsphere whispering-gallery mode evanescent-wave sensor |
| US7266271B2 (en) | 1999-10-06 | 2007-09-04 | Nomadics, Inc. | System, probe and methods for colorimetric testing |
| US7167615B1 (en) | 1999-11-05 | 2007-01-23 | Board Of Regents, The University Of Texas System | Resonant waveguide-grating filters and sensors and methods for making and using same |
| US8111401B2 (en) | 1999-11-05 | 2012-02-07 | Robert Magnusson | Guided-mode resonance sensors employing angular, spectral, modal, and polarization diversity for high-precision sensing in compact formats |
| JP3853549B2 (en) | 1999-11-10 | 2006-12-06 | 花王株式会社 | Functional alcohol release material |
| JP4733331B2 (en) | 2000-03-14 | 2011-07-27 | マイクロニックス、インコーポレーテッド | Microfluidic analysis device |
| US6852816B2 (en) | 2000-10-06 | 2005-02-08 | Biocompatibles Uk Limited | Zwitterionic polymers |
| US6558626B1 (en) | 2000-10-17 | 2003-05-06 | Nomadics, Inc. | Vapor sensing instrument for ultra trace chemical detection |
| US7087203B2 (en) | 2000-11-17 | 2006-08-08 | Nagaoka & Co., Ltd. | Methods and apparatus for blood typing with optical bio-disc |
| US6661950B1 (en) | 2001-01-10 | 2003-12-09 | Nomadics, Inc. | Microresonator-based tuned optical filter |
| US7075954B2 (en) | 2001-05-29 | 2006-07-11 | Nl Nanosemiconductor Gmbh | Intelligent wavelength division multiplexing systems based on arrays of wavelength tunable lasers and wavelength tunable resonant photodetectors |
| US7008559B2 (en) | 2001-06-06 | 2006-03-07 | Nomadics, Inc. | Manganese doped upconversion luminescence nanoparticles |
| US7501092B2 (en) | 2001-06-06 | 2009-03-10 | Nomadics, Inc. | Manganese doped upconversion luminescence nanoparticles |
| US6782205B2 (en) | 2001-06-25 | 2004-08-24 | Silicon Light Machines | Method and apparatus for dynamic equalization in wavelength division multiplexing |
| DE10132173A1 (en) | 2001-07-03 | 2003-01-23 | Goldschmidt Ag Th | New beta nests |
| US7067072B2 (en) | 2001-08-17 | 2006-06-27 | Nomadics, Inc. | Nanophase luminescence particulate material |
| US8021848B2 (en) | 2001-09-06 | 2011-09-20 | Straus Holdings Inc. | Rapid and sensitive detection of cells and viruses |
| US6834152B2 (en) | 2001-09-10 | 2004-12-21 | California Institute Of Technology | Strip loaded waveguide with low-index transition layer |
| US7082235B2 (en) | 2001-09-10 | 2006-07-25 | California Institute Of Technology | Structure and method for coupling light between dissimilar waveguides |
| WO2003023474A1 (en) | 2001-09-10 | 2003-03-20 | California Institute Of Technology | Tunable resonant cavity based on the field effect in semiconductors |
| US20070133001A1 (en) | 2001-09-12 | 2007-06-14 | Honeywell International Inc. | Laser sensor having a block ring activity |
| US7145165B2 (en) | 2001-09-12 | 2006-12-05 | Honeywell International Inc. | Tunable laser fluid sensor |
| US6974673B2 (en) | 2001-09-24 | 2005-12-13 | Veridian Systems Division | Coupled capillary fiber based waveguide biosensor |
| AU2002357724A1 (en) | 2001-11-14 | 2003-05-26 | Massachusetts Institute Of Technology | Tunable optical add/drop multiplexer with multi-function optical amplifiers |
| US7462325B2 (en) | 2001-11-30 | 2008-12-09 | Nomadics, Inc. | Luminescent polymer particles |
| WO2003074026A1 (en) | 2002-03-07 | 2003-09-12 | Biocompatibles Uk Limited | Drug carriers comprising amphiphilic block copolymers |
| JP4189322B2 (en) | 2002-03-08 | 2008-12-03 | センシス メディカル インク | Compact instrument for non-invasive measurement of glucose by near infrared spectroscopy |
| US20050054908A1 (en) | 2003-03-07 | 2005-03-10 | Blank Thomas B. | Photostimulation method and apparatus in combination with glucose determination |
| US7807348B2 (en) | 2002-03-20 | 2010-10-05 | Wisconsin Alumni Research Foundation | Optical imaging of nanostructured substrates |
| US6853756B2 (en) | 2002-03-25 | 2005-02-08 | Helios Photonics, Inc. | Tunable optical waveguide filters with optimized lengths and method of designing same |
| CN100419426C (en) | 2002-04-22 | 2008-09-17 | 佛罗里达州立大学 | Functionalized nanoparticles and methods of use thereof |
| US7027476B2 (en) | 2002-08-09 | 2006-04-11 | California Institute Of Technology | Tunable semiconductor lasers |
| CA2496777A1 (en) | 2002-08-29 | 2004-05-06 | Bioscale, Inc. | Resonant sensor and sensing system |
| US20050058689A1 (en) | 2003-07-03 | 2005-03-17 | Reactive Surfaces, Ltd. | Antifungal paints and coatings |
| US7157409B2 (en) | 2002-09-25 | 2007-01-02 | M-I Llc | Surfactant-polymer compositions for enhancing the stability of viscoelastic-surfactant based fluid |
| US6920272B2 (en) | 2002-10-09 | 2005-07-19 | Nanoopto Corporation | Monolithic tunable lasers and reflectors |
| US7139459B2 (en) | 2002-10-16 | 2006-11-21 | Lake Shore Cryotronics, Inc. | Spectral filter for green and longer wavelengths |
| US7095010B2 (en) | 2002-12-04 | 2006-08-22 | California Institute Of Technology | Silicon on insulator resonator sensors and modulators and method of operating the same |
| US20040121337A1 (en) | 2002-12-19 | 2004-06-24 | Nomadics, Inc. | Luminescent polymers and methods of use thereof |
| DE10261750A1 (en) | 2002-12-30 | 2004-07-15 | Basf Ag | Ampholytic copolymer and its use |
| US7419638B2 (en) | 2003-01-14 | 2008-09-02 | Micronics, Inc. | Microfluidic devices for fluid manipulation and analysis |
| DE602004021685D1 (en) | 2003-03-27 | 2009-08-06 | Corning Inc | FLAG-FREE DETECTION OF BIOLOGICAL AND CHEMICAL SUBSTANCES BY EVANESCENCE FIELD |
| SE0400073D0 (en) | 2003-04-04 | 2004-01-14 | Appear Sweden Hb | Antibacterial material |
| US7497992B2 (en) | 2003-05-08 | 2009-03-03 | Sru Biosystems, Inc. | Detection of biochemical interactions on a biosensor using tunable filters and tunable lasers |
| EP1624754B1 (en) | 2003-05-15 | 2011-02-09 | Arch UK Biocides Limited | Antimicrobial composition containing a polymeric biguanide and a copolymer and use thereof |
| US6943881B2 (en) | 2003-06-04 | 2005-09-13 | Tomophase Corporation | Measurements of optical inhomogeneity and other properties in substances using propagation modes of light |
| JP4758891B2 (en) | 2003-06-06 | 2011-08-31 | マイクロニクス, インコーポレイテッド | Systems and methods for heating, cooling and thermal cycling on microfluidic devices |
| US7648835B2 (en) | 2003-06-06 | 2010-01-19 | Micronics, Inc. | System and method for heating, cooling and heat cycling on microfluidic device |
| US7244926B2 (en) | 2004-02-26 | 2007-07-17 | Nomadics, Inc. | Microresonator-based high-performance high-pressure sensor and system |
| US7177492B2 (en) | 2004-03-11 | 2007-02-13 | Nomadics, Inc. | System, probe and methods for colorimetric testing |
| US7291427B2 (en) | 2004-03-19 | 2007-11-06 | Fujifilm Corporation | Surface graft material, conductive pattern material, and production method thereof |
| TWI251393B (en) | 2004-03-31 | 2006-03-11 | Nec Corp | Tunable laser |
| EP1744795A1 (en) | 2004-05-14 | 2007-01-24 | Becton, Dickinson and Company | Articles having bioactive surfaces and solvent-free methods of preparation thereof |
| JP4332067B2 (en) | 2004-05-25 | 2009-09-16 | 富士通株式会社 | Tunable laser device |
| US7315679B2 (en) | 2004-06-07 | 2008-01-01 | California Institute Of Technology | Segmented waveguide structures |
| EP1779444A4 (en) | 2004-07-08 | 2011-01-05 | Ion Optics Inc | ADJUSTABLE PHOTONIC CRYSTAL |
| US7307719B2 (en) | 2004-09-14 | 2007-12-11 | Hewlett-Packard Development Company, L.P. | Wavelength-tunable excitation radiation amplifying structure and method |
| US7324199B2 (en) | 2004-09-20 | 2008-01-29 | Nomadics, Inc. | System and deconvolution process for an optical filtering device based on WGM resonance |
| ITVR20040149A1 (en) | 2004-09-22 | 2004-12-22 | Sanitaria Scaligera Spa | RAPID MONITORING SYSTEM OF THE BLOOD GROUP AND FOR THE DETECTION OF IMMUNOHEMATOLOGICAL REACTIONS |
| US7835006B2 (en) | 2004-11-05 | 2010-11-16 | Nomadics, Inc. | Optical fiber sensors using grating-assisted surface plasmon-coupled emission (GASPCE) |
| US7067342B2 (en) | 2004-11-15 | 2006-06-27 | Freescale Semiconductor, Inc. | Method of integrating optical devices and electronic devices on an integrated circuit |
| US7309628B2 (en) | 2004-11-15 | 2007-12-18 | Omar Zia | Method of forming a semiconductor device |
| US7519257B2 (en) | 2004-11-24 | 2009-04-14 | Cornell Research Foundation, Inc. | Waveguide structure for guiding light in low-index material |
| US7397043B2 (en) | 2005-01-26 | 2008-07-08 | Nomadics, Inc. | Standoff optical detection platform based on surface plasmon-coupled emission |
| US7538329B2 (en) | 2005-02-02 | 2009-05-26 | Nomadics, Inc. | Energy-transfer nanocomposite materials and methods of making and using same |
| US20060183863A1 (en) | 2005-02-14 | 2006-08-17 | Ciphergen Biosystems, Inc. | Zwitterionic polymers |
| JP4774761B2 (en) | 2005-03-03 | 2011-09-14 | 日本電気株式会社 | Wavelength tunable resonator, wavelength tunable laser, optical module, and control method thereof |
| JP2006278770A (en) | 2005-03-29 | 2006-10-12 | Nec Corp | Variable wavelength laser |
| FR2883971B1 (en) | 2005-03-31 | 2007-11-16 | C2 Diagnostics Sa | OPTICAL BLOOD ANALYSIS DEVICE, ANALYZING APPARATUS EQUIPPED WITH SUCH A DEVICE |
| WO2006108183A2 (en) | 2005-04-05 | 2006-10-12 | Corning Incorporated | Label free biosensors and cells |
| US7528403B1 (en) | 2005-04-25 | 2009-05-05 | California Institute Of Technology | Hybrid silicon-on-insulator waveguide devices |
| US7228016B2 (en) | 2005-05-11 | 2007-06-05 | Hewlett-Packard Development Company, L.P. | Evanescent nanosensor using an optical resonator |
| JP4746038B2 (en) | 2005-06-08 | 2011-08-10 | 富士通セミコンダクター株式会社 | Semiconductor memory device and electronic device |
| TWI326691B (en) | 2005-07-22 | 2010-07-01 | Kraton Polymers Res Bv | Sulfonated block copolymers, method for making same, and various uses for such block copolymers |
| US7445879B2 (en) | 2005-08-23 | 2008-11-04 | Nukote International, Inc. | Preparation of suspension polymerized toners |
| EP1924654B1 (en) | 2005-08-25 | 2020-05-06 | University of Washington | Super-low fouling sulfobetaine and carboxybetaine materials and related methods |
| US20110097277A1 (en) | 2005-08-25 | 2011-04-28 | University Of Washington | Particles coated with zwitterionic polymers |
| US7799573B2 (en) | 2005-08-31 | 2010-09-21 | Normadics, Inc. | Detection of explosives and other species |
| US20070111321A1 (en) | 2005-08-31 | 2007-05-17 | Nomadics, Inc. | Detection of explosives and other species |
| CN101287805B (en) | 2005-09-06 | 2011-11-02 | 诺华丝国际股份有限公司 | Marine antifouling coating compositions |
| WO2007035527A2 (en) | 2005-09-15 | 2007-03-29 | Duke University | Non-fouling polymeric surface modification and signal amplification method for biomolecular detection |
| US7361501B2 (en) | 2005-09-30 | 2008-04-22 | Intel Corporation | Miniaturized spectrometer using optical waveguide and integrated Raman system on-chip |
| US7831298B1 (en) | 2005-10-04 | 2010-11-09 | Tomophase Corporation | Mapping physiological functions of tissues in lungs and other organs |
| US7826688B1 (en) | 2005-10-21 | 2010-11-02 | Luxtera, Inc. | Enhancing the sensitivity of resonant optical modulating and switching devices |
| US8124128B2 (en) | 2005-11-08 | 2012-02-28 | Industrial Technology Research Institute | Amphiphilic block copolymers and nano particles comprising the same |
| JP4961133B2 (en) | 2005-11-10 | 2012-06-27 | 大阪有機化学工業株式会社 | Medical materials |
| US20070114477A1 (en) | 2005-11-18 | 2007-05-24 | Iwao Teraoka | Enhanced sensitivity of a whispering gallery mode microsphere sensor by a high-refractive index surface layer |
| US7763453B2 (en) | 2005-11-30 | 2010-07-27 | Micronics, Inc. | Microfluidic mixing and analytic apparatus |
| EP1969391B1 (en) | 2005-12-12 | 2014-07-16 | Irina Puscasu | Thin film emitter-absorber apparatus and methods |
| FR2894585B1 (en) | 2005-12-14 | 2012-04-27 | Rhodia Recherches Et Tech | COPOLYMER COMPRISING ZWITTERIONIC UNITS AND OTHER UNITS, COMPOSITION COMPRISING THE COPOLYMER, AND USE |
| US7336859B2 (en) | 2005-12-28 | 2008-02-26 | Honeywell International, Inc. | Sensor using ultra thin waveguides and optical fibers |
| US7738527B2 (en) | 2005-12-30 | 2010-06-15 | Jian-Jun He | Wavelength switchable semiconductor laser using half-wave coupled active double-ring resonator |
| DE102006004111B4 (en) | 2006-01-28 | 2015-11-19 | Wöhlk-Contact-Linsen GmbH | Contact lens material |
| US20090304551A1 (en) | 2006-01-31 | 2009-12-10 | Drexel University | Ultra Sensitive Tapered Fiber Optic Biosensor For Pathogens, Proteins, and DNA |
| FR2898067B1 (en) | 2006-03-03 | 2008-05-30 | Rhodia Recherches & Tech | MODIFICATION OF SOLID SURFACES BY POLYMER ASSOCIATIONS |
| US8288157B2 (en) | 2007-09-12 | 2012-10-16 | Plc Diagnostics, Inc. | Waveguide-based optical scanning systems |
| ATE515700T1 (en) | 2006-03-23 | 2011-07-15 | Absorber Ab | BLOOD GROUP ANTIGENS OF DIFFERENT TYPES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| US7693369B2 (en) | 2006-04-07 | 2010-04-06 | The Curators Of The University Of Missouri | Hollow core optical ring resonator sensor, sensing methods, and methods of fabrication |
| US7613369B2 (en) | 2006-04-13 | 2009-11-03 | Luxtera, Inc. | Design of CMOS integrated germanium photodiodes |
| US7783144B2 (en) | 2006-04-24 | 2010-08-24 | The Hong Kong University Of Science And Technology | Electrically tunable microresonators using photoaligned liquid crystals |
| WO2007143034A1 (en) | 2006-05-30 | 2007-12-13 | University Of Utah Research Foundation | Simultaneous amplification and detection if ribonucleic acid by an optical method using surface plasmon resonance |
| US7488930B2 (en) | 2006-06-02 | 2009-02-10 | Medeikon Corporation | Multi-channel low coherence interferometer |
| JP2009545747A (en) | 2006-08-02 | 2009-12-24 | カリフォルニア インスティチュート オブ テクノロジー | Method and system for detecting and / or sorting targets |
| CA2665493A1 (en) | 2006-08-07 | 2008-02-14 | University Of Washington | Mixed charge copolymers and hydrogels |
| WO2008030468A2 (en) | 2006-09-07 | 2008-03-13 | Massachusetts Institute Of Technology | Microphotonic waveguide including core/cladding interface layer |
| US7961988B2 (en) | 2006-09-11 | 2011-06-14 | The Boeing Company | Rapidly tunable wavelength selective ring resonator |
| WO2008083390A2 (en) | 2006-12-29 | 2008-07-10 | University Of Washington | Dual-functional nonfouling surfaces and materials |
| WO2008082664A2 (en) | 2006-12-29 | 2008-07-10 | Massachusetts Institute Of Technology | Fabrication-tolerant waveguides and resonators |
| US7633629B2 (en) | 2007-02-05 | 2009-12-15 | Palo Alto Research Center Incorporated | Tuning optical cavities |
| US7936463B2 (en) | 2007-02-05 | 2011-05-03 | Palo Alto Research Center Incorporated | Containing analyte in optical cavity structures |
| JP2008251673A (en) | 2007-03-29 | 2008-10-16 | Nec Corp | Optical device and manufacturing method therefor |
| GB2448162A (en) | 2007-04-03 | 2008-10-08 | Bookham Technology Plc | Tunable semiconductor laser |
| GB0706820D0 (en) | 2007-04-10 | 2007-05-16 | Common Services Agency | Blood grouop antibody screening |
| FR2914966B1 (en) | 2007-04-12 | 2010-09-10 | Eris | METHOD FOR MANUFACTURING RIVET AND RIVET OBTAINED ACCORDING TO THIS PROCESS |
| CA2601836C (en) | 2007-05-21 | 2017-02-28 | Adam Densmore | Silicon photonic wire waveguide biosensor |
| US7796262B1 (en) | 2007-05-31 | 2010-09-14 | Nomadics, Inc. | Integrated optical resonator device for measuring chemical and biological analyte concentrations |
| US20080311045A1 (en) | 2007-06-06 | 2008-12-18 | Biovaluation & Analysis, Inc. | Polymersomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo |
| US8298496B2 (en) | 2007-07-23 | 2012-10-30 | Flir Systems, Inc. | Fluidic configuration for flow injection analysis |
| JP2010537194A (en) | 2007-08-20 | 2010-12-02 | ノーマディックス インコーポレイテッド | Gradient injection for biosensing |
| WO2009029957A1 (en) | 2007-08-30 | 2009-03-05 | Cornell University | Nanoscale optofluidic devices for molecular detection |
| US8139904B2 (en) | 2007-09-18 | 2012-03-20 | International Business Machines Corporation | Method and apparatus for implementing optical deflection switching using coupled resonators |
| US7982878B1 (en) | 2007-10-03 | 2011-07-19 | Nomadics, Inc. | Optical emission collection and detection device and method |
| US20090325211A1 (en) | 2007-10-06 | 2009-12-31 | Ye Fang | System and method for dual-detection of a cellular response |
| US7903909B2 (en) | 2007-10-22 | 2011-03-08 | Massachusetts Institute Of Technology | Low-loss bloch wave guiding in open structures and highly compact efficient waveguide-crossing arrays |
| EP2208052A2 (en) | 2007-11-06 | 2010-07-21 | Nxp B.V. | A biosensor device and a method of detecting biological particles |
| EP2225331B1 (en) | 2007-11-19 | 2016-01-06 | University of Washington | Marine coatings |
| MX2010005295A (en) | 2007-11-19 | 2010-06-23 | Univ Washington | Cationic beataine precursors to zwitterionic betaines having controlled biological properties. |
| US8658192B2 (en) | 2007-11-19 | 2014-02-25 | University Of Washington | Integrated antimicrobial and low fouling materials |
| WO2009076323A2 (en) | 2007-12-06 | 2009-06-18 | Genalyte Inc. | Monitoring enzymatic process |
| WO2009099126A1 (en) | 2008-02-07 | 2009-08-13 | Riken | Photoreactive copolymer, surface modifier, hydrophilic treatment agent, adsorption inhibitor, substance-immobilizing agent, surface modification method, hydrophilization method, adsorption inhibition method, and substance-immobilizing method |
| US8019185B2 (en) | 2008-02-14 | 2011-09-13 | Hrl Laboratories, Llc | Unit-cell array optical signal processor |
| WO2009107808A1 (en) | 2008-02-29 | 2009-09-03 | 株式会社フジクラ | Substrate-type optical waveguide device, wavelength dispersion compensation device and designing method thereof, light filter and designing method thereof, and optical resonator and designing method thereof |
| WO2009107798A1 (en) | 2008-02-29 | 2009-09-03 | 株式会社フジクラ | Optical waveguide element, wavelength dispersion compensation element, method for designing the same, optical filter, method for designing the same, optical resonator and method for designing the same |
| US8195011B2 (en) | 2008-03-03 | 2012-06-05 | Ramot At Tel-Aviv University Ltd. | Electro-optical modulator structure |
| US7885490B2 (en) | 2008-03-10 | 2011-02-08 | Octrolix Bv | Optical chemical detector and method |
| WO2009137202A2 (en) | 2008-04-03 | 2009-11-12 | California Institute Of Technology | Optical sensing based on overlapping optical modes in optical resonator sensors and interferometric sensors |
| US7616850B1 (en) | 2008-04-09 | 2009-11-10 | Sandia Corporation | Wavelength-tunable optical ring resonators |
| US8537353B2 (en) | 2008-05-05 | 2013-09-17 | Agency For Science, Technology And Research | Sensor chip for biological and chemical sensing |
| US8045834B2 (en) | 2008-05-19 | 2011-10-25 | California Institute Of Technology | Silica-on-silicon waveguides and related fabrication methods |
| WO2010030251A2 (en) | 2008-09-15 | 2010-03-18 | Agency For Science, Technology And Research | Integrated optical sensors operating in the frequency domain |
| US7643710B1 (en) | 2008-09-17 | 2010-01-05 | Intel Corporation | Method and apparatus for efficient coupling between silicon photonic chip and optical fiber |
| JP5304158B2 (en) | 2008-10-07 | 2013-10-02 | 沖電気工業株式会社 | Optical resonator and tunable laser |
| US8307724B1 (en) | 2008-10-21 | 2012-11-13 | Nomadics, Inc. | Two mode vapor/particulate sampling device |
| US9846126B2 (en) | 2008-10-27 | 2017-12-19 | Genalyte, Inc. | Biosensors based on optical probing and sensing |
| US8213751B1 (en) | 2008-11-26 | 2012-07-03 | Optonet Inc. | Electronic-integration compatible photonic integrated circuit and method for fabricating electronic-integration compatible photonic integrated circuit |
| US20100152726A1 (en) | 2008-12-16 | 2010-06-17 | Arthrocare Corporation | Electrosurgical system with selective control of active and return electrodes |
| US8000565B2 (en) | 2008-12-31 | 2011-08-16 | Intel Corporation | Buried dual taper waveguide for passive alignment and photonic integration |
| WO2010120293A1 (en) | 2009-04-15 | 2010-10-21 | Nomadics, Inc. | Non-planar biosensing surfaces |
| US8467858B2 (en) | 2009-04-29 | 2013-06-18 | Tomophase Corporation | Image-guided thermotherapy based on selective tissue thermal treatment |
| US8263986B2 (en) | 2009-07-02 | 2012-09-11 | The Royal Institution For The Advancement Of Learning/Mcgill University | Optically interrogated solid state biosensors incorporating porous materials—devices |
| BR112012006678A2 (en) | 2009-09-25 | 2016-05-10 | Origene Technologies Inc | method for creating a protein array, protein arrangement and methods for determining the specificity of antibody binding or antibody preparation, for determining disease biomarkers, for diagnosing a disease, for monitoring signal transduction pathways, and for determining interactions between small molecules and proteins |
| WO2011044317A2 (en) | 2009-10-07 | 2011-04-14 | Aidi Corporation | Athermal silicon photonics array waveguide grating (awg) employing different core geometries in the array waveguides |
| WO2011057224A2 (en) | 2009-11-06 | 2011-05-12 | University Of Washington Through Its Center For Commercialization | Zwitterionic polymer bioconjugates and related methods |
| WO2011057225A2 (en) | 2009-11-06 | 2011-05-12 | University Of Washington Through Its Center For Commercialization | Self-assembled particles from zwitterionic polymers and related methods |
| EP2496550B1 (en) | 2009-11-06 | 2015-08-05 | University Of Washington Through Its Center For Commercialization | Crosslinked zwitterionic hydrogels |
| KR101242138B1 (en) | 2009-11-27 | 2013-03-12 | 한국전자통신연구원 | Photonic Biosensor, Photonic Biosensor Array, and Method for Detecting Biomaterials Using Them |
| US8791405B2 (en) | 2009-12-03 | 2014-07-29 | Samsung Electronics Co., Ltd. | Optical waveguide and coupler apparatus and method of manufacturing the same |
| US20110158582A1 (en) | 2009-12-30 | 2011-06-30 | Tzung-I Su | Structure of a semiconductor device having a waveguide and method of forming the same |
| US20130157251A1 (en) | 2010-01-13 | 2013-06-20 | John Gerard Quinn | In situ-dilution method and system for measuring molecular and chemical interactions |
| US9772284B2 (en) | 2010-04-20 | 2017-09-26 | President And Fellows Of Harvard College | Biomedical and chemical sensing with nanobeam photonic crystal cavities using optical bistability |
| WO2011152747A1 (en) | 2010-06-01 | 2011-12-08 | H.L Human Laser Limited | Photoacoustic material analysis |
| US8493560B2 (en) | 2010-08-09 | 2013-07-23 | Polytechnic Institute Of New York University | Plasmonic enhancement of whispering gallery mode biosensors |
| CA3060724A1 (en) | 2010-11-05 | 2012-05-10 | Genalyte, Inc. | Optical analyte detection systems and methods of use |
| US20120225475A1 (en) | 2010-11-16 | 2012-09-06 | 1087 Systems, Inc. | Cytometry system with quantum cascade laser source, acoustic detector, and micro-fluidic cell handling system configured for inspection of individual cells |
| US8941062B2 (en) | 2010-11-16 | 2015-01-27 | 1087 Systems, Inc. | System for identifying and sorting living cells |
| US8908723B2 (en) | 2011-01-27 | 2014-12-09 | Gideon Yoffe | External cavity widely tunable laser using a silicon resonator and micromechanically adjustable coupling |
| US9829435B2 (en) | 2011-04-07 | 2017-11-28 | The Board Of Trustees Of The University Of Illinois | External cavity laser biosensor arrangements |
| WO2012149497A2 (en) | 2011-04-29 | 2012-11-01 | The Regents Of The University Of California | Vertical cavity surface emitting lasers with silicon-on-insulator high contrast grating |
| US9272126B2 (en) | 2011-04-29 | 2016-03-01 | The Board Of Trustees Of The University Of Illinois | Photonic biosensors incorporated into tubing, methods of manufacture and instruments for analyzing the biosensors |
| CA2872378C (en) * | 2011-07-20 | 2016-01-12 | University Of Washington Through Its Center For Commercialization | Photonic blood typing |
| SG10201502164TA (en) | 2011-09-21 | 2015-05-28 | Agency Science Tech & Res | Optical Circuit For Sensing A Biological Entity In A Fluid And Method Of Configuring The Same |
| US9692207B2 (en) | 2011-09-30 | 2017-06-27 | Aurrion, Inc. | Tunable laser with integrated wavelength reference |
| US20130109941A1 (en) | 2011-10-28 | 2013-05-02 | Nellcor Puritan Bennett Llc | Methods and systems for photoacoustic signal processing |
| US9186068B2 (en) | 2011-12-05 | 2015-11-17 | Covidien Lp | Methods and systems for photoacoustic monitoring using hypertonic and isotonic indicator dilutions |
| US10031138B2 (en) | 2012-01-20 | 2018-07-24 | University Of Washington Through Its Center For Commercialization | Hierarchical films having ultra low fouling and high recognition element loading properties |
| US9637538B2 (en) | 2012-04-27 | 2017-05-02 | Universite Paul Sabatier Toulouse Iii | Anti-HLA monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulin |
-
2013
- 2013-01-22 US US13/747,290 patent/US10031138B2/en active Active
-
2018
- 2018-07-23 US US16/042,883 patent/US20190154683A1/en not_active Abandoned
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020263516A1 (en) * | 2019-06-28 | 2020-12-30 | Rhodia Operations | Use of polyphenol compounds and hydrophilic polymers for reducing or preventing colloids adhesion and/or fouling on a substrate |
| CN114072469A (en) * | 2019-06-28 | 2022-02-18 | 罗地亚经营管理公司 | Use of polyphenol compounds and hydrophilic polymers for reducing or preventing colloidal adhesion and/or fouling on a substrate |
| US20220306891A1 (en) * | 2019-06-28 | 2022-09-29 | Rhodia Operations | Use of polyphenol compounds and hydrophilic polymers for reducing or preventing colloids adhesion and/or fouling on a substrate |
Also Published As
| Publication number | Publication date |
|---|---|
| US10031138B2 (en) | 2018-07-24 |
| US20130244249A1 (en) | 2013-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10031138B2 (en) | Hierarchical films having ultra low fouling and high recognition element loading properties | |
| US10060918B2 (en) | Dual-functional nonfouling surfaces comprising target binding partner covalently coupled to polymer attached to substrate | |
| US9255929B2 (en) | Zwitterionic polymers having biomimetic adhesive linkages | |
| Baggerman et al. | Romantic surfaces: a systematic overview of stable, biospecific, and antifouling zwitterionic surfaces | |
| van Andel et al. | Systematic comparison of zwitterionic and non-zwitterionic antifouling polymer brushes on a bead-based platform | |
| de los Santos Pereira et al. | Hierarchical antifouling brushes for biosensing applications | |
| Brown et al. | Synthesis of oligo (ethylene glycol) methacrylate polymer brushes | |
| Vaisocherová et al. | Functionalizable surface platform with reduced nonspecific protein adsorption from full blood plasma—Material selection and protein immobilization optimization | |
| Vaisocherová et al. | Functionalizable low-fouling coatings for label-free biosensing in complex biological media: advances and applications | |
| JP2010530955A5 (en) | ||
| Iwata et al. | Covalent immobilization of antibody fragments on well-defined polymer brushes via site-directed method | |
| US7205161B2 (en) | Polymer brushes for immobilizing molecules to a surface or substrate having improved stability | |
| US20200408785A1 (en) | Photonic pathogen detection | |
| Li et al. | Block copolymer modified surfaces for conjugation of biomacromolecules with control of quantity and activity | |
| Song et al. | Fabrication of a detection platform with boronic-acid-containing zwitterionic polymer brush | |
| Wiarachai et al. | Clickable and Antifouling Platform of Poly [(propargyl methacrylate)-ran-(2-methacryloyloxyethyl phosphorylcholine)] for Biosensing Applications | |
| Kidakova et al. | Preparation of a surface-grafted protein-selective polymer film by combined use of controlled/living radical photopolymerization and microcontact imprinting | |
| Ye et al. | Zwitterionic peptide enhances protein-resistant performance of hyaluronic acid-modified surfaces | |
| JP2009057549A (en) | Structure and manufacturing method thereof | |
| Ferrand-Drake del Castillo et al. | Quantitative analysis of thickness and pH actuation of weak polyelectrolyte brushes | |
| Rastogi et al. | Preventing nonspecific adsorption on polymer brush covered gold electrodes using a modified ATRP initiator | |
| Jin et al. | Enhancement of Localized Surface Plasmon Resonance polymer based biosensor chips using well-defined glycopolymers for lectin detection | |
| JP2009286968A (en) | Graft polymer-containing substrate, its production method and magnetic biosensor | |
| Kitano et al. | Polymer brush with pendent glucosylurea groups constructed on a glass substrate by RAFT polymerization | |
| Lu et al. | Improvement of surface hydrophilicity and biological sample-compatibility of molecularly imprinted polymer microspheres by facile surface modification with α-cyclodextrin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |